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INTRODUCTION
End-of-life care in the Netherlands
Until the ﬁ rst decades of the 20th century, the main responsibility of doctors was care.1 
During the 20th century this attitude steadily changed, simultaneously with an epidemi-
ological transition in Western societies that led to older populations and more patients 
with chronic diseases.2 Determinants of the changes in demographics were improve-
ments in public health (e.g. hygiene), cultural factors, socio-economical factors and new 
developments in medical care and technology.3 Important was the use of antibiotics that 
made it possible to cure formerly lethal infections,4 as were improvements in surgery, 
intensive care medicine and vaccination.3 During this period of economic prosperity and 
interwoven changes in medicine, demographics and society, the goal of medical care 
gradually altered from care towards cure.1 
By the 1950s, the main attitude in medicine was that cure was a possibility, and that 
medicine had failed when the doctor could not cure the patient.5 Unfortunately, this 
optimism proved not to be a reality for all patients, and many died without being cured. 
These patients were often given a lower priority, and some died without attention to 
their pain and suffering in physical and psychosocial respects.1 A response to these de-
velopments in the UK was the foundation of St. Christopher’s Hospice in London, 1967.6 
Instead of the message that ‘nothing could be done anymore’, the hospice focused on 
pain and symptom control, nursing and psychosocial and spiritual care.6 Other Western 
countries developed ways to deal with the needs of dying people as well.7,8 Central in 
these developments was that there was something that could be done for patients 
who were not expected to recover, and that the complex and diverse symptoms of 
these patients needed a ‘total care’ approach.1 
In the Netherlands, the development of end-of-life or so-called palliative care has been 
inﬂ uenced by the strong emphasis on primary care.9,10 Dutch general practitioners 
(GPs) have experienced care at home for dying patients as an important aspect of 
achieving their goal of ‘integral, continuous and personal care’ for dying patients.11 
From the time of the establishment of nursing homes in the 1960s, experience has 
been gained in the care of dying patients in this setting.12 The ﬁ rst specialist palliative 
care service was developed in 1975, for terminally-ill patients in the nursing home ‘Anto-
nius IJsselmonde’.9 In 1991, the ﬁ rst ‘high care’ hospice was founded: hospice Johannes in 
Vleuten.7 Although there have always been concerns about appropriate end-of-life care, 
the focus of government policy on end-of-life care increased considerably during the 
1990s.13 The actual formal approach of the Dutch government is that palliative care 
should be provided as much as possible by generalists.10,14,15 
To support initiatives concerning end-of-life care by generalists, the Minister of Health 
initiated a stimulation programme with the aim of providing palliative care preferably 
by doctors, nurses and care-workers in regular non-private settings.13 The stimulati-
on programme consisted of three speciﬁ c separate programmes: (1) encouragement 
of research initiatives under a programme of the Health Research and Development 
Council/Medical Sciences (ZonMw); (2) promotion and guidance of palliative care by six 
university centres; the Centres for the Development of Palliative Care (COPZs); and (3) 
stimulation of the integration of hospice facilities in regular health care by the Hospice 
Care Integration Project Group (PIH). An important aspect of this policy was to make 
possible the responsible, complex and demanding tasks of providing palliative care, by 
stimulating adequate education, support and research for professional care providers 
working in primary care. 
9Professionalisation of end-of-life care at home in the Netherlands
Within primary care, the GP is the central professional in the management and coordi-
nation of the patient’s treatment, and almost 100% of the inhabitants of the Nether-
lands have their own GP.16 GPs also provide care to the inhabitants of the homes for the 
elderly. Almost 60% of the patients with non-acute illnesses die at home,17 and there is 
a general consensus that end-of-life care preferably should be provided in the patient’s 
home, if possible.9 The ageing of the population and the growing number of non-acute 
deaths are expected to increase the GP’s contribution to meeting the rising needs of 
terminally-ill patients.18,19 These transitions in demographics, morbidity and mortality 
will require more effort from health care professionals, while the relative number of care 
givers decreases. GPs will work more frequently in primary care cooperatives and more 
GPs will work part-time.20 These developments will change the goals and structure of 
primary care in the Netherlands. For these reasons, in the COPZ stimulation programme 
special attention was given to supporting the role of GPs with palliative care education 
programmes, professional support and academic research. 
These initiatives to stimulate education involve both basic and postgraduate educa-
tion. To integrate palliative care as a structural element in the basic academic training 
for medical doctors, courses were developed that were transferable to other academic 
settings.21 The Dutch College of General Practitioners have set up and are running an 
intensive course on Palliative Care for General Practitioners.21,22 This course is desig-
ned to train GPs as specialists in palliative care, and as consultants for colleagues.23 
Another structural educational programme is the Palliative Care Peer Group Training: 
an education based on inter-GP consultation.24,25
To support and enhance the expertise of primary care professionals, local palliative care 
consultant teams were developed. These teams are frequently consulted by GPs, and 
according to the requesting care givers, these consultations contributed to improving 
the quality of palliative care.26 Since the discontinuation of the COPZs in 2002, consul-
tation services for, among others, primary care have been continued by the Compre-
hensive Cancer Centres (IKCs).27 This approach, in which the GP consults the palliative 
care consultation team, might help to enhance the general knowledge and experience 
of GPs in palliative care.26
End-of-life care research activities concerning general practice were initiated because 
few studies have been performed in order to describe and understand the role of the GP 
in palliative care. Pionering work was published in the thesis of Spreeuwenberg (1981) 
with his study of the role of the GP in caring for dying patients, using qualitative methods 
to explore how terminal care by the GP could inﬂ uence the patient’s quality of dying.28 
Other studies in general practice were performed by Schadé (1986) concerning cause of 
death and accompanying problems in treatment, care and guidance of end-of-life (can-
cer) patients29, and by Van der Wal (1992), concerning end-of-life decision making.30
Recently, three research projects in palliative care have resulted in a PhD thesis on GP ac-
tivities. In 1998, Schuit presented a thesis with studies that described several research 
and educational activities concerning palliative care for patients with cancer in general 
practice that had started in 1993.31 He concluded that an active and patient-oriented 
approach was needed. Second, in 2001, Van den Muijsenbergh found that GPs were able 
to perform palliative care by such an approach, and that there were no great differences 
between the patient’s expectations of palliative care and their needs according to the 
GPs.32 She found that due to continuous personal relationships and integrated treat-
ment of patient and family, the GP is able to perform palliative care. And third, in 2006, 
Osse successfully developed instruments with which the GP can assess the problems 
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and needs of cancer patients and their families in palliative care.33
Although these studies investigated important aspects of palliative care in general 
practice in the Netherlands, there are still signiﬁ cant gaps in knowledge. There are no 
studies that included non-cancer patients and we lack epidemiological data derived 
from large scale studies of representative populations. We also have no insight into 
the values of good care by patients and their GPs. To ﬁ ll some of these gaps, two pro-
jects were started in the context of the COPZ-research programme: one in Nijmegen by 
Groot, and the other in Amsterdam, with the present thesis as a ﬁ nal result.
Aim and research questions
This thesis aims to investigate issues of current practice in end-of-life care in general 
practice in the Netherlands. The main aim is to study epidemiological issues of end-of-life 
care in general practice: we will investigate the needs of end-of-life patients, indicators 
for the quality of end-of-life care by the GP, and the organisation of end-of-life care at 
home. We also aim to explore the opinions of two important groups involved: the patients 
and their GPs. 
A problem we encountered when we had to deﬁ ne inclusion criteria for the design of 
our study was that there is no generally accepted research deﬁ nition of palliative care. 
This led us to our ﬁ rst research question:
•  1. What are the consequences of using different inclusion criteria on the selected 
palliative care populations in terms of size, number of doctor-patient contacts and 
demographic characteristics?
For the patient’s needs we will focus on the prevalence of pain and symptoms in general 
practice. As indicator for the quality of palliative care, we will investigate the manage-
ment of one of the most prevalent symptoms, pain, and compare the GPs’ prescribing 
with current standards and guidelines. For the organization of care, we study coopera-
tion between GPs and other care providers in palliative care. The accompanying research 
questions are:
•  2. What is the prevalence of pain and other symptoms in patients receiving palliative 
care at home?
•  3. What pain medication is prescribed to patients receiving palliative care at home?
•  4. What is the extent and the level of GP cooperation with other caregivers in palliative 
care at home?
We explore the opinions of the patients receiving end-of-life care and their GPs concer-
ning two issues. First, we analyse their experiences with end-of-life care investigating 
what they consider as ‘good care’ by answering the next research question:
•  5. What are the aspects valued in end-of-life care at home by patients and their general 
practitioners?
As in the Dutch context euthanasia is one of the end-of-life options, our second explo-
ration concerns communication about this topic. The ﬁ nal research question we will 
address is: 
•  6. Do patients talk about euthanasia with their GP and if so, how do they communicate 
about this subject?
11
METHODS 
Deﬁ nitions and terms
So far in this introduction, we have alternately used the terms palliative care and end-of-
life care. The most commonly used term is palliative care*, deﬁ ned by the World Health 
Organization as: ‘an approach that improves the quality of life of patients and their fami-
lies facing the problems associated with life-threatening illness, through the prevention 
and relief of suffering by means of early identiﬁ cation and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual’.34 However, 
for multiple reasons this deﬁ nition is problematic, as we will explain in Chapter 2. The 
broadest approach denotes ‘end-of-life’ as the part of life when a person is impaired with 
an eventually fatal condition, even if the prognosis is ambiguous, e.g. patients with heart 
failure or chronic obstructive pulmonary disease (COPD).35 We will refer to this meaning 
of ‘end-of-life’ when we talk about the care by the GP for patients who are provided with 
‘palliative care’ or ‘end-of-life care’. In this thesis, both terms have the same meaning, 
unless we directly refer to a particular deﬁ nition. 
Furthermore, we used the same terminology in this thesis as we used in our published 
and submitted articles. This implies that in the different chapters we use different words 
to indicate our setting: general practice for publications submitted to European journals 
and family practice for American journals. These terms both have the same meaning.
 
Data collection
For this thesis, data from two different studies were used. Quantitative data were col-
lected within the framework of the Second Dutch National Survey of General Practice, 
and qualitative data were obtained by interviews with 30 patients and their GPs. This 
paragraph describes the main characteristics of these studies. In the various chapters 
the methods will be described in more detail.
The second Dutch National Survey of General Practice
In the second Dutch National Survey of General Practice (DNSGP-2) a representative 
sample of 104 Dutch family practices participated.36 Data from eight practices were ex-
cluded: three practices delivered incomplete data; ﬁ ve practices were excluded because 
the data did not meet the minimum quality criteria. The study population of the remai-
ning 96 practices was 375,899 patients. In these practices 2,194 patients died during the 
survey year (0.6%). The one-year period of each practice ended between April 2001 and 
January 2002. Computerised data for demographic characteristics, GP-patient contacts 
and prescribing were obtained.
At the end of the survey period, the GPs received a post-mortem questionnaire designed 
for this study for each patient who died during the survey year. In this questionnaire, the 
GPs reported the patient’s underlying disease, answered questions on end-of-life care 
issues, and labelled each patient according to possible criteria for end-of-life care. 
Patient and GP interviews
A total of 17 GPs who were following an advanced postgraduate training in end-of-life 
care, organized by the Dutch College of General Practitioners22,37 and 14 of their colleagues 
 *  PubMed Search 06-07-2006. Number of publications selected by “palliative care”: free text=27,637, title words=3,515. 
Number of publications selected by “terminal care”: free text=14,718, title words=691. Number of publications selected 
by “end-of-life care”: free text=1,679, title words=686 (www.pubmed.gov).
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without speciﬁ c interest in end-of-life care, agreed to participate in qualitative interviews. 
Of the 31 participating GPs, 20 GPs included 30 patients who were receiving end-of-life 
care in their practices according to the following inclusion criteria: (1) a life expectancy of 
less than six months; (2) cancer, heart failure or chronic obstructive pulmonary disease as 
underlying disease; (3) the GP was (one of) the primary caregiver(s), and (4) the patient 
had adequate command of the Dutch language. Semi-structured, in-depth interviews 
were carried out in the patients’ home. Approximately two weeks after the patient inter-
view the GP was interviewed according to a similar topic list. 
Outline of the thesis
Following this introduction, the chapters 2-7 of this thesis are based on articles, which 
have been published, accepted or submitted for publication. This implies that the various 
chapters overlap, especially with regard to the methods sections. 
Chapter 2 describes the consequences of different deﬁ nitions that may be used to in-
clude patients in palliative care populations: how do the populations differ from each 
other as the result of different inclusion criteria with regard to size, underlying disease, 
age distribution and gender?
Chapter 3 presents the symptoms that are prevalent in patients receiving palliative 
care in general practice in the Netherlands, and analyses differences between younger 
and older patients, males and females and cancer versus non-cancer patients. 
In Chapter 4 we analyse the pharmacological management of pain: one of the most 
frequent and disturbing symptoms in palliative care. We investigate the prescribing 
of different drugs, the longitudinal development, and some aspects of the quality of 
prescribing.  
Chapter 5 shows with whom Dutch GPs cooperate in the care of patients receiving end-of-
life care at home. Potential predictors for cooperation between GPs and other caregivers 
will be analysed.
Chapter 6 explores the aspects valued in end-of-life care at home by patients and their 
GPs, and reﬂ ects upon these results in the context of future developments in European 
primary care. 
In Chapter 7 we explore whether patients and their GPs talk about euthanasia and, if so, 
how they communicate about this subject, and discuss the meaning of communication 
about euthanasia in the context of end-of-life care.
Finally, in Chapter 8 we summarize the major ﬁ ndings and reﬂ ect on the methodological 
aspects of the studies. Also, we discuss the implications for the further development of 
end-of-life policy, practice, and research.
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ABSTRACT
There is a lack of clear deﬁ nition and clear inclusion criteria in palliative care research. 
The aim of this study was to describe consequences of three inclusion criteria in the 
build up of different study populations, studied in terms of size, number of doctor-pa-
tient contacts and demographic characteristics. General practitioners received a ques-
tionnaire for all patients who died during the second Dutch National Survey of General 
Practice (n=2,194), to determine whether (1) patients received non-curative treatment; 
(2) patients received palliative care; and (3) death was expected (total response rate 
= 73%). The criterion ‘death was expected’ included most patients (62%) followed by 
‘palliative care’ (46%) and ‘non-curative treatment’ (39%). Similarity between the de-
ﬁ nition-based populations was fair to moderate. More ‘palliative care’ and ‘death was 
expected’ patients had cancer than ‘non-curative treatment’ patients. The conclusions 
show substantial differences in populations according to the different inclusion criteria 
used to select them. Future research in palliative care should acknowledge the limitations 
of using certain inclusion criteria and explore potential bias.
INTRODUCTION
In 1990, the World Health Organization (WHO) deﬁ ned palliative care as ‘the active total 
care of people whose disease is not responsive to curative treatment. Control of pain, 
of other symptoms and of psychological, social, emotional and spiritual problems is 
paramount. The goal of palliative care is achievement of the best possible quality of life 
for patients and their families. Many aspects of palliative care are also applicable earlier 
in the course of the illness in conjunction with anticancer treatment’.1 Nowadays, it is 
recognized that the principles of palliative care should be applied as early as possible 
in the course of any chronic disease. Hence, the WHO adapted the deﬁ nition in 2002 to: 
‘an approach that improves the quality of life of patients and their families facing the 
problem associated with life-threatening illness, through the prevention and relief of 
suffering by means of early identiﬁ cation and impeccable assessment and treatment 
of pain and other problems, physical, psychosocial and spiritual’.2 According to both 
WHO deﬁ nitions palliative care ‘intends neither to hasten nor postpone death’.1,2 
Both deﬁ nitions deﬁ ne the intentions or goals of palliative care, but are rather vague in 
describing the eligible population. While the goals are focusing on the symptoms and 
problems of the patients, the population in the WHO deﬁ nitions is deﬁ ned by the illness 
of the patient, ie, diseases not responsive to curative treatment (1990), or illnesses 
that are life-threatening (2002). As a consequence, palliative care populations have 
been deﬁ ned by health policy makers or by researchers in many different ways.3,4A ma-
jor problem in the further development of palliative care is the lack of an accepted way 
of deﬁ ning research populations.4-6 However, clear population criteria are essential to 
make possible the comparison of results across studies and countries.5,6 In the study 
of a general population, the effects of the chosen inclusion criteria on the outcome 
and characteristics of the population are, as yet, unknown. Therefore, it is useful to 
know the effects of using different inclusion criteria on the build up of the selected 
populations. 
The aim of this study was to discover and describe the consequences of using different 
inclusion criteria on the selected populations. We used three criteria. The ﬁ rst, treat-
ment ‘not directed at cure nor at life-prolongation’, is taken directly from the 1990 
19
WHO palliative care deﬁ nition.1 The second criterion, the treating physician labels the 
patient as ‘were provided with palliative care’, has been chosen because it is the most 
commonly used concept. Furthermore, this subjective label allows all kinds of factors 
which are related to palliative care in the perception of the labeler to be taken into 
account. Finally, the third criterion, the death of the patient was not ‘suddenly and 
unexpectedly’, was chosen to include patients who were at risk of receiving palliative 
care because their death did not occur unexpectedly. This criterion has been used in 
different Dutch and European end-of-life studies.7,8
The research question addressed in this study is: what are the similarities and differences 
in terms of size, number of doctor-patient contacts and demographic characteristics 
between the populations selected by the different criteria? 
METHODS
Data collection
The data used in this study were obtained from the second Dutch National Survey of General 
Practice (DNSGP-2), in which a representative sample of 96 Dutch general practices participa-
ted with a total of 375,899 patients. The start of the one-year registration period in the study 
practices varied between April 2000 and January 2001.9 In the participating general practices, 
approximately 1.6 million contacts with patients were digitally recorded, and in these ﬁ les 
the morbidity and diagnoses were registered according to the International Classiﬁ cation of 
Primary Care (ICPC-1).10 Data on the demographic and clinical characteristics of all patients 
were collected. The study was carried out according to Dutch legislation on privacy. The pri-
vacy regulation of the study was approved by the Dutch Data Protection Authority.9
Criteria for palliative care
In an additional questionnaire designed for this study, the patients who died during the 
period of registration were categorized according to the general practitioners’ answers 
to three questions: (1) did this patient receive treatment directed at cure or life-prolon-
gation? (2) did you or your co-operative provide palliative care? and (3) was the patient’s 
death sudden and unexpected? We tried to make this text easier to read by translating 
these three questions into criteria, so that a ‘yes’ for a criterion meant that the patient 
received palliative care according to that criterion. We translated the questions as fol-
lows: if the general practitioner’s answer to the ﬁ rst question was ‘no, the treatment 
was not directed at cure nor at life-prolongation’, we categorized the patient as positive 
on criterion 1: ‘non-curative treatment’. A positive answer to question two, ‘yes’, implied 
inclusion on criterion 2: ‘palliative care’. If the answer to question 3 was ‘no’, the patient 
was categorized positively on criterion 3: ‘death was expected’. Figure 1 illustrates this 
categorization and shows the eight possible combinations, where combination 8 repre-
sents patients who were categorized as negative on all three criteria.
As all patients died during the year of registration, we had varying prior-to-death data. 
To analyse contact information, we deﬁ ned a population of patients who died at least 
three months after the start of the study. In this population we analysed the contact 
registration with regard to the number of doctor-patient contacts over a ﬁ xed period 
of three months before death.
Analysis
To determine differences in the size of outcome populations, we used frequency tables. 
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To answer the question about similarity, we compared the frequencies of the variables 
gender, age and underlying diseases within the three criteria, using frequency tables 
and kappas (к) to express similarity: a value < 0.2 = poor similarity, between 0.21 and 
0.40 = fair, 0.41 and 0.60 = moderate, 0.61 and 0.80 = good, and a value > 0.80 = very 
good similarity.11 This comparison was carried out for the variable gender and underly-
ing disease, using data from the complete sample. Data from fewer patients were avai-
lable for comparing the number of doctor-patient contacts in the last three months of 
life, since some patients were excluded because they died within the ﬁ rst three months 
of the study. To answer the question on differences between populations of patients 
who met the inclusion criteria, a pair-wise comparison was made of the differences 
between the categories which excluded each other. 
We used a χ-square test to determine whether of the differences were statistically sig-
niﬁ cant, with an alpha-level of 5%. The same variables as for similarity were included 
in this analysis.
RESULTS
Population size
In the 96 general practices 2,194 of the 375,899 patients died during the year of regi-
stration (0.6%). Of the 2,194 questionnaires sent to the general practitioners, 1,771 
were returned (81%), and 1,608 were ﬁ lled in completely (73% valid response rate). 
Most patients (69%) were categorized as positive on at least one palliative care crite-
rion, and 26% on all three (Table 1). For 62% of all included patients death was expected, 
46% received palliative care and 39% received non-curative treatment. In 31% of cases 
the patients did not ﬁ t any of the criteria. 
Characteristics and similarities of included populations
There were no differences in the mean age and the gender proportions between the 
three criteria-based populations (Table 2). The similarity between the ‘non-curative 
treatment’ population versus both those deﬁ ned as receiving ‘palliative care’ (к=0.36) 
and ‘death was expected’ (к=0.39) was fair; and between receiving ‘palliative care’ and 
‘death was expected’ the similarity was moderate (к=0.57). 
In the ‘non-curative treatment’ population there were relatively fewer cancer patients 
and more patients with other diseases than in the other populations, and in the ‘pallia-
tive care’ population there were relatively more cancer patients than in the ‘death was 
expected’ population. For cancer as underlying disease similarity was poor between the 
‘non-curative treatment’ population and the ‘palliative care’ and ‘death was expected’ 
populations, and fair between the ‘palliative care’ and ‘death was expected’ populations. 
Between all populations, similarity for heart failure as underlying disease was moderate, 
and for COPD it was poor to fair. The overall similarity between the three populations 
was fair to moderate. 
A higher proportion of patients receiving ‘palliative care’ had at least one doctor-patient 
contact in the last three months of life (95%) compared to those receiving ‘non-curative 
treatment’ and those whose ‘death was expected’ (90%). The mean number of doctor-
patient contacts was 12.4 for the ‘palliative care’ population, 11.2 for the ‘non-curative 
treatment’ population and 10.9 for the ‘death was expected’ population. 
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Characteristics and differences in populations excluded by the criteria
In Table 3 we focus pair-wise on the differences between populations excluded by each 
other. A total of 940 patients were deﬁ ned by either ‘non-curative treatment’ or ‘pal-
liative care’, and there was an overlap of 431 patients (combinations 1 and 5). Exclu-
ded by palliative care and only included by ‘non-curative treatment’ were 197 patients 
(combinations 3 and 7), compared to 312 patients included only by ‘palliative care’ 
(combinations 2 and 6). Between these two sub-populations, there was no difference 
in gender distribution, but patients exclusively categorized as ‘non-curative treatment’ 
were signiﬁ cantly older than patients exclusively categorized as ‘palliative care’. The 
‘palliative care’ population had a higher proportion of cancer patients and a lower pro-
portion of patients with other diseases than the ‘non-curative treatment’ population. 
A higher proportion of patients exclusively categorized as ‘palliative care’ had at least 
one doctor-patient contact during the last three months of life, and the mean number 
of doctor-patient contacts in the last three months of life was higher, compared to the 
population exclusively categorized as ‘non-curative treatment’.
Within the combination of ‘non-curative treatment’ and ‘death was expected’, there 
were 78 exclusive ‘non-curative treatment’ patients and 441 exclusive ‘death was ex-
pected’ patients. Between these two populations, there were no signiﬁ cant demographic 
differences, but the ‘death was expected’ population had a higher proportion of can-
cer patients and a lower proportion of patients with other diseases. No differences were 
found in the proportion of patients with at least one doctor-patient contact, but the 
mean number of doctor-patient contacts for ‘death was expected’ patients was higher 
than for ‘non-curative treatment’ patients. 
Within the combination of ‘palliative care’ and/or ‘death was expected’, there were 64 
exclusive ‘palliative care’ patients and 312 exclusive ‘death was expected’ patients. 
Between these two sub-populations there was no difference with regard to gender, 
age and underlying disease. Compared to the ‘death was expected’ patients, more ‘pal-
liative care’ patients had at least one doctor-patient contact, and the mean number of 
doctor-patient contacts for these patients was higher. 
DISCUSSION
In this study, we applied three different criteria for palliative care to the same palliative 
care research population, namely (1) non-curative treatment, (2) palliative care or (3) 
death was expected. This made it possible to compare similarities and differences bet-
ween the selected sub-populations. The criterion ‘death was expected’ included most 
patients (62%) followed by ‘palliative care’ (46%) and ‘non-curative treatment’(39%). 
Similarity between the three deﬁ nition-based populations was fair to moderate. More 
‘palliative care’ and ‘death was expected’ patients had cancer than ‘non-curative treat-
ment’ patients, and the ‘palliative care’ population had more doctor-patient contacts. 
This study was embedded in the second Dutch National Survey of General Practice 
(DNSGP-2), a nationwide study of doctor-patient contacts in a representative sample 
of general practices in the Netherlands.9 With mean non-response rates of 39% repor-
ted in published studies carried out in general practice, and a trend of decreasing rates 
of response to mail questionnaires, the total response rate of 73% for the additional 
questionnaire was high.12 However, this study has some limitations. The DNSGP-2 was 
not designed speciﬁ cally for palliative care research, so there was no data available on 
several items that are relevant for palliative care. For example, there is no data available 
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on some important and relevant issues that might have inﬂ uenced the need for pallia-
tive care and the number of doctor-patient contacts, e.g. whether or not the patients 
had a reliable support system.13 
The ﬁ ndings of this study have implications for the understanding of the composition 
of populations included in palliative care research. First, the overall distribution shows 
that there is little similarity between patient groups deﬁ ned as ‘end-of-life’ patients. 
It also illustrates the extreme difﬁ culty of deﬁ ning groups in palliative care research. 
One explanation for this might be that the three pragmatically chosen criteria measure 
related, but somewhat different concepts. ‘Non-curative treatment’ might measure 
the intention of palliative treatment, and the second criterion ‘palliative care’ might 
measure whether the general practitioner considers the care to be palliative. This may 
be linked to the severity of the problems and the frequency of doctor-patient contacts. 
The third criterion ‘death was expected’ might measure the likelihood that the patient 
would die soon. Hence, these three concepts are not fully interchangeable, and do not 
generate populations with a full overlap. Apparently, patients receiving palliative care 
can, at the same time, be receiving non-curative treatment, and their death is not al-
ways expected. 
Furthermore, the labeling of patients may possibly inﬂ uence patient care itself. In a 
study focusing on patients with colon and lung cancer, patients whose general practi-
tioner considered the care to be palliative, died earlier than those who whose general 
practitioner did not.14 This might indicate that the label ‘palliative care’ is associated 
with a more serious illness. Our study shows that the ‘palliative care’ population inclu-
ded patients who had more doctor-patient contacts than patients included by the other 
criteria, and that most of these patients had cancer. This supports the argument that 
palliative care is related to intensiﬁ ed care. However, the question is: do these patients 
receive the label ‘palliative care’ because they have cancer, or because they need and 
receive intensiﬁ ed care? If it is the ﬁ rst reason, patients with a chronic illness who are 
labeled as ‘death was expected’, but not as ‘palliative care’ patients, might possibly be 
excluded from receiving the more intensiﬁ ed care that they might need.
Given the major research consequences of applying different inclusion criteria, we still 
face the problem of choosing the best criterion for palliative care research. This study 
shows that there are substantial differences between populations when certain crite-
ria are chosen. Future research should focus on further investigation of the diversity 
in characteristics of palliative care populations. This is only possible if future studies 
describe in more detail the way in which their population is included. 
If we want to describe differences between sub-populations without omitting any po-
tential palliative care patients, we must apply the broadest possible inclusion criteria. 
Hence, we recommend the use of a combination of different inclusion criteria, which 
should include at least ‘palliative care’ as labeled by (professional) carers, the intention 
of the palliative care treatment provided, and an assessment of the patient’s life-expec-
tancy, not meant to predict because this is rather difﬁ cult,15 but as an indicator of the 
possibility of a palliative care trajectory. 
To improve our current knowledge about palliative care, it would be preferable if we 
could ﬁ nd an internationally accepted combination of criteria to make it possible to 
compare palliative care in different settings, countries and sub-populations. This can be 
the starting point for the development of an internationally accepted research deﬁ niti-
on, something that is essential for the further development of palliative care research.
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ABSTRACT
Most people with an incurable disease prefer to stay and die at home, cared for by 
their family physician. This study aims at describing the prevalence and frequency 
of symptoms in patients receiving palliative care at home. Within the framework of a 
nation wide survey of family practice in the Netherlands, family physicians identiﬁ ed 
those patients who received palliative care out of all patients who died within the one-
year survey period (valid response rate 73%). Patients with an observation period of 
at least three months, and who received palliative care by their family physician until 
death were included (n=429). Information regarding encounters during the last three 
months of life was derived from the electronic medical records kept by the family physi-
cians. A symptom was prevalent when it was registered by the family physician in a 
patient-physician encounter. Digestive symptoms (59%) and pain (56%) were the most 
prevalent. The mean number of symptoms was higher in cancer patients (11.99) than in 
non-cancer patients (7.62). The number of digestive symptoms, pain and psychological 
symptoms was higher in the lower than in the higher age groups, and higher in can-
cer than in non-cancer patients. Most symptoms (36%) were concentrated in the last 
two weeks of life. Not reported in previous palliative care studies were musculoskeletal 
symptoms (20%), chronic ulcer (18%) and discussion about euthanasia (14%). Future 
studies should explore the severity and inﬂ uence on quality of life of these lesser known 
symptoms in palliative care.
INTRODUCTION
Most people with an incurable disease prefer to remain at home surrounded by relatives 
during the last stage of their life.1-3 In the Netherlands, health care is characterised by 
its strong emphasis on primary care, where the family physician is the central profes-
sional in the management and coordination of the patient’s care.4 Almost 60% of the 
patients with non-acute illnesses die at home,5 and there is a general consensus that 
palliative care preferably should be provided in the patient’s home.6 The aging of the 
population and the growing number of non-acute deaths will increase the need for pal-
liative care.7,8 This will also impact on the family physician’s workload. 
Symptom management is an important aspect of palliative care, as the World Health Or-
ganization (WHO) deﬁ nes palliative care as: ‘an approach that improves the quality of 
life of patients and their families facing the problems associated with life-threatening 
illness, through the prevention and relief of suffering by means of early identiﬁ cation and 
impeccable assessment and treatment of pain and other problems, physical, psychoso-
cial and spiritual’.9 Common symptoms in palliative care are pain, dyspnoea, constipa-
tion, confusion, nausea and vomiting.10,11 Most studies on symptoms were performed in 
a speciﬁ c setting, such as a palliative care unit in a hospital or a hospice. Findings from 
these specialised settings are not always transposable to the community as symptom 
prevalence differs between settings.12 To our knowledge, there is no study in primary 
care that measures symptoms in a general population receiving palliative care. 
Several patient characteristics are associated with symptom prevalence. The underly-
ing disease seems to inﬂ uence prevalence of symptoms e.g. in patients with heart fai-
lure who died in a hospice the symptom proﬁ le was different from cancer patients.13 In 
cancer patients, symptom prevalence was found to differ with severity of the disease, 
gender and age.14 However, primary care studies have not yet reported on both cancer 
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and non-cancer patients within the same study. 
Family physicians face symptoms in palliative care patients during patient-physician 
encounters. Detailed information on the prevalence and frequency of symptoms in 
primary care is scarce and fragmented. However, this information is needed to orga-
nise future palliative care, to focus education on the most frequent symptoms and to 
initiate collaboration between relevant disciplines. This study aims to ﬁ ll this gap by 
describing the prevalence and frequency of symptoms in patients receiving palliative 
care at home and to analyse differences by gender, age and underlying disease; i.e. in 
cancer and non-cancer patients. Furthermore, we aim to longitudinally investigate the 
prevalences of symptoms in six two-week periods until death.
 
METHODS
Patients
The data used in this study were obtained from the second Dutch National Survey of 
General Practice (DNSGP-2), in which a representative sample of 104 Dutch family prac-
tices participated, with a total of 399,068 patients involved.15 Data from eight practices 
were excluded; three practices delivered incomplete data; ﬁ ve practices were excluded 
because the data did not meet the minimum quality criteria. The listed population of 
the remaining 96 practices was 375,899 patients. In these practices 2,194 patients died 
during the survey year (0.6%). The one-year period of each practice ended between 
April 2001 and January 2002. 
At the end of the survey period, the family physicians received a post-mortem ques-
tionnaire designed for this study for each patient who died during the survey year. 
They reported the patient’s underlying disease, and labeled each patient who received 
palliative care patient by indicating whether the patient was or was not ‘provided with 
palliative care until death’. Of the questionnaires sent to family physicians, 1,771 were 
returned (81%), and 1,608 were ﬁ lled in completely (73% valid response rate). 
As deaths occured throughout the survey year, we had a varying follow-up: some pa-
tients died in the ﬁ rst days of the survey, others died later in the study. To ensure we 
had an observation period of at least three months for each patient, we deﬁ ned our 
source population as those who died at least three months after the start of the survey 
year (n=1,115). We deﬁ ned our study population as patients with an observation period 
of at least three months, and who were labeled as palliative care patients by their family 
physician (n=429; 38%). 
Measurements
•  Symptoms: the family physicians deﬁ ned the patient’s health problem according to the 
ICPC.16 This could be either a symptom or a disease diagnosis. In addition, the digital 
free text information about the contact registered by the family physicians was avai-
lable. To retrieve as much information as possible, all free text information was read 
and scored using a restrictive list of symptoms, combining information from previous 
studies.12,14,17-21 A symptom was present when it was registered by the family physician 
either as ICPC code, or as free text. The scoring of free text was subject to inter-rater 
reliability testing. Cohen’s kappas were calculated and the inter-rater reliability was 
good (к=0.79).22
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Symptoms were classiﬁ ed in main categories according to the ICPC chapters based on 
body systems, in combination with general symptoms, pain and fatigue. Symptoms in 
body systems with a prevalence larger than 20% were named according to the speciﬁ c 
ICPC-chapter, all other were lumped in the category ‘other’. Within this classiﬁ cation 
we made sub categories of symptoms with a prevalence larger than 5%, all other were 
categorised as ‘other symptoms’ under the relevant body system. 
•  Frequency: data based on routine care delivery during the one-year study period 
were extracted from the electronic patient records. For all patients, encounters 
were analysed during the three months before the patient’s death. The frequency of 
symptoms was expressed as the number of days on which the speciﬁ c symptom was 
registered during a patient-physician encounter. Means for number of symptoms 
were calculated for the total population, and for the patients who had at least one 
encounter concerning the speciﬁ c symptom.
•  Prevalence: the prevalence of a symptom was deﬁ ned as the number of patients with 
at least one encounter about a speciﬁ c symptom during the last three months of life 
(numerator) divided by the total number of patients (denominator). 
Furthermore, patient characteristics were extracted from the patient registration data 
of the practice administration. In the post-mortem questionnaire, we asked about exi-
sting underlying diseases using a limitative list. 
 
Statistical analysis
Characteristics of the palliative care population were analysed. Descriptive statistics 
were used for prevalence of symptoms in palliative care patients and the mean number 
of symptoms per patient. Differences in prevalence of symptoms between sub-popula-
tions were calculated for the characteristics sex, age and underlying disease, i.e. cancer 
versus non-cancer patients, and tested using χ-square test (α= 0.05). The mean number 
of symptoms was compared between sexes and between cancer and non-cancer patients 
with Student's t-tests. For the longitudinal analysis during the last 12 weeks of life, we cal-
culated the prevalence of symptoms in six two-week periods before the patient’s death. 
RESULTS
Prevalence and frequency of symptoms 
In total, 429 patients with an observation period of at least three months received pal-
liative care by their family physician until death. Characteristics of the study population 
are presented in Table 1. In patient-physician encounters during the last three months of 
life, the mean number of symptoms registered by the family physician was 10.0 (Table 
2). Digestive symptoms were prevalent in 255 (59%) of the patients. The total number 
of digestive symptoms was 887, resulting in a mean number of 2.07 per patient in the 
last three months of life. Within the digestive symptoms, most patients had problems 
with eating or drinking (29%), and nausea or vomiting (25%). The prevalence of pain in 
palliative care patients was 56%. Within psychological symptoms, restlessness (25%), 
sleeping problems (17%) and anxiety (13%) were the most prevalent symptoms. Within 
the category other, musculoskeletal symptoms (20%), chronic ulcer (18%) and requests 
for/talking about euthanasia (14%) were most common. There was a mean number of 
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Table 1.
Characteristics of the study population of patients who received palliative care until death 
in family practice in the Netherlands, with an observation period of at least three months 
(n=429).
    % (n=429)
 Sex
  Male 47
  Female 53
 Age (years)
  < 70  28
  70-79 24
  80-89 31
  ≥ 90 16
  Mean (SD) 76.8 (13.9)
 Underlying disease* 
  Cancer  56
  Non-cancer 44
   Heart failure  11
   COPD 3.1
   Other disease 25
   Multiple non-cancer diseases 4.5
* Number of missing values for underlying disease was 3.
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Table 2.
Prevalence and frequency of symptoms in patients receiving palliative care during the last 
three months of life (n=429).
      Mean number of
     Number of symptoms 
 Symptom Prevalence % (n) of symptoms (all patients)
 Digestive  59 (255) 887 2.07
  Problems with eating or drinking 29 (124) 208 0.48
  Nausea or vomiting 25 (107) 253 0.59
  Constipation  19 (81) 113 0.26
  Diarrea 9.3 (40) 70 0.16
  Anorexia 8.6 (37) 59 0.14
  Mouth problems 6.5 (28) 29 0.07
  Other digestive symptoms 20 (87) 155 0.36
 Pain 56 (240) 801 1.87
 Psychological 45 (194) 517 1.21
  Restlessness /confusion 25 (107) 214 0.50
  Sleeping problems 17 (74) 113 0.26
  Anxiety 13 (55) 75 0.17
  Depression 8.6 (37) 49 0.11
  Other psychological symptoms 11 (47) 66 0.15
 Respiratory  44 (189) 587 1.37
  Dyspnoea 27 (115) 287 0.67
  Coughing or slime 20 (84) 146 0.34
  Infection 16 (67) 109 0.25
  Other respiratory symptoms 7.5 (32) 45 0.10
 Fatigue 36 (153) 327 0.76
 Urogenital  31 (131) 235 0.55
 Circulatory  24 (104) 180 0.42
  Oedema 16 (69) 95 0.22
  Anaemia 8.9 (38) 71 0.17
  Other circulatory symptoms 2.1 (9) 14 0.03
 Other  63 (272) 775 1.81
  Musculoskeletal symptoms 20 (85) 167 0.39
  Chronic ulcer 18 (77) 162 0.38
  Request for/talking about euthanasia 14 (58) 123 0.29
  Feeling ill 5.8 (25) 53 0.12
  Itching 5.8 (25) 33 0.08
  Dizziness 5.6(24) 30 0.07
  Other  30 (129) 207 0.48
 Total 98 (419) 4309 10.0
35
10.0 symptoms in the last three months of life, and the corresponding range was wide 
(0-68, median=8).
Symptoms by sex, age and underlying disease
There was no difference in the prevalence of symptoms between males and females re-
ceiving palliative care at home. The mean number of respiratory symptoms and fatigue 
was higher in males than in females, while the mean number of other symptoms was 
higher in females (p<0.05, data not shown).
There was a lower prevalence of digestive symptoms, pain and psychological symptoms 
by patients in older age groups (Table 3). The prevalence of urogenital symptoms was 
higher in older age groups. The mean number of symptoms was signiﬁ cantly higher in 
patients younger than 70 years (11.25) than in patients older than 90 years (9.0). 
Cancer patients had more pain, digestive symptoms, psychological symptoms and 
fatigue than non-cancer patients (Table 4). Compared to cancer patients, non-cancer 
patients had more urogenital symptoms. The mean number of all symptoms was 12.99 
for cancer patients and 7.62 for non-cancer patients. 
Table 5 shows symptom prevalences for cancer and non-cancer patients by age-group. 
In cancer patients, the prevalence of psychological symptoms was lower in older age-
groups. This trend was not signiﬁ cant for pain. In cancer patients, prevalence of fatigue 
and urogenital symptoms was higher in older age-groups. In non-cancer patients the 
prevalence of fatigue and other symptoms was higher in older age-groups. 
Symptoms during the last 12 weeks of life
Figure 1 shows the prevalence of symptoms in different body systems in the last 
three months of life. With the exception of circulatory and urogenital symptoms, all 
symptoms showed a small increase in prevalence in the period 2-3 weeks before death 
and a substantial increase in prevalence in the last two weeks before death. In total, 
36% of all symptoms within the three month period occurred in the last two weeks of 
life and 61% of all patients had at least one symptom during these last two weeks. 
DISCUSSION
In the patients who died at home and who received care until death by their family 
physician, digestive symptoms (59%), pain (56%) and psychosocial symptoms (45%) 
were most prevalent. Also, musculoskeletal symptoms (20%), chronic ulcer (18%) 
and request for/talking about euthanasia (14%) were prevalent in patient-physici-
an encounters. The mean number of encounters about any symptom was higher in 
cancer patients (11.99) than in non-cancer patients (7.62). Also, in younger patients 
and in cancer patients the prevalence of digestive symptoms, pain and psychological 
symptoms was higher than in the elderly. Most symptoms (36%) were concentrated in 
the last two weeks of life. 
This study was embedded in the second Dutch National Survey of General Practice, 
which has generated solid data due to its quality and size. The total response rate of 
73% for the additional questionnaire was high compared to mean response rates of 
61% reported in studies carried out in general practice, and a trend of decreasing rates 
of response to mail questionnaires.23 As most studies in palliative care are limited to 
cancer patients24, a further strength is that this study is population based, and that we 
included both cancer and non-cancer patients. 
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Figure 1.
Prevalence of symptoms in patients receiving palliative care in six two-week periods before death.
 
The limitations of this study are that no information was obtained about the seve-
rity of symptoms, and we were unable to measure whether the management of the 
symptoms resulted in improvement of symptom control. Besides, we measured 
symptoms that were prevalent in encounters according to physicians. In primary care, 
agreement between patients and family physicians assessment on the prevalence of 
physical symptoms is acceptable,17 but it is likely that family physicians did not regis-
ter all symptoms affecting these patients. Hence, it is likely that patients had other 
symptoms that did not result in a registration or in a patient-physician encounter, and 
that the numbers of symptom related encounters we found are underestimations of 
total symptom prevalence in patients receiving palliative care at home. Nevertheless 
we may presume that the symptoms registered in the electronic medical records re-
present the most important symptoms for both the patient and the family physician.
The most important result is that prevalence of symptoms differs by age group and un-
derlying disease. Overall, prevalence of symptoms is higher for younger patients and 
for cancer patients. For cancer patients, prevalence of pain and psychological problems 
decreases with age, while prevalence of fatigue and urogenital symptoms increases 
with age. Because of the different nature of the disease, the frequency of symptoms 
in cancer patients might be higher than in non-cancer patients. On the other hand, a 
study that compared symptoms in lung cancer patients with COPD patients, found a 
similar symptom burden in both patient populations.25 As we have not measured the 
needs, the severity of symptoms and the need for encounters we cannot say whether 
the received care met the needs of the patients. 
Other studies have found that prevalence of symptoms was higher in younger patients.14,26 
Our study conﬁ rms this general ﬁ nding in both cancer and non-cancer patients, although 
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some symptoms show a higher prevalence in older age groups e.g. fatigue and urogenital 
symptoms. A possible explanation for the ﬁ nding that younger patients and cancer pa-
tients have more encounters about symptoms is that they can stay at home with a more 
severe disease because they have a reliable support system or that older patients have a 
more mitigated disease trajectory.27
The wide range of symptom prevalence across studies, and between patients within a 
study, makes comparisons between studies difﬁ cult. Our study is based on symptoms 
registered during encounters, where most other studies measured symptoms that 
were prevalent using a list of possible symptoms, e.g. the Palliative care Outcome Sca-
le (POS) or the Edmonton Symptom Assessment System (ESAS).28,29 Hence, symptom 
prevalence is probably underreported in our study. 
Not reported in previous palliative care studies were musculoskeletal symptoms, chro-
nic ulcer and request for/talking about euthanasia. The ﬁ rst two might be included in 
future palliative care studies on symptom prevalence. The last seems to be a typically 
Dutch subject as communication on euthanasia is part of communication on end-of-life 
preferences in the Netherlands.30 Future studies should explicitly explore the preva-
lence of, and the need for communication on end-of-life issues in patients receiving 
palliative care.
This study shows that the number symptoms is the highest for cancer patients and 
that it is concentrated in the last two weeks of life. This requires a peak performance 
from family physicians, especially when they care for more than one palliative care pa-
tient at a time. In primary care, future developments such as the restriction of time 
for home visits, more part-time jobs and cooperatives responsible for care after ofﬁ ce 
hours4, may threaten the core values of palliative care, such as the availability of the 
family physician for home and after-hours visits.31 Palliative care faces the challenge 
of combining these future developments with the necessity for family physicians to be 
available to give palliative care to more patients needing symptom control.
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ABSTRACT
This study aims to understand what pain medication is prescribed to patients receiving 
palliative care at home, and to determine the longitudinal development of prescribing 
during the last three months of life. We also examine whether family physicians pres-
cribe analgesics according to the WHO analgesic ladder, and if opioids are combined 
with laxatives. Within the framework of a nation-wide survey of family practice in The 
Netherlands, family physicians identiﬁ ed from amongst all patients who died within 
the one-year survey period those who received palliative care (response-rate 74%). 
We analysed the prescribing data of analgesics, laxatives and antiemetics to patients 
with an observation period of at least three months (n=425). Of these patients, 73% 
were prescribed pain medication: 55% a drug from step 1 of the WHO analgesic ladder 
(acetaminophen, NSAIDs), 21% a step 2 drug (weak opioids), and 51% a step 3 drug 
(strong opioids). More younger patients were prescribed a strong opioid, and more can-
cer patients were prescribed a drug from all three steps of the WHO analgesic ladder. 
The proportion of patients prescribed a step 1 or 2 drug increased gradually, and the 
proportion of patients prescribed a step 3 drug increased exponentially nearing the pa-
tient’s death. In 40% of patients prescribed a step 1 analgesic, prescription of a strong 
opioid was not in line with the WHO analgesic ladder. A total of 48% was prescribed an 
opioid without any prescribed laxative. Current practice concerning the use of the WHO 
analgesic ladder and the prescribing of laxatives differs substantially from accepted 
guidelines. 
INTRODUCTION
Most people with an incurable disease prefer to remain at home surrounded by their 
relatives during the last part of their lives.1-3 In the Netherlands, health care is charac-
terised by its strong emphasis on primary care, where the family doctor is the central 
professional in the management and coordination of the patient’s treatment.4 Almost 
60% of patients with non-acute illnesses die at home,5 and there is a general consen-
sus that palliative care should be provided in the patient’s home if possible.6 The aging 
population and the growing number of non-acute deaths are expected to increase the 
family physician’s contribution to meeting the increasing needs of terminally-ill pa-
tients.7,8
Pain is one of the symptoms that physicians most frequently encounter in patients re-
ceiving palliative care.9,10 An important aid for pain management that was developed as 
an educational tool for the treatment of cancer pain, is the World Health Organization 
(WHO) analgesic ladder. According to the WHO analgesic ladder, pain management is a 
part of comprehensive palliative care which includes psychosocial and spiritual care. 
Drug treatment is the mainstay of cancer pain management and is composed of three 
steps of pharmacological therapy.11,12 The sequential use of drugs starts with the non-
opioid analgesics acetaminophen and nonsteroidal anti-inﬂ ammatory drugs (NSAIDs) 
in step 1, as well as adjuvant drugs to treat adverse effects, to enhance pain relief or 
to treat concomitant psychological disturbances.11 Opioids for mild to moderate pain 
are prescribed in step 2 and opioids for moderate to severe pain in step 3. Non-opioid 
analgesics and adjuvant drugs from step 1 may be combined with step 2 and step 3 
opioids. Pain management according to the WHO guideline is effective,13 yet substantial 
improvement in the control of pain is still possible: pain management by clinicians and 
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in the community is suboptimal,14-16 and patients lack adherence with their analgesic 
regimen.17 Above, although recommendations state that opioids should be combined 
with laxatives to prevent obstipation, and might be combined with antiemetics to pre-
vent nausea, still many doctors prescribe opioids without prescribing a laxative simul-
taneously.18-20 
Data about the treatment of pain and the prescribing of pain medication are often 
derived from specialised settings,21,22 and these are not always transposable to the 
community as the prevalence and treatment of pain differs between settings.9 To our 
knowledge, there is no study in primary care that has measured the prescribing of pain 
medication in a general population receiving palliative care at home from their family 
physicians. To indicate whether there is a potential problem in a general population and, 
if so, to predict the magnitude of this problem, population-based statistics are needed. 
Above all, statistics showing the current prescribing patterns can serve as a reference 
point with which to compare future studies or studies in different countries, and as a 
source of information to guide the future education of patients and prescribers. 
To understand better what drugs are prescribed, and to determine the longitudinal 
development of prescribing during the last three months of life, we aimed ﬁ rstly to 
investigate the prescribing of pain medication in patients receiving palliative care in fa-
mily practice, and to analyse differences by gender, age and underlying disease; i.e. in 
cancer and non-cancer patients. Secondly, we examined two aspects of the quality of 
prescribing: (1) whether family physicians prescribed analgesics according to the WHO 
analgesic ladder, and (2) if opioids were combined with laxatives and antiemetics.
 
 
METHODS
Patient selection
The data used in this study were obtained from the second Dutch National Survey of 
General Practice (DNSGP-2), in which a representative sample of 104 Dutch family prac-
tices participated, with a total of 399,068 patients involved.23 Data from nine practices 
were excluded; four practices delivered incomplete data; ﬁ ve practices were excluded 
because the data did not meet the minimum quality criteria. The listed population of 
the remaining 95 practices was 374,070 patients. In these practices 2,169 patients died 
during the survey year (0.6%). The one-year period of each practice ended between 
April 2001 and January 2002. 
At the end of the survey period, the family physicians received a post-mortem questi-
onnaire designed for this study for each patient who died during the survey year. They 
reported the patient’s underlying disease, and labeled each patient who received pal-
liative care by indicating whether the patient was or was not ‘provided with palliative 
care until death’. The labeling of the patient served as the ﬁ rst inclusion criterion. As 
all deaths occured throughout the survey year, we had a varying follow-up time: some 
patients died in the ﬁ rst days of the survey, others died later in the study. To ensure 
that we had an observation period of at least three months for each patient, the second 
inclusion criterion was that the patient died at least three months after the start of the 
survey year. 
Prescriptions
All prescriptions were derived from the prescription database of the DNSGP-2, which was 
connected to the data bases with the patient characteristics and the questionnaires, 
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and contained information about the Anatomical Therapeutic Chemical classiﬁ cation 
code (ATC-code) of the prescribed drugs.24 We included all analgesics, with the exception 
of anti-depressants and neuroleptics, and classiﬁ ed them according to the three steps 
of the WHO analgesic ladder11 by their corresponding ATC-code (see Table 1). Step 1 in-
cluded all non-opioid analgesics: acetaminophen and NSAIDs. Step 2 included all weak 
opioids: codeine; tramadol and dextropropoxyphen. Step 3 included all strong opioids: 
morphine, fentanyl, and other strong opioids. When a drug with one ATC-code included 
two components from different steps of the WHO analgesic ladder, that drug was in-
cluded in both steps. Of the adjuvant drugs prescribed to control adverse effects,11 we 
included laxatives and antiemetics to investigate possible treatment of two adverse ef-
fects of opiods: nausea and constipation. Drugs and corresponding ATC-codes not listed 
in Table 1, were not prescribed during the DNSGP-2. 
Measurements
•  Steps in the WHO analgesic ladder: we analysed for each patient whether and if so 
when any drug from each of the three steps of the WHO analgesic ladder had been 
prescribed during the three months observation period before death.
•  First prescription: each prescription was recorded as a ﬁ rst issue or a repeat pres-
cription. A ﬁ rst prescription was deﬁ ned as such when it was the ﬁ rst prescription 
in the three months observation period, and when the GP had not prescribed a drug 
from the same ATC-code in the six months before this ﬁ rst prescription. When a drug 
was ﬁ rst prescribed, the number of weeks between the date of prescription and the 
patient’s death was calculated. 
•  Combination with laxatives and antiemetics: for each patient who was prescribed an 
opioid, we speciﬁ ed whether any laxative or antiemetic had been prescribed in the 
period an opioid was prescribed, and if so, whether the laxative was started before, 
or within three days after the start of the opioid. We did not distinguish between dif-
ferent types of laxatives or antiemetics.
Analysis 
Descriptive analyses were carried out for patient characteristics and for the most fre-
quently prescribed drugs in the three steps of the WHO analgesic ladder. Differences in 
prescribing between sub-populations were calculated at the start of the observation 
period, and over the last three months of life, for the characteristics sex, age and un-
derlying disease, i.e. cancer versus non-cancer patients, using χ-square test (α = 0.05). 
For all three steps, we longitudinally analysed the prescriptions in the total population 
by calculating the cumulative percentage of patients prescribed at least one drug in 
the three steps of the WHO analgesic ladder and patients prescribed nothing during 
the last three months of life, starting at 90 days before the patient’s death. Further, we 
analysed the increase of analgesics prescribed during the three months observation 
period. When a patient was prescribed nothing or a step 1-drug, we analysed whether 
the prescribing of weak and strong opioids would have been appropiate according to 
the WHO analgesic ladder. Combinations of opioids with laxatives and antiemetics 
were calculated for the patients who were prescribed an opioid (WHO step 2 or 3). 
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Table 1.
Drugs included in the analysis and their corresponding ATC-codes and for pain medication 
classiﬁ ed according to the three steps of the WHO analgesic ladder.
   Step WHO analgesic ladder /  ATC-code Drug name
   class of drug
   Step 1 WHO analgesic ladder N02BE01 Acetaminophen 
    N02AA59 Acetaminophen (+ codeine)
    N02BE51 Acetaminophen (+ other)
     (excl.psycholeptics)
    M01AE01 Diclofenac
    M01 (other) Other NSAIDs
    N02BA Salicylic acid + derivates
   Step 2 WHO analgesic ladder N02AA59 Codeine (+acetaminophen)
    N02BE51 Codeine (+acetaminophen)
    N02AX02 Tramadol
    N02AC04 Dextropropoxyphene
   Step 3 WHO analgesic ladder N02AA01 Morphine
    N02BA03 Fentanyl
    N02 Other
   Laxatives A06 
   Antiemitics A03FA 
    A04 
RESULTS
Of the 2,169 questionnaires sent to family physicians, 1,760 were returned (81%), and 
1,596 were ﬁ lled in completely (74% valid response rate). In total, 425 patients with an 
observation period of at least three months received palliative care from their family 
physician until death. Characteristics of the patients studied are presented in Table 
2. Of all patients who received palliative care, 73% were prescribed at least one drug 
for pain during the observation period (Table 3). Of these patients, 31% received this 
prescription at the start of the observation period of 90 days before death. For most of 
these patients, the prescriptions were from step 1 of the WHO analgesic ladder, with 
acetaminophen prescribed for 14% of the patients. Drugs from step 2 and step 3 were 
already subsequently prescribed for 5.6% and 6.4% of the patients at 90 days before 
the patient’s death. During the observation period, 55% of the patients received a step 
1 prescription, 21% a step 2 prescription and 51% a step 3 prescription, with morphine 
and transdermal fentalyl as the most frequently prescribed drugs in step 3. 
Of the analgesics which comprise step 1 of the WHO analgesic ladder, more cancer pa-
tients than non-cancer patients were prescribed diclophenac at 90 days before death, 
and over the full observation period. Also more cancer patients were prescribed tramadol 
over the full observation period than were non-cancer patients. More cancer patients 
than non-cancer patients were receiving a prescription for a strong opioid at 90 days be-
fore death and over the full observation period, with signiﬁ cantly more cancer patients 
being prescribed morphine and fentanyl over the full observation period.
Table 4 shows that at 90 days before the patient’s death, there were no signiﬁ cant diffe-
rences between the patients in different age categories, nor between males and females 
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Table 2.
Characteristics of the studied patients who received palliative care until death in family practice, 
with an observation period of at least three months (n=425). 
    % (n=425)
 Gender
  Male 47 
  Female 53 
 Age (years)  
  < 70  28 
  70-79 24 
  80-89 32 
  ≥ 90 16 
  Mean (SD) 76.9 (14.0) 
 Underlying disease a  
  Cancer  55 
  Non-cancer 45 
   Heart failure  11 
   COPD 3.1 
   Other disease 26 
   Multiple non-cancer diseases 4.5 
a Number of missing values for underlying diseases was 3.
49
Table 3.
Proportion of patients with drugs prescribed for pain during the last three months of life in 
patients who received palliative care until death in family practice in cancer and non-cancer 
patients and the total population (n=425).
A. Pain medication initiated before the observation period.
 Prescribed drug Cancera Non-cancer p Total
    (n=234) (n=188) (χ-square) (n=425)
 No prescription (%)  65 73 0.113 69 
 At least one prescription (%)  35 27  31 
 Step 1 WHO analgesic ladder (%)  28 24 0.315 26
  Acetaminophen (%)  15 13 0.675 14 
  Diclofenac (%)  12 5.3 0.017 9.2 
  Other NSAIDs (%)  7.3 7.4 1.000 7.3 
 Step 2 WHO analgesic ladder (%)  6.8 4.3 0.295 5.6 
  Codeine (%)  2.6 2.7 1.000 2.6 
  Tramadol + otherb (%)  4.3 2.1 0.280 3.3 
 Step 3 WHO analgesic ladder (%)  8.5 3.7 0.047 6.4 
  Morphine (%)  5.6 2.1 0.085 4.0 
  Fentanyl (%)  4.7 2.1 0.192 3.5 
  Other (%)  0.4 0.0 1.000 0.2 
B. Pain medication prescribed during the full observation period.
 Prescribed drug Cancera Non-cancer p Total
    (n=234) (n=188) (χ-square) (n=425)
 No prescription (%)  19 36 0.000 27 
 At least one prescription (%)  81 64  73 
 Step 1 WHO analgesic ladder (%)  62 46 0.001 55 
  Acetaminophen (%)  39 34 0.312 37 
  Diclofenac (%)  29 13 0.000 22 
  Other NSAIDs (%)  17 11 0.095 14 
 Step 2 WHO analgesic ladder (%)  27 14 0.001 21 
  Codeine (%)  12 9.6 0.530 11 
  Tramadol + otherb (%)  19 7.4 0.001 14 
 Step 3 WHO analgesic ladder (%)  62 37 0.000 51 
  Morphine (%)  39 24 0.001 32 
  Fentanyl (%)  45 20 0.000 34 
  Other (%)  5.1 1.6 0.064 3.5 
a Number of missing values for underlying diseases was 3.
b One patient was prescribed dextropropoxyphene.
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Figure 1.
Proportion of patients who were described nothing, and those prescribed at least one drug
In each of the three steps of the WHO analgesic ladder in the weeks preceding the patient’s death (n=425).
 
in proportion to patients who received at least one prescription, a step 1, a step 2 or a step 
3 prescription. During the full observation period, there were no differences by gender in 
the proportion of patients who were prescribed pain medication (Table 4). More younger 
patients were prescribed a strong opioid than were older patients.
Longitudinal development of prescribing during the last three months before the 
patient’s death
Figure 1 shows the proportion of patients who were prescribed no drug, and at least 
one drug from each of the three steps of the WHO analgesic ladder in the weeks prece-
ding death. At 90 days before death, the proportion of patients who had no prescrip-
tion was 65% for cancer patients and 73% for non-cancer patients. This proportion 
descreased gradually towards the patient’s death, with a steeper increase in the last 
week before death, resulting in 19% of the cancer patients and 36% of the non-can-
cer patients having received no prescription over the three months observation period 
(see also Table 3). At 90 days before death, the proportion of patients who received a 
step 1 prescription was 24 % for non-cancer and 28% for cancer patients. Towards the 
patient’s death the proportion increased gradually, resulting in 46% of the non-cancer 
patients having received a step 1 prescription, and 62% of the cancer patients during 
the last three months of life (see also Table 4). The proportion of patients prescribed a 
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Table 5.
Prescribed pain medication during the last three months of the patient’s before the patient’s 
death and relation to the WHO analgesic ladder. 
       Cancer  Non-cancer Change according 
  Step in WHO Total patients   patients to the WHO
 analgesic ladder % (n=425) % (n=234)  % (n=188)  analgesic ladder 
 No pain medication  27 19 36 Not relevant
 prescribed
 Only Step 1  16 11 21 Yes
 Step 1  Step 2 2.8 3.4 2.1 Yes
 Step 1  Step 2  Step 3 4.5 6.4 2.1 Yes
 Step 1  Step 3 16 20 11 No
 Only Step 2 4.0 4.3 3.7 Unknown
 Step 2  Step 3 8.5 11 5.9 Unknown
 Only step 3 22.1 25 18 Unknown
step 2 analgesic showed a similar gradual increase, with lower proportions of patients 
prescribed at 90 days before death and during the observation period of three months. 
For step 3 analgesics, the proportion of patients prescribed a strong opioid showed an 
exponential increase starting at three weeks before death for cancer patients, and one 
week later for non-cancer patients. 
Prescribing according to the WHO analgesic ladder and co-medication to treat ad-
verse effects
Table 5 shows that in the three month time frame, 16% were prescribed a step 1 anal-
gesic during the observation period, and were not prescribed an analgesic from a higher 
WHO-step. Of the patients prescribed a step 1 drug, 40% received a step 3 prescrip-
tion without having received a step 2 prescription, which is not in line with the WHO 
analgesic ladder. This occurred more frequently in cancer than in non-cancer patients 
(p=0.016). Of the 244 patients prescribed an opioid (step 2 and/or step 3), 17% were 
prescribed a laxative before the start of the opioid (data not shown). In 22% of all pa-
tients, the laxative was prescribed within three days of the prescription of the opioid, 
and in 14% more than three days after the start of the opioid. In 48% of the patients 
using an opioid, no laxative was being prescribed during the observation period, with 
no difference between oral and transdermal administration (p=0.142). A laxative was 
more frequently not prescribed to non-cancer patients than to cancer patients (60% 
v 41%; p=0.006). In total, 29% (n=70) of patients prescribed an opioid received a pre-
scription against nausea, and of these prescriptions 34% were started more than three 
days after the opioid prescription. 
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DISCUSSION
Summary of main ﬁ ndings
In the last 90 days before death, 73% of patients receiving palliative care from their 
family physician were prescribed pain medication: 55% were prescribed a drug from 
step 1 of the WHO analgesic ladder (acetaminophen or NSAIDs), 21% a drug from step 
2 of the ladder (weak opioids, e.g. codeine and tramadol), and 51% a drug from step 3 
(strong opioids). Over the full period, more younger patients were prescribed a strong 
opioid, and more cancer patients were prescribed a drug from all three steps of the 
WHO analgesic ladder. There were no signiﬁ cant differences in prescribing by sex. Du-
ring the last 90 days, the proportion of patients prescribed a step 1 or a step 2 drug 
increased gradually and the proportion of patients prescribed a step 3 drug increased 
exponentially, starting at three and two weeks before the patient’s death for cancer 
and non-cancer patients, respectively. Of the patients who were prescribed a step 1 
analgesic, 40% were prescribed a strong opioid without having been prescribed a step 
2 analgesic. A total of 60% of non-cancer patients and 41% of cancer patients were 
prescribed an opioid without any prescribed laxative, and 14% of all patients were 
prescribed a laxative three or more days after the start of the opioid.
Strengths and the limitations of this study
Limitations of this study are that no information was obtained about the severity of the 
pain, and whether prescribing resulted in adverse events. Furthermore, we were unable 
to measure whether, in the prescriber’s or the patient’s opinion, pain control had been 
achieved. Also, we did not include drugs started before the 90-days observation period. 
As medication in The Netherlands is dispensed for a maximum of 90 days, this did not 
exclude medication that was intended to be used over the entire observation period. 
This study was embedded in the second Dutch National Survey of General Practice, 
which has generated solid data due to its quality and size, and has allowed us to ana-
lyse the prescribing of pain medication longitudinally over the last three months before 
a patient’s death. The total response rate of 74% for the additional questionnaire was 
high compared to mean response rates of 61% reported in studies carried out in ge-
neral practice, and a trend of decreasing rates of response to mail questionnaires.25 As 
most studies in palliative care are limited to cancer patients,26 a further strength of this 
study is that we included both cancer and non-cancer patients. 
Comparison with existing literature
A total of 27% of patients receiving palliative care in family practice, and 19% of the 
cancer patients, were not prescribed analgesics. Although pain is extremely common in 
cancer patients, studies report a wide variation in the prevalence of pain (33-88%).27 The 
proportion of patients receiving a prescription for analgesics in our study is comparable 
to numbers found in other studies.13,28 Weak opioids (step 2 of the WHO analgesic lad-
der) are prescribed to 27% of our cancer population, which is substantially lower than in 
the cancer population receiving care at home in Italy (52%)13 and cancer patients treated 
at a pain center in Germany (60%).29 This may be due to the fact that in both studies 
doctors were instructed to prescribe according to the WHO analgesic ladder. Our study 
shows that family doctors often pass over step 2 of the ladder. Although we have not 
collected data on the level of pain control, the exponential increase in prescriptions for 
strong opioids nearing the patient’s death suggests a corresponding increase in pain. 
Our data suggest that for the optimal management of pain, some patients beneﬁ t from 
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the omission of step 2 of the WHO analgesic ladder, as advised in recent Dutch guideli-
nes30 and suggested by other authors.12
It is striking that the increase in opioid prescribing occurs in cancer as well as non-
cancer patients, as pain is less common in non-cancer diseases. Possibly, non-cancer 
patients suffer a common increase in the need for strong opioids as patients, to ma-
nage pain and/or dyspnea.31,32 It might also be that during the illness trajectory family 
doctors are reluctant to prescribe strong opioids for non-cancer patients, but when 
the end of life is near family physicians are more willing to prescribe the level of pain 
medication that the patient needs.33,34
A point of concern is the lack of prescribing of co-medication when prescribing opioids. 
Antiemetics are prescribed in only 27% of the patients. In 48% of the patients, no laxa-
tive has been prescribed and in 14% the laxative was initiated after the prescription of 
the opioid, suggesting the possibility that these patients were already constipated. The 
proportion of patients who are prescribed laxatives as co-medication is low, although 
this combination is advised in most guidelines.11,35,36 Results from this population-based 
study show that family doctors do not act according to these guidelines. It might be 
that patients buy some laxatives without prescription over the counter. Possibly, it is 
difﬁ cult for the family physician to keep in mind the need for co-medication, and this 
aspect needs more attention in education and/or collaboration with pharmacists.20 On 
the other hand, it might also be that there is a substantial proportion of patients who 
will not beneﬁ t from the prescription of laxatives, and family physicians in some way 
are able to discriminate between patients. The question of whether laxatives need to 
be prescribed to all patients using opioids is even more important to the non-cancer 
patients as 60% do not receive the laxatives they might beneﬁ t from. 
Finally, we found that 34% of patients receive fentanyl via a transdermal patch. This 
could be an indication that GPs prescribe the fentanyl patch more often than advised in 
the WHO and EAPC recommendations, which prefer oral administration.11,35 It appears 
that the practical advantages in the use of the transdermal patches for many patients 
and their GPs outweigh the advantages of oral dosing: a trend seen in other countries 
as well.37
Implications for future research or clinical practice
In total, 27% of the patients receiving end-of-life care in general practice are not prescri-
bed analgetics. Further studies need to investigate why these patients are not prescri-
bed analgesics: is it because there is no need for pharmacological management of pain, 
or is it because GPs do not adequately manage pain. To optimise pain management, 
we need to know why current practice with regard to the WHO analgesic ladder and 
the (lack of) prescription of laxatives differs substantially from guidelines. It cannot be 
ruled out that due to greater awareness and education in the last years, family practice 
has developed new insights into the optimising of pain management in palliative care 
patients, which are not reﬂ ected in the guidelines. Also, we need to know how we can 
optimally manage pain nearing end-of-life in non-cancer patients. Although they are 
difﬁ cult in design, detailed observational studies and/or randomised controlled trials 
are needed to answer these questions, and future education will preferably be based on 
the results of these studies. 
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ABSTRACT
•  Background: Palliative care is considered to be a multidisciplinary approach. However, 
the extent of cooperation between GPs and other caregivers is unknown. 
•  Objective: To investigate the occurrence and determinants of cooperation between 
GPs and other caregivers in palliative care at home.
•  Methods: For each patient who died during the one-year registration period (2000-
2001) of the Second Dutch National Survey of General Practice, the relevant GP was 
surveyed on palliative care issues by an additional mail questionnaire.
•  Results: Of all patients, 2,194 (0.6%) patients died during the study period. GPs re-
turned 1,771 (73%) of the additional questionnaires. According to the GPs 743 (46%) of 
their patients received palliative care. In almost all patients (98%), the GP cooperated 
with at least one other caregiver, with a mean number of four others. Cooperation with 
informal caregivers (83%) was most prevalent, followed by cooperation with other GPs 
(71%) and district nurses (63%). The best determinants for cooperation between GPs 
and other caregivers were the patient’s age, the underlying disease and the importan-
ce of psychosocial care in the care for the actual patient. 
•  Conclusion: In patients receiving palliative care, GP cooperation with other caregivers 
is highly prevalent, especially with informal caregivers and other primary care colla-
borators. Cooperation is more prevalent in younger patients, patients with cancer as 
underlying disease, and if psychosocial care is important in care for the actual patient.
INTRODUCTION
In the Netherlands, health care is characterized by a strong emphasis on primary care, 
where the GP is the central professional in the management and coordination of the 
patient’s treatment.1 Primary care also provides home care to the inhabitants of the 
homes for the elderly. Almost 60% of patients with non-acute illnesses die at home2, 
and there is general consensus that palliative care should be provided in the patient’s 
home, if possible.3 The aging population and the growing number of non-acute deaths 
are expected to increase the GP’s contribution to meeting the increasing need for pal-
liative care.4,5 
The World Health Organization (WHO) deﬁ nes palliative care as: ‘an approach that im-
proves the quality of life of patients and their families facing the problems associated 
with life-threatening illness, through the prevention and relief of suffering by means 
of early identiﬁ cation and impeccable assessment and treatment of pain and other 
problems, physical, psychosocial and spiritual’.6 Team work has been an integral part 
of the philosophy of palliative care7 and is included in the WHO deﬁ nition which further 
describes the content of palliative care as using ‘a team approach to address the needs 
of patients and their families if indicated’.6 Qualitative studies show that patients and 
GPs experience cooperation between GPs and other caregivers as an important aspect 
of palliative care.8,9 A systematic review comparing interventions by teams in palliative 
and hospice care with usual practice showed beneﬁ ts for the team approach.10 Also, 
formal arrangements requiring GPs to work with specialist teams have been shown to 
improve outcomes.11 However, the extent and level of cooperation in palliative care at 
home is unknown. 
Some factors might predict GP cooperation with other caregivers. As both older and 
female patients receive less informal care12, it might be expected that age and gender 
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may determine GP cooperation with others. In patients with greater pain and somatic 
problems, and in patients with psychosocial problems, cooperation may be more pre-
valent because multidisciplinary knowledge is needed to care for these patients. The 
aim of this study is to investigate the extent and the level of GP cooperation with other 
caregivers in palliative care at home and the determinants of that cooperation. 
METHODS
Patients
The data used in this study were obtained from the second Dutch National Survey of 
General Practice, in which a representative sample of 96 Dutch general practices partici-
pated, with a total of 375,899 patients involved. The start of the one-year registration 
period of the study practices varied between April 2000 and January 2001.13 The GPs 
received an additional post-mortem questionnaire designed for this study for each 
patient who died during the year of registration. 
Measurements
We deﬁ ned a ‘palliative care patient’ as those to whom the GP had provided palliative 
care. We also asked for underlying diseases. We assessed the importance in the care 
of the three palliative care domains included in the WHO deﬁ nition: somatic care, psy-
chosocial care, and spiritual care. The importance of these domains in the care for the 
actual patient was assessed on a ﬁ ve point likert scale (1=lowest importance of speciﬁ c 
care item to 5=maximum importance). Finally, we asked the GPs to identify the level 
of cooperation in the care of each patient with the following caregivers: informal care-
giver, colleague GP, district nurse (DN), specialist (physician), member of the home care 
team other than DN, pharmacist, social worker, physiotherapist, volunteer non-family 
caregiver, spiritual caregiver and other caregivers. GPs recorded the level of cooperation 
according to the following categories: none, incidental, and intensive.
Statistical analysis
We analysed GP cooperation with other caregivers in palliative care at the level of care for 
the individual patient. Descriptive statistics were computed for patient characteristics, im-
portance of the three palliative care domains in care for the actual patient, GP cooperation 
with other caregivers, and the mean number of collaborators per patient. GP cooperation 
with other caregivers by patient characteristics and by the importance of palliative care 
domains in care for the actual patient was expressed using relative proportions. To test 
differences between groups (α = 0.05), we calculated p-values of χ-square test. 
We recoded scores of importance of palliative care domains in care for the actual patient 
into two categories: scores of 1, 2 and 3 were lumped together as ‘not so important’ and 
scores of 4 and 5 as ‘important’. In the open text ‘cooperation with another collabora-
tor’, homes for the elderly were frequently cited (n=104). We recoded GP cooperation 
with other caregivers as cooperation with homes for the elderly when cooperation with 
(a professional in) the homes for the elderly was recorded in the open text. Cooperation 
with social workers was not frequent (n=25). We removed cooperation with social wor-
kers and recoded this category as ‘cooperation with another caregiver’. In the tables we 
use the recoded deﬁ nitions of collaborators.
Logistic regression analysis was used to identify determinants for GP cooperation with 
other caregivers. Plausible interactions (e.g., gender by age, age by underlying disease, 
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underlying disease by importance of somatic care) were included. First, all possible de-
terminants were tested univariately, after which the one with the highest p-value was 
entered into the model (α=0.05). This was repeated until addition of the next determi-
nant did not improve the model signiﬁ cantly. To check for any change in the model, we 
varied this procedure. In the case of signiﬁ cant interaction, two models were presented. 
For each model, the R2 was calculated to express the variation explained by the model. 
RESULTS
In the 96 general practices 2,194 of the 375,899 patients died during the year of regi-
stration (0.6%). Of the 2,194 questionnaires sent to GPs 1,771 were returned (81%), 
and 1,608 were ﬁ lled in completely, with regard to the identiﬁ cation of palliative care 
patients (73% valid response rate). These GPs worked in 86 general practices, and pro-
vided palliative care to 743 patients (46%). Table 1 shows the patient characteristics of 
the study population. 
Table 2 shows the importance of palliative care domains in care for the actual patient. 
GPs perceived somatic care (mean score 4.1) as more important than psychosocial care 
(mean score 3.4) and spiritual care (mean score 2.1). 
In almost all patients, GPs (98% ) cooperated with at least one other caregiver (Table 3). 
The mean number of collaborators was near to 4 (median=4), with a mean of almost 1 
intensive cooperation per patient.
Cooperation with informal caregivers (83%) was most prevalent, followed by cooperation 
with other GPs (71%), district nurses (63%), and specialists (55%). Intensive cooperation 
was most frequent between GPs and informal caregivers (63%), and incidental coopera-
tion was most frequent between GPs and colleague GPs (60%). 
In the case of male patients, more GPs cooperated with informal caregivers, DNs and 
specialists than in that of female patients, while with female patients, more GPs coo-
perated with homes for the elderly and spiritual caregivers than they did for male pa-
tients (Table 4). In case of younger patients, more GPs cooperated with informal carers, 
colleague GPs, DNs, specialists, home care other than DNs and pharmacists than in that 
of older patients. With older patients, more GPs cooperated with homes for the elderly. 
For cancer patients, more GPs cooperated with informal caregivers, DNs, specialists 
and pharmacists than with non-cancer patients. With non-cancer patients, more GPs 
cooperated with homes for the elderly and physiotherapists than in the case of cancer 
patients. 
With patients for whom somatic care was ‘important’, more GPs cooperated with GP col-
leagues, specialists and pharmacists than in the case of patients for whom somatic care 
was ‘not so important’ (Table 5). With the exception of homes for the elderly, voluntary 
non-family caregivers and other caregivers, cooperation was more prevalent in cases 
where psychosocial care was ‘important’ than with patients for whom psychosocial care 
was ‘not so important’. In patients for whom spiritual care was ‘important’, more GPs 
cooperated with specialists, voluntary non-family caregivers and spiritual caregivers 
than they did when spiritual care was ‘not so important’. 
Table 6 shows the signiﬁ cant factors in the model predicting GP cooperation with other 
caregivers in patients receiving palliative care. All models had relatively low values of 
the variation explained by the model. Being a female patient was a positive determi-
nant for GP cooperation with homes for the elderly and spiritual caregivers. In informal 
caregivers, specialists and pharmacists we found the interaction between cancer as 
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Table 1.
Characteristics of patients receiving palliative care by their GP in the Netherlands (n=743)a. 
 Age % (n)
  <70 years 28 (207)
  70-80 years 27 (196)
  80-90 years 31 (228)
  > 90 years 14 (106)
  mean age, years [95% CI] 76 [61-91]
 Gender % (n)
  Male 47 (349)
  Female 53 (394)
 Underlying disease % (n)
  Cancer 56 (412)
  Non-cancer 44 (327)
 
a Number of missing values: age=6, underlying disease=4.
Table 2.
Importance of the three palliative care domains in care for the actual patient: somatic care, 
psychosocial care, and spiritual care (n=743)a. 
 Importance of palliative care domains 
 in care for the actual patient b % (n)
 Somatic care  not so important (1-3) 22 (152)
    important (4-5) 78 (580)
    mean score [95% CI] 4,1 [3.1-5.0]
 Psychosocial care not so important (1-3) 48 (350)
    important (4-5) 52 (380)
    mean score [95% CI] 3.4 [2.3-4.6]
 Spiritual care not so important (1-3) 85 (605)
    important (4-5) 15 (103)
    mean score [95% CI] 2.1 [0.9-3.3]
 
a Number of missing values for somatic care=11, psychosocial care=13, and spiritual care=35.
b  Scores were assessed on a ﬁ ve point likert scale (1=low importance, 5 =maximum importance) answering 
the questions: ‘in what degree was the following aspect important for the care of this patient? Treatment of 
somatic problems / psychosocial care / spiritual care.’ The scores 1-3 were recoded as ‘not so important’ and 
4-5 as ‘important’.
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underlying disease and age as signiﬁ cant factor in our initial model, hence we presen-
ted two models: one for cancer patients, and one for non-cancer patients. Age was 
a negative determinant in the models for informal caregivers (only cancer patients), 
DNs, specialists and pharmacists (only non-cancer patients). For predicting coopera-
tion between GPs and homes for the elderly, age was a positive determinant. Cancer as 
underlying disease was a positive determinant in the model for cooperation between 
GPs and DNs; for the model predicting cooperation between GPs and homes for the el-
derly non-cancer was a positive determinant. Somatic care as important in care for the 
actual patient was a positive determinant for cooperation between GPs and colleague 
GPs, homes for the elderly, physiotherapists and spiritual caregivers. Psychosocial care 
as important in care for the actual patient was in many models a positive determinant; 
in the model predicting cooperation between GPs and homes for the elderly it was a 
negative determinant. Spiritual care as important in care for the actual patient was 
a positive determinant for cooperation with physiotherapists, voluntary non-family 
caregivers and spiritual caregivers.
DISCUSSION
In almost all cases of patients receiving palliative care at home in the Netherlands, the 
GP cooperated with at least one other caregiver, with a mean number of 3.8 collabora-
tors. In patients receiving palliative care, GP cooperation with other caregivers is highly 
prevalent, with informal caregivers and other primary caregivers the most common. 
The best determinants for cooperation in palliative care between GPs and other care-
givers were the patient’s lower age, cancer as the underlying disease and psychosocial 
care as important in care for the actual patient. 
This study was embedded in the second Dutch National Survey of General Practice, 
which has generated solid data due to its quality and size. Another strength of this 
study is the total response rate of 73% for the additional questionnaire, which is high 
compared to mean non-response rates of 39% reported in published studies carried 
out in general practice, and a trend of decreasing rates of response to mail question-
naires.14 As most studies in palliative care are limited to cancer patients,15 a further 
strength is that we included both cancer and non-cancer patients. 
Limitations of this study are that no information was obtained about the content and 
frequency of cooperation nor about the criteria which motivated GP cooperation with 
other caregivers. Furthermore, we were unable to measure outcomes, hence we could 
not analyze any possible relation between quality of care and GP cooperation with other 
caregivers. We were also unable to search for association between GP cooperation and 
GP characteristics. All models predicting GP cooperation show relatively low values of 
the variation explained by the model, so it appears that GP cooperation is associated 
with many more factors than those included in this study.
To our knowledge, this is the ﬁ rst study that quantiﬁ es GP cooperation with other ca-
regivers in palliative care patients. The results of this study show that in palliative care 
GPs seldom work alone. With a mean of four collaborators for each patient receiving pal-
liative care, GPs contribute to the goal of palliative care as multidisciplinary approach.6 
In most patients the GP works with one collaborator at a level labelled as intensive, 
and in most cases this is the informal caregiver or the district nurse. However, with 
the aim of directing palliative care at ‘the patient and their family’6 cooperation with 
informal caregivers can be improved to meet the concerns of both patients and the 
69
informal carers.16 In 63% of the patients GPs cooperate with DNs. This is not considered 
to be low, as DNs are involved with more serious physical and psychosocial problems, 
or when technical bedside expertise is needed. GP cooperation with colleague GPs was 
only present in 55% of the patients. This is low as patient information is expected to 
be handed over after ofﬁ ce hours. In the Netherlands over 90% of the population is co-
vered by out-of-hours cooperatives.17 It is possible that GPs take care for their palliative 
care patients themselves, or that GPs do not deﬁ ne handing over patient information 
as cooperation. Although this needs future exploration, it does question the quality of 
communication and continuity by the GP during out-of-ofﬁ ce hours, a difﬁ cult area in 
palliative care at home.18 Cooperation between GPs and homes for the elderly is charac-
terised by more female and elderly patients, as might be expected due to the population 
living in homes for the elderly. 
In contrast to our expectations, we found that in general GP cooperation with other 
caregivers is associated with the age of the patient and that patient’s sex is no determi-
nant. The most plausible reason is that because younger patients have more informal 
caregivers, they can stay longer at home with more complex diseases. GPs cooperated 
with others caregivers more in the case of cancer patients than in non-cancer patients. 
This may be because more caregivers are needed for symptoms that occur more fre-
quently and are difﬁ cult to control.19 However, this raises the question of whether older 
and non-cancer patients need such cooperation less or whether they are being excluded 
from something from which they might beneﬁ t.
The most striking determinant of GP cooperation with other caregivers is the importance 
of psychosocial care in care for the actual patient. This ﬁ nding is difﬁ cult to interpret, 
as we have no data on the content of the collaboration. An explanation may be that the 
nature of the psychosocial problems itself may demand more communication and coor-
dination,20 or that the prevalence of psychosocial problems is intertwined with somatic 
issues.21 
This study shows that cooperation between GPs and other caregivers is prevalent in 
almost all cases where patients receive palliative care from their GP. Present studies 
on communication in palliative care pay limited attention to interdisciplinary com-
munication,22 so future research should focus on the underlying problems that need 
cooperation, how caregivers communicate, and what possible barriers they meet. Our 
ﬁ nding that few GPs cooperate with social workers and spiritual caregivers may mean 
that GPs deal with most social and spiritual problems themselves or that few patients 
have social or spiritual problems. However, also plausible is that patients and GPs them-
selves do not see it as the task of the GP to provide spiritual23 or social care, or that GPs 
don’t recognise or don’t respond to these problems. Given the importance of spiritual 
and social aspects within palliative care,24,25 these issues will need special attention in 
future studies.
More palliative care at home will be needed due to changing demographics and the 
changing face of primary care in Europe.2 Given the complexity of palliative care and 
the diversity of problems that may require attention, the involvement of all necessary 
disciplines must be encouraged. On the other hand, the number of caregivers needs to 
be limited because patients and family prefer fewer caregivers and personal continu-
ity.2 One of the caregivers involved in palliative care must be responsible for the orga-
nisation of the involvement of all relevant disciplines. In palliative care at home, GPs 
or DNs could perform this task,26 however there is still discussion on who should be in 
charge.9,27,28 For the patient, this is less important as long as any competent caregiver 
will perform this task. All caregivers involved should make clear arrangements about 
 
CH
A
PT
ER
 5
the use of available and needed expertise, responsibilities and communication; after 
all that is what cooperation is about. 
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ABSTRACT
•  Background: Most patients prefer to die at home, where a GP provides end-of-life 
care. A few previous studies have been directed at the GPs’ values on good end-of-
life care, yet no study combined values of patients and their own GP.
•  Aim: To explore the aspects valued by both patients and GPs in end-of-life care at home, 
and to reﬂ ect upon the results in the context of future developments in primary care. 
•  Design of study: Interviews with patients and their own GP.
•  Setting: Primary care in the Netherlands.
•  Methods: Qualitative, semi-structured interviews with 20 GPs and 30 of their pa-
tients with a life expectancy of less than six months, and cancer, heart failure or 
chronic obstructive pulmonary disease as underlying disease. 
•  Results: Patients and GPs had comparable perceptions of good end-of-life care.
•  Patients and GPs identiﬁ ed four core items that they valued in end-of-life care: 
availability of the GP for home visits and after ofﬁ ce-hours, medical competence and 
cooperation with other professionals, attention and continuity of care. 
•  Conclusions: Future developments in the organisation of primary care such as the 
restriction of time for home visits, more part-time jobs and GP cooperatives respon-
sible for care after ofﬁ ce hours, may threaten valued aspects in end-of-life care. 
INTRODUCTION
In Western countries most people prefer to remain at home during the last part of their 
life, surrounded by their relatives.1-3 In the Netherlands, health care is characterized 
by its strong emphasis on primary care: almost 100% of the inhabitants have their 
own GP who is the central professional in the management and coordination of the pa-
tient’s treatment.4 When needed, the GP initiates care at home by other professionals, 
like district nurses who provide nursing care, and home help for personal care. Almost 
60% of patients with non-acute illnesses die at home,5 and there is general consensus 
that end-of-life care should be provided in the patient’s home, if possible.6 The aging 
population and the growing number of non-acute deaths are expected to increase the 
contribution GPs must make to meet the rising needs for end-of-life care.7,8 
The World Health Organization promotes palliative care as the preferred approach to 
improve the quality of life of terminally-ill patients and their families.9 Several stu-
dies have evaluated the quality of care and the needs of terminally-ill patients in non-
primary care settings. Qualitative and quantitative studies showed that terminally-ill 
patients considered emotional support, pain and symptom management, and acces-
sibility as important aspects of the skills needed by physicians to providing end-of-life 
care.10-12 In the Netherlands, two studies incorporated qualitative interviews to inves-
tigate the experiences of patients with cancer who received end-of-life care at home. 
In these studies it was found that pain and symptom management, attention, involve-
ment and availability were important aspects of good end-of-life care.5,13 Few studies 
have focused on the viewpoint of GPs with regard to the quality of end-of-life care, and 
those that did, were based on structured questionnaires. Hence, the aspects that were 
rated did not emerge from the GP’s perspective. The GPs in these studies experienced 
care for dying people as rewarding and important.14 To our knowledge, no single study 
has yet combined the values of both patients and their own GP with regard to end-of-
life care.
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In Europe, the structure and goals of primary care are changing: the population is ageing 
with a growing demand for health care on the one hand, while the relative number of 
caregivers decreases. GPs will work more frequently in primary care cooperatives and 
more GPs will work part-time.15 These developments may threaten the core values of 
end-of-life care at home.
In order to investigate the nature of these core values of patients and their GPs with 
regard to end-of-life care, we conducted a qualitative study in primary care in which 
the viewpoints of both patients and their GPs regarding the quality of end-of-life care 
at home were described. The goal of this study was to explore the aspects valued in 
end-of-life care at home by patients and their GPs, and to reﬂ ect upon the results in 
the context of future developments in European primary care that may threaten these 
valued aspects. 
METHOD
GP selection
A total of 17 GPs who were following an advanced postgraduate training in end-of-life 
care, organised by the Dutch College of General Practitioners,16,17 agreed to participate 
in this study. To represent the opinions of GPs who were not trained in end-of-life care, 
and the opinions of their patients, we extended our sample: the GPs who agreed to par-
ticipate were asked to invite a colleague of theirs in the same district with no speciﬁ c 
interest in end-of-life care to participate. A total of 14 GPs with no speciﬁ c interest in 
end-of-life care agreed to participate, resulting in a total number of 31 participating 
GPs. 
Patient selection
After enrolment in the study, the GPs were asked to select for inclusion the ﬁ rst pa-
tient they encountered in their practice who met the following inclusion criteria: (1) a 
life expectancy of less than six months; (2) cancer, heart failure or chronic obstructive 
pulmonary disease (COPD) as underlying disease; (3) the GP was (one of) the primary 
caregiver(s), and (4) the patient had adequate command of the Dutch language. If for 
any reason, a GP did not approach a patient who met the inclusion criteria, the GP was 
asked to give the reasons for not doing so. If a patient met the inclusion criteria, the GP 
brieﬂ y described the study to this potential participant, and handed over an envelope 
containing an information sheet. The investigators then made an appointment with 
the patient to arrange an interview. Before the interview started the patient was asked 
to give informed consent. If the investigators could not make an appointment because 
the patient could not, or did not want to participate, the GP was asked to select the 
next patient who met the inclusion criteria. To include the potential range of opinions 
of patient views with different illnesses, we aimed to interview patients with the three 
most frequently presented terminal diseases in general practice: cancer, heart failure, 
and COPD,5 with both male and female patients in each group. 
Interviews
Semi-structured, in-depth interviews were carried out in the patients’ home. Patients 
were interviewed for 45-80 minutes guided by a topic list (Box 1). During most of the 
interviews a partner or family member was present, and their comments were welco-
med and included in the data. No information from the patient interview was made 
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known to the GP. Approximately two weeks after the patient interview the GP was in-
terviewed according to a similar topic list. All interviews were audiotaped, transcribed 
verbatim, and rendered anonymous. The investigators read the transcript while liste-
ning to an interview to ensure textual accuracy. The transcripts of the interviews then 
served as data. 
The interviews were performed by an academic researcher/pharmacist and a health 
sciences student. Prior to the interviews, both had followed an interview course, and 
during the entire interview period they were supervised by experienced qualitative re-
searchers. 
Analysis
All interview transcripts were analysed with support of QSR Nvivo 2.0, an established 
software package for ordering qualitative data. After 12 interviews, certain themes be-
gan to be repeated (data saturation). The investigators coded these ﬁ rst 12 transcripts 
independently to identify key themes, using the themes from the topic list and themes 
that the patients and the GPs considered to be important, as codes. In the subsequent 
interviews these themes were further developed until additional interviews provided 
no new information with respect to the research question. During the analysis, the 
authors ensured the validity of the results by critical discussion and searching for ca-
ses which seemed to verify or to conﬂ ict with the insights derived from the interim 
analysis.
RESULTS
Between January 2002 - August 2003, 20 GPs selected 31 patients who were receiving 
end-of-life care in their practices. In total, 11 GPs did not include any patients, six of 
whom were following the training in end-of-life care.
Patient characteristics 
A total of 30 patients were included in the study: one patient could not be interviewed 
because her condition suddenly worsened. In the interviews the GPs reported that 13 
patients had not been selected even though they met the inclusion criteria. The follo-
wing reasons for not selecting a patient were given by the GP: very short life expectancy; 
cognitively, physically or emotionally not capable of being interviewed; communication 
problems between patient and GP; and denial of terminal illness. 
During the study, patients with heart failure and COPD proved to be more difﬁ cult to 
recruit. As we had a limited time frame in which to hold the interviews, we asked all 
GPs, including those who had already included a patient, to select other patients who 
met the inclusion criteria and who had heart failure or COPD, in order to achieve our aim 
of including not only cancer patients, but also several patients with heart failure and 
COPD. In total 20 GPs included 30 patients: 14 GPs included one patient, three GPs inclu-
ded two patients, two GPs included three patients and one GP included four patients. 
Table 1 summarises the characteristics of the patients and GPs who were interviewed. 
Half of the patient population was between 70 - 80 years old, and more males (63%) 
than females (37%) were interviewed. Of the 14 non-cancer patients, seven had heart 
failure, four had COPD and three patients had both underlying illnesses. 
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Box 1.
Topics of the interview.
    Patient interview  GP interview
 •  Disease history  • Disease history
 •  Experience with care at home performed by the GP • Gxperience with care at home for this patient
 • Good care performed by the GP • good care for this patient
 • The ideal GP  • Good end-of-life care by the GP in general
     • What patients had not been approached and why
Table 1.
Demographic, clinical and practice characteristics of interviewees (30 patients and 20 GPs).
    Patients GPs 
     (n=30) (n=20)
 Male sex  19 (63%) 11 (55%)
 Median age (range)  78 (49-93) -
 Underlying disease  
  Cancer 16 (53%) -
  Non-cancer 14 (47%) -
 Median years of experience as GP (range) - 20.5 (6-33)
 Palliative care training  - 11 (55%)
 Solo practice - 8 (40%)
Aspects emerging from the analysis
The four items that were valued in end-of-life care by patients as well as GPs were 
availability of the GP for home visits and after ofﬁ ce hours, medical competence and 
cooperation with other professionals, attention and continuity of care. The aspect of 
attention was more prominent in the patient interviews. There was no indication of any 
differences in the aspects that were mentioned by (patients of) GPs who were trained 
in end-of-life care and their counterparts who were not trained. The citations shown 
are exemplary for the opinions of the patients and the GPs.
Availability of the GP 
Availability of the GP can be subdivided into the presence of the GP in the patient’s 
home during home visits, and the availability of the GP after ofﬁ ce hours. The inter-
views showed that most of the contacts between GPs and patients in end-of-life care 
were home visits:
  ‘The doctor came in and sat down, quite relaxed. She asked if I had any complaints, if 
anything needed to be done. She asked about the home care services… After the death 
of my wife, she discussed everything with me. She took all the time in the world for me.’ 
(Patient, male, 78, heart failure.)
This is a typical example of a home visit: by sitting down, the GP showed the patient 
that she had time, and then she enquired how things were going in general, and about 
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health-related issues in particular. The physical presence of the GP was a mixture of 
attention and interest. 
The availability of the GP was experienced positively by the patient: 
  ‘That she’s here whenever I need her. That’s what I consider good care. You see, she comes 
here once a week. Spontaneously, you know.’ (Patient, female, 49, breast cancer.)
GPs also considered regular home visits to be important. 
  ‘The most important thing [about good palliative care] is that you visit them. That 
you’re standing by, that they can call you, that there’s no barrier. I always try to make 
an appointment for the next visit when I’m there. Then they know they can count on 
you.’ (GP, cared for patient, male, 71, colon cancer.)
In the interviews, the patients stressed the importance of the availability of a GP in 
case of an emergency, during the weekend, or at night. Patients appreciated it very 
much if they could reach their own GP in case of an emergency:
  ‘When I need him, he’s there for me. I don’t need him that often. Nowadays that’s dif-
ferent, but when I need him, he’s there… I phone, or my children phone. I have his mobile 
number.’ (Patient, female, 80, heart failure.)
 
Some GPs gave patients their mobile or home number so that they could phone in ca-
ses of emergency in the evenings and at the weekends:
  ‘I’ve given him my home number so that he can call me. I’m not always at home in the 
weekends but when I’m there he can reach me. Because I think it’s important for him to 
have peace.’ (GP, cared for patient, male, 75, mesothelioma.)
Some patients reported a lack of care because their GP visited them rarely, although 
they could understand that their GP time was limited:
  ‘Once in a while a doctor comes by, and she sees me quickly and then she’s gone. We 
understand that they don’t do everything for you nowadays … but I really would appre-
ciate it if the doctor visited me once every couple of weeks to check on how I’m doing.’ 
(Patient, female, 77, heart failure.)
The GPs could not always satisfy the needs of their patients, due to lack of time and 
physical distance to the patient’s home: 
  ‘The medical care is not bad, but I think more support is appropriate sometimes… I 
think supportive and emotional care is only sometimes sufﬁ cient in some cases. But I 
honestly think that counts for many of us. Because these are all home visits it’s impos-
sible to manage. For GPs, it’s not reasonable any longer.’ (GP, cared for patient, female, 
78, heart failure.)
Medical competence and cooperation with other professionals
During the home visits the patients asked questions and told the GP about their medical 
problems and how they felt. Most patients described the GP’s competence indirectly by 
expressing their satisfaction with interventions and medication. Some patients men-
tioned competence explicitly:
  ‘A good GP, in this case doctor K, is someone who takes time to talk to you, even in these 
days, and someone who has adequate knowledge about my disease… She’s very compe-
tent. That’s what I consider very important.’ (Patient, female, 84, breast cancer.)
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GPs considered the treatment of physical and psychological symptoms to be an aspect 
of medical competence:  
  ‘For me at least, good palliative care is for me good medical care, it’s good history-ta-
king, carefully listening, a right diagnosis, and proper treatment.’ (GP, cared for patient, 
male, 80, COPD and heart failure.) 
According to the GPs, coordination of care and cooperation with other professionals 
were essential abilities of their medical competence in end-of-life care. GPs said they 
cooperated well with district nurses, the home care team, specialists and other GPs. 
Patients who received care from multiple healthcare professionals mentioned that 
good end-of-life care was dependent on cooperation and communication:
  ‘She [the GP] takes everything quietly. She talks with the nurses about those pills: 
should we do this or should we do that? Well, that’s it all about, isn’t it?’ (Patient, female, 
93, COPD and heart failure.)
However, some patients experienced problems with cooperation when too many pro-
fessionals were involved, and/or when they were not communicating well with each 
other: 
  ‘It’s difﬁ cult when you visit the hospital, and later the GP. It’s far easier if you visit only 
the hospital or the GP. They work against each other. They have other ideas. This is from 
the hospital, that’s from the GP. He [the GP] says “let’s try this [medicine]”. Then you 
visit the hospital again and they disapprove.’ (Patient, female, 80, heart failure.)
The link between medical competence and continuity of care is demonstrated by the 
following citation. Home visits had both a social and a medical goal: not only did the 
GPs show involvement with the patient and the patient’s family, they also dealt with 
current problems and could anticipate future problems. 
  ‘It’s [the disease] not predictable, like there’s some kind of scenario ready to use. Each 
time you have to evaluate: what are the current problems and how do I have to manage 
these? Some things you can foresee, so you can anticipate.’ (GP, cared for patient, female, 
55, breast cancer.)
Attention
Patients described attention from the GP as important element of good end-of-life 
care. They used terms such as, ‘appropriate time’, ‘peace during the contact’, as well 
as ‘openness’, ‘honesty’ and ‘carefully listening’. They also thought that a GP should 
‘communicate respectfully’ with them. The following citations contain some of these 
elements:
  ‘[A good doctor is] someone who listens, and accepts it when I’m down and takes time 
to listen to my story. Why am I terribly sad? And then, she tries to encourage me.’ (Pa-
tient, female, 72, heart failure.)
  ‘[Good GP care is] that he pays enough attention to you and doesn’t rush in saying “I 
can see it immediately”. And asks: “What can I do for you and what are the problems. 
Do you feel anything or do you feel nothing?”’ (Patient, male, 75, stomach cancer.)
The GPs did not describe attention as a separate or special element, but considered 
that attention for the patient and family was a normal aspect of the care provided:
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  ‘When I visit her, it’s like visiting an acquaintance, we talk about the weather and how 
things are going, how the children are, and we just have a pleasant conversation. Then, 
the medical and technical things come up, and also the perception of her illness.’ (GP, 
cared for patient, female 80, heart failure.) 
Continuity of care
The GP’s care for the patient usually started much earlier than the moment when the 
patient was diagnosed as terminally-ill - the patient and GP often shared a history:
  ‘Any other one [GP] could do the same [care], but he wouldn’t know that much about me. 
Through the years you develop a bond. And that’s when you call each other to account, 
when you trust each other.’ (Patient, female, 53, blood cancer.)
The interviews revealed that the GPs also knew, and often provided medical care and 
support for the patient’s partner and/or children. For example, one GP’s care was in-
ﬂ uenced by knowledge about the patient’s worries about a son with schizophrenia. 
Background information and a common history made end-of-life care easier, because 
the GP could interpret signals earlier and better:
  ‘When you’ve already done things well, and you reach a certain situation you don’t have 
to ask for information and you don’t have to explore, then you can talk easier and fall 
back on things. You know the patient, the family, and the environment. Yes, that mat-
ters. I mean, with Miss A, we obviously went through a very intensive period after the 
death of her husband. That was totally different, but you know the whole family.’ (GP, 
cared for patient, female, 86, breast cancer.)
A shared history, speciﬁ c medical knowledge about the disease, the background and 
family knowledge, were reasons why most patients preferred to be visited by their 
own GP. In some cases, familiarity with their own GP was a reason to postpone consul-
tation:
  ‘When we have to call for another doctor, well, we don’t like that. I don’t want that. We 
don’t like all those strange doctors, and they don’t know anything about my husband. 
Well, we’d rather wait till our own GP can come.’ (Partner of patient, male, 75 stomach 
cancer.)
DISCUSSION
Summary of main ﬁ ndings
Patients and GPs identiﬁ ed the same four core aspects valued in end-of-life care: avai-
lability of the GP for home visits and after ofﬁ ce-hours, medical competence and co-
operation with other professionals, attention and continuity of care. These values were 
identiﬁ ed by patients and their own GP, and by cancer patients as well as by non-cancer 
patients. 
Comparison with existing literature
The four core aspects valued in end-of-life care: availability of the GP for home visits 
and after ofﬁ ce-hours, medical competence and cooperation with other professionals, 
attention, and continuity of care: were identiﬁ ed separately in different patient popu-
lations,18,19 or by carers for terminally-ill patients.20 This is the ﬁ rst study where these 
values were found together, identiﬁ ed by patients and their own GP, and by cancer 
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patients as well as by non-cancer patients. The aspects valued in end-of-life care are 
comparable with those found in chronically ill patients.21,22 
The ability to coordinate care and cooperate with other health care professionals is 
an essential part of the competence of the GP, because end-of-life care at home is a 
team approach.23 The problems we found regarding cooperation and communication 
between health professionals, conﬁ rm the ﬁ ndings from other studies and show that 
these problems may be felt by patients. This conﬁ rms, once again, the paramount im-
portance of the quality of collaboration between GPs and other health professionals,24 
and of optimal interdisciplinary communication recognising the speciﬁ c contribution 
of each professional.25 
Some authors have tried to combine the results from different studies in a concep-
tual framework for good end-of-life care. Stewart et al. identiﬁ ed in their quality of 
life model three factors that determine quality of life in terminal care: (1) ﬁ xed pa-
tient and family factors, not amenable to change, (2) structure and process factors, 
and (3) outcome factors.26 The aspects mentioned by the patients and GPs in our study 
are also present in Stewarts model. Availability of the GP for home visits and medical 
competence are part of the categories of structure and process of terminal care. At-
tention is related to communication and interpersonal skills, which are elements of the 
process of terminal care. Continuity is also included in the (technical) process factors. 
The aspects we found are all at the level of structure and process of care; we found no 
outcome-related aspects of good end-of-life care. In our study, potential results of GP 
interventions, such as less pain or better symptom control, were less emphasised than 
the availability of the GP. One reason might be that the patients expected that GPs who 
were in the patients’ opinion medically competent, would achieve good control of pain 
and symptoms, or the lack of outcomes mentioned by the patients might be that the 
patients considered the importance of outcomes to be obvious. It might also be the 
opposite: the failure of health care to cure their illness or failure to achieve pain control 
in the hospital, may possibly have led to low expectations with regard to outcomes of 
care at home. 
Within their framework, Stewart et al. focus on outcome factors of terminal care, such 
as quality of life. Our ﬁ ndings suggest that their framework should be shifted to fo-
cus more on process and structure categories. With the increasing pressure from go-
vernment and health care funding agencies to evaluate the quality of the care that is 
provided,15 evaluations should not only be directed towards outcomes, but should also 
include the domains of structure and process. 
Strengths and the limitations of this study
Strengths of this study were that we included both GPs with and without special in-
terest in end-of-life care, and patients with cancer as well as non-cancer patients. The 
researchers were not involved in providing end-of-life care themselves and interviewed 
the patients and their GPs according to a similar topic list. A limitation of this study was 
that the patients were terminally-ill and largely dependent on their GP. This situation 
might limit free expression of thought, although we assured the patients that the in-
formation would remain conﬁ dential and that conﬁ dentiality was also assured for their 
own GP. Secondly, the GPs conﬁ rmed that they had made a selection of patients who 
they thought were suitable to be interviewed. Some GPs did not approach patients if 
the GP-patient communication was difﬁ cult, and did not approach patients who were in 
an instable phase of their illness. Hence, we probably interviewed the patients who were 
relatively healthy and who were satisﬁ ed with their GP. Patients who are less satisﬁ ed 
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and who are unstable may value different aspects, such as achieving pain control, be-
cause they may have a greater risk of poor symptom control. 
Implications for future research or clinical practice
Our study does raise some questions about the quality of future end-of-life care at 
home. Aspects valued in our study might be subject to developments in primary care 
which will change care at home and the role of the GP. First, home visits and adequate 
time for doctor-patient contacts are already under pressure.27 Home visits without a 
speciﬁ c intervention as a goal might not be covered by health insurances, and even if 
they are, the single rate that applies does not include the extra time needed for end-
of-life care. Although GPs consider end-of-life care to be rewarding, and an important 
aspect of primary care,14 they might be less willing to care for end-of-life patients if 
their efforts are not ﬁ nancially reimbursed.
Secondly, in primary care there are developments favouring more part-time jobs, wider 
career possibilities, fewer solo practices and local cooperation of GPs, especially with 
respect to after-ofﬁ ce-hours services.15,28,29 This is a threat for the personal continuity 
and after-ofﬁ ce-hours services for end-of-life care patients.30-32 It will be more difﬁ cult 
to organise personal continuity for part-timers, especially after ofﬁ ce hours. The wider 
career possibilities will make it easier for GPs to move to another practice during their 
career, and this will also decrease the duration of patient-doctor contacts.29 Large-scale 
organisation of after-ofﬁ ce-hours services by GP cooperatives will probably not only 
decrease the number of visits after ofﬁ ce hours, but will also imply that these visits will 
be made by a GP who is unfamiliar with the patient and the family. These developments 
are a challenge for general practice to ﬁ nd a way to both organise a modern primary 
care system, and to continue to provide good end-of-life care at home according to the 
valued aspects: availability of the GP for home visits and after ofﬁ ce hours, medical 
competence, attention and continuity of care. 
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ABSTRACT
•  Objective: public opinion and professional organisations dominate the euthanasia 
debate, and there is a need to understand the opinions of people confronted with 
euthanasia. The aim of this study was to investigate whether patients and their GPs 
talk about euthanasia, and if so, how they communicate about this. 
•  Methods: qualitative, semi-structured interviews were held with 20 GPs and 30 of 
their patients in primary care in the Netherlands, where euthanasia is legalised. The 
patients had a life-expectancy of less than six months, and cancer, heart failure or 
chronic obstructive pulmonary disease as underlying disease. 
•  Results: many patients did not communicate about euthanasia with their GP. Neither 
the patient nor the GP were clear in formulating their expectations concerning future 
decision making. 
•  Conclusion: the initial patient-GP communication consisted of an exchange of opinions 
about situations in which euthanasia would be desirable. GPs had different opinions 
about who should initiate communication, and found it difﬁ cult to judge the right mo-
ment to talk. 
•  Practice implications: it is essential to pay attention to education in communication 
about dying and euthanasia and to train the GPs to gain insight in the patient’s end-
of-life preferences, and to direct care at the best possible quality of life. 
INTRODUCTION
Health care in the Netherlands is characterized by a strong emphasis on primary care, 
where the GP is the central professional in the management and co-ordination of the 
patient’s treatment.1 Almost 60% of patients with a non-acute illness die at home,2 
and there is general consensus that palliative care should be provided there.3 In 2001, 
death was preceded by end-of-life decision-making in approximately 40% of all cases.4 
While 7% of patients had made an explicit request for euthanasia or assisted suicide, 
2.6% of all deaths were the result of euthanasia. GPs performed euthanasia more fre-
quently than all other doctors.4 
In the Netherlands, euthanasia is legal and is deﬁ ned as an act, undertaken by a third 
party, which intentionally ends the life of a person at his or her request.5 This decision 
is taken within the doctor-patient relationship, and societal control has been incorpo-
rated into post-death review procedures.6 Prudent practice is required of doctors and 
this includes the patient being well informed about diagnosis, prognosis, and treat-
ment options.6 Moreover, both doctor and patient must be convinced that there is no 
other reasonable option. In this process, communication between patient and doctor 
is essential. 
The status of euthanasia in relation to palliative care is not clear: some authors claim 
that euthanasia can be part of palliative care7, but most argue that there is no place for 
euthanasia in palliative care.8 The same standpoint is adopted in the World Health Or-
ganization (WHO) deﬁ nition which states that palliative care ‘intends neither to hasten 
nor postpone death’.9 The European Association of Palliative Care (EAPC) ethics task 
force says that ‘individual requests for euthanasia require respect, careful attention, 
together with open and sensitive communication’, and ‘provision of euthanasia should 
not be part of the responsibility of palliative care’.10 This makes the status of commu-
nication about euthanasia in palliative care ambiguous: while the two are considered 
87
incompatible, communication becomes essential. More insight is essential for a better 
understanding of the complex relationship between euthanasia and palliative care. 
In the current debate on euthanasia where the voices of professional organisations and 
politicians have been dominant, there is need for more understanding of the subjective 
experiences of those involved.11 Due to legalisation in the Netherlands, euthanasia can 
be one potential result of the communication process. In this context, we investigated 
the opinions of doctors and patients regarding good end-of-life care, using a qualitative 
design in primary care.12 This paper investigates an important research question that 
came up during that study: do terminally-ill patients and their GPs talk about euthana-
sia and, if so, how do they communicate about it, for instance about what topics and on 
whose initiative.
METHODS 
GP selection
Of 49 GPs following an intensive postgraduate course in end-of-life care, organised by 
the Dutch College of General Practitioners,13,14 17 agreed to participate in this study. To 
represent the opinions of GPs who were not trained in end-of-life care, and the opinions 
of their patients, we extended our sample: the GPs who agreed to participate were as-
ked to invite a colleague in the same district with no speciﬁ c interest in end-of-life care 
to participate also. A total of 14 GPs with no speciﬁ c interest in end-of-life care agreed, 
resulting in 31 GPs taking part, 20 of whom included one or more patient. 
Patient selection
After enrolment in the study, the GPs were asked to select for inclusion the ﬁ rst patient 
they encountered who met the following criteria: (1) a life-expectancy of less than six 
months; (2) cancer, heart failure or chronic obstructive pulmonary disease (COPD) as 
underlying disease; (3) the GP as (one of) the primary caregiver(s); and (4) an adequate 
command of the Dutch language. GPs who, for any reason, did not select a patient who 
met the inclusion criteria, were asked to give their reasons for not doing so. If a patient 
met the inclusion criteria, the GP brieﬂ y described the study to them, and handed over 
an envelope containing an information sheet. The investigators (SDB and CGR) then 
made an appointment with the patient for an interview. Before the interview the patient 
was asked to give informed consent. If the patient could not or did not want to participa-
te, the GP was asked to select the next patient who met the inclusion criteria. We aimed 
to include the opinions of both cancer patients and patients with the other two terminal 
diseases most frequently presented in general practice: heart failure and COPD.2 
Interviews
Semi-structured, in-depth interviews were carried out in the patient’s home. During 
most of these interviews a partner or relative was present. The interviews with the ﬁ rst 
12 patients and those with their GPs, started with the goal of exploring the aspects of 
end-of-life care at home most valued by both patients and GPs.12 As is usual in qualita-
tive research, interim analysis, steered subsequent data-collection and analysis. During 
the interim analysis we found that communication about euthanasia was an interes-
ting topic in most interviews. In subsequent interviews, we aimed to investigate this 
further, and therefore added the following questions: (1) did you talk (with your GP / with 
your patient) about euthanasia, and in the GP interviews (2) how do you communicate 
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with patients in general about euthanasia? If the answer to the ﬁ rst question was posi-
tive, we asked the interviewee to elaborate. 
Approximately two weeks after the patient interview, the GP was interviewed according 
to a similar topic list. No information from the patient interview was revealed to the GP. 
All interviews were audio-taped, transcribed verbatim, and rendered anonymous. The 
investigators read the transcript while listening to the interview to ensure textual ac-
curacy. The transcripts of the interviews then served as data. 
The interviewers were an academic researcher/pharmacist (SDB) and a health scientist 
(CGR). Prior to the interviews, both had followed an interview course, and during the 
interview period they were supervised by experienced qualitative researchers (ALF and 
DLW). 
Analysis
All interview transcripts were analysed with the support of QSR Nvivo 2.0, an established 
software package for ordering qualitative data. The fragments concerning euthanasia 
from all interviews were identiﬁ ed and coded by the two researchers according to the-
mes that patients and GPs considered to be important. During the analysis, the validity 
was ensured by critical discussion and by searching for cases which seemed either to 
verify or contradict the insights derived from the interim analysis.
RESULTS 
Patient characteristics
Between January 2002 and August 2003, 20 GPs recruited 31 patients receiving end-of-
life care; one patient could not be interviewed because her condition suddenly worse-
ned. A total of 11 GPs, six of whom were on the end-of-life care course, did not recruit 
any patient. In the interviews the GPs reported that 13 patients had not been selected, 
even though they met the inclusion criteria. They gave the following reasons for not 
selecting a patient: very short life-expectancy; cognitively, physically or emotionally 
unable to be interviewed; communication problems between patient and GP; and denial 
of terminal illness. 
During the study, patients with heart failure and COPD proved to be more difﬁ cult to 
recruit. As we had a limited time-frame in which to hold the interviews, we asked all 
GPs, including those who had already included a patient, to select other patients with 
heart failure or COPD who met the inclusion criteria in order to achieve our aim of in-
cluding not only cancer patients. As a result, 14 GPs each included one patient, three 
GPs included two patients, two GPs included three patients and one GP included four 
patients. 
Table 1 summarizes the characteristics of the patients and the GPs who were intervie-
wed. Half the patients were between 70 and 80 years old, and more men than women 
were interviewed. Of the 14 non-cancer patients, seven had heart failure, four had COPD 
and three had both illnesses. In 25 patient-interviews euthanasia was a topic, and in 14 
of these the patient and GP communicated about euthanasia (Table 2). 
Aspects emerging from the analysis
Four main aspects of communication about euthanasia emerged from the interviews: 
(1) many patients did not communicate about euthanasia, (2) future decision making, 
(3) clarifying and ﬁ ne-tuning, and (4) initiative and timing. 
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Table 1.
Demographic, clinical and practice characteristics of interviewees (30 patients and 20 GPs).
    Patients GPs 
     (n=30) (n=20)
 Male gender  19 (63%) 11 (55%)
 Median age (range)  78 (49-93) -
 Underlying disease  
  Cancer 16 (53%) -
  Non-cancer 14 (47%) -
 Median years of experience as GP (range) - 20.5 (6-33)
 Palliative care training  - 11 (55%)
 Solo practice - 8 (40%)
Table 2.
Patient and GP characteristics of all patients who mentioned euthanasia in the interview 
(n=25). 
    Did patient and GP communicate All patients who mentioned
    about euthanasia?   euthanasia in the interview 
    Yes (n=14)  No (n=11) (n=25)
 Patient characteristics   
 Underlying disease:   
  cancer 10  2 12
  non-cancer 4  9 13
 Gender   
  male 10  6 16
  female 4  5 9
 Age   
  > 78 years 7  3 10a
  ≤ 78 years 7  8 15
 GP characteristics of
 these patients   
 Training in palliative care   
  Yes 9  9 18b
  No 5  2 7
 Years of experience   
  > 20  6  5 11
  ≤ 20 8  6 14
a  Most younger patients had cancer (n=6 out of 10) and most older patients did not have cancer as underlying 
disease (n=9 out of 15).
b  GPs trained in palliative care included more non-cancer patients (n=11 out of 18), and GPs not trained in 
palliative care included more cancer patients (n=5 out of 7).
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Most quotations concerning euthanasia were from GPs. These reﬂ ect their experiences 
with euthanasia during their career, but do not necessarily involve communication with 
the patient(s) they had included in this study. The reason for this was that the patient 
and the GP had often not had extensive communication about it. The GPs found that pro-
blems around euthanasia usually arose closer to the end-of-life. There was no indication 
that whether the GP was or was not trained in end-of-life care made any difference. 
Many patients did not communicate about euthanasia
Table 2 shows that 11 out of 25 patients did not communicate about euthanasia. For 
many patients euthanasia was not an issue in their end-of-life trajectory, and therefore 
they did not feel it was necessary to talk about it. Sometimes patients had religious 
reasons for not wanting to talk about euthanasia:
  I don’t want to talk about euthanasia. Man proposes, God disposes. There’s nothing to 
decide about. (Patient, male, 78, COPD and heart failure.)
GPs said they often did not initiate communication with patients who were religious. 
However, there were religious patients who wanted to talk about euthanasia, and 
requested euthanasia.
Table 2 also shows that communication about euthanasia was more frequent with cancer 
patients than with non-cancer patients. This matched the experiences of GPs, that eu-
thanasia was more frequently a topic of communication with cancer patients:
  With them [patients with COPD or heart failure] you tend less to talk about euthanasia. 
Studies show how difﬁ cult it is to predict when someone with heart failure or COPD will 
die. And to say to them a year before they die: ‘what would you prefer when things get 
worse?’, that’s something you don’t do. So it might sound strange, but it doesn’t hap-
pen. (GP, cared for patient, male, 82 years heart failure.)
Future decision making 
In one interview, communication concerned an actual request for euthanasia. All other 
communications concerned future decision making. Patients and GPs exchanged opi-
nions about situations which could give rise to euthanasia requests. In some cases the 
communication was a (written) statement from the patient that he no longer wanted 
to live if the suffering was unbearable. Handing over a written request was not expe-
rienced as proper communication by one GP; a detailed discussion was a prerequisite 
to the communication process. 
When talking about euthanasia, patients had in mind situations in which their life would 
no longer be worth living. They often had an idea about how they did or did not want to 
die. The fear they expressed involved physical aspects of suffering such as pain:
  I wrote a request for euthanasia in the presence of Dr. E., she signed it, and I also signed 
it. She’s willing. I just wrote down that if I become paralysed, or if the pain is unbearable, 
and if I become a poor, little, ill woman, conﬁ ned to bed, then she is prepared to give me 
euthanasia. (Patient, 55, female, breast cancer.)
However, not all requests from patients were as clear as this. GPs were confronted by 
rather vague, more general requests:
  Patients often make indirect statements such as: ‘Doctor, you won’t let me down, will 
you?’ Well, what do they mean by such a statement, and how should we react? What do 
they expect? (GP, cared for patient, 55, female, breast cancer.)
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GPs mentioned that patients did not only speak about euthanasia; discussion was ac-
companied by exploring other end-of-life situations which provided insight into the 
patient’s end-of-life preferences. 
Clarifying and ﬁ ne-tuning 
In a typical response to a request, GPs promised they would support patients in the 
performance of euthanasia, on the condition that when the situation arose, the GP and 
the patient must both agree that it was the best option:
  Quite soon [after the diagnosis] the possibility of euthanasia was discussed in detail 
with him and his wife. He clearly stated that he didn’t want to go through hell and that 
when life really becomes unbearable, he will ask me for [active] euthanasia. I agreed, 
on the condition that I must also be convinced. (GP, cared for patient, 60, male, lung 
cancer.)
 Neither the patients nor the GPs were very clear in formulating their expectations 
about the conditions under which euthanasia would be performed. The following quote 
illustrates that communication often involved a general exchange of expectations:
  We talked about it (euthanasia) and my GP agrees. ‘Not for some time’, she says, ‘at the 
moment, you can still handle it.’ But as soon as it becomes too bad, I will say: ‘please 
bring this to an end.’ (Patient, 86, male, stomach cancer.) 
 An important aspect of communication was the clariﬁ cation of the euthanasia ques-
tion. What do the words ‘unbearable’ or ‘inhumane’ mean? Do patient and GP have the 
same view of what would justify euthanasia? One GP foresaw a potential dilemma. The 
patient and GP had not yet explored their views on what they meant by ‘unbearable’, 
hence it was unclear what they expected from each other:
  I told him that if the suffering really becomes unbearable, I think that he should not 
have to live any longer, but that I would do anything to make his life bearable. There 
are many possibilities, but I haven’t met a patient whose life became unbearable. At 
that moment we were both satisﬁ ed, and he had no further questions. It might become 
a problem when we reach a situation in which I think life is still worth living, and he 
doesn’t. (GP, cared for patient, 75, male, mesothelioma.)
Monitoring changes in opinion during the illness trajectory was important. A patient 
who said that she wanted euthanasia at the onset of her disease, changed her mind 
during the illness trajectory. Her GP expected that in the end, she would not require 
euthanasia.
Initiative and timing 
 Most GPs left the initiative to talk about euthanasia to their patients, but were sensi-
tive to signals that might indicate a patient’s wish to talk: 
  I have developed the policy that as long as people don’t raise the subject [euthanasia] 
themselves, I won’t be the one to start talking, although I am sensitive to signals. As 
soon as there is any indication, I will raise the subject. (GP, cared for patient, 75, male, 
oesophagus cancer.)
 Other GPs initiated the subject when they foresaw problems in the near future:
  Whether I raise the topic of euthanasia, depends on the situation. For example, with 
someone who has larynx carcinoma that can close up the throat, I raise the topic sooner 
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and more actively in case that occurs. Then everybody knows: what is preferred in that 
case. (GP, cared for patient, 80, male, COPD.)
GPs stated that it was difﬁ cult to judge the right moment for communication about eu-
thanasia. Some GPs took initiatives themselves to plan future activities, to co-ordinate 
care, and to communicate about the patient’s preferences. 
Another aspect according to some GPs was that they wanted to be sensitive and talk 
about the subject without suggesting that they promoted euthanasia:
  When the end of life is near, I want to make euthanasia a topic of consideration. Ho-
wever, I don’t want to put the words into their mouth. I’m always afraid that people 
will feel: ‘I must have euthanasia or else I’ll be a burden for the doctor or for everybody 
else.’ A request for euthanasia must come from the people themselves, when they feel 
there’s no way out. (GP, cared for patient, 68, male, lung cancer.)
Both patients and GPs acknowledged that it was an advantage if the GP had known the 
patient for a longer period and shared a common history, and if they could communicate 
in the patient’s home. 
DISCUSSION AND CONCLUSION
Discussion
We interviewed patients and GPs in one of the few countries in which euthanasia is 
legalised. Patients prepare themselves for a (worst case) scenario in which they might 
consider euthanasia. At the same time, GPs also anticipate the worst case scenario: 
a situation in which they are requested to administer lethal drugs. GPs had different 
opinions about whether they should initiate communication, and found it difﬁ cult to 
judge the right moment to do so. 
The strengths of this study is that we interviewed both patients and their GPs, using 
a similar topic list. We included GPs with and without special interest in end-of-life 
care, and patients with cancer and non-cancer as underlying disease. We assured the 
patients that the information would remain conﬁ dential and that conﬁ dentiality was 
guaranteed to their own GP. 
Obviously, our study has some limitations. The GPs admitted that they had selected 
patients who they thought were suitable to be interviewed. Hence, we probably inter-
viewed patients who were relatively healthy and satisﬁ ed with their GP. Due to good 
patient-doctor contact, euthanasia might be easier to talk about, and the GP more 
sensitive in reacting to signals. GPs mentioned their experiences with communication 
about euthanasia during their careers, while one interview was held with each patient. 
Hence, we collected more data on the experiences of GPs than of patients. Yet, given 
these limitations, we are of the opinion that they do not change the meaning of our 
ﬁ ndings.
In other countries, apart from Belgium, the performance of euthanasia is illegal and 
communication about euthanasia is less frequent.15 In studies directed at end-of-life 
communication the main barriers doctors identiﬁ ed were associated with the timing of 
communication,16 an aspect also found in our study. Most of the GPs we interviewed 
were careful, and some were reluctant, to initiate communication about euthanasia, 
and approximately half of the patients communicated with them on this subject. In the 
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context of euthanasia as one of the end-of-life options, we might have expected more 
communication. 
We also expected that more GPs would have initiated communication, because pa-
tients should be informed about all possible options to enable them to make informed 
decisions.17 It seems that the fact that euthanasia is legal does not make it any easier 
to initiate communication about it. In our opinion, open communication may result in 
agreement between patient and doctor on whether to perform euthanasia or not. With 
this in mind, it is unclear what the EAPC and WHO mean by open communication about 
euthanasia in the context of the explicit exclusion of the act.9,10 
Conclusion 
The initial communication between patient and GP consists of an exchange of opinions 
about possible situations in which euthanasia is desirable. GPs have different opinions 
about whether communication should be initiated by the patient or the GP, and ﬁ nd it 
difﬁ cult to judge the right moment to talk about euthanasia. 
Practice Implications
Since talking about death is experienced as difﬁ cult by doctors,18 it is essential to pay 
more attention to training in communication about death, dying and euthanasia.19 
Communication should be directed at end-of-life decisions that are allowed in each 
speciﬁ c regional setting. Not only to make good decisions, but also to gain insight in 
the patient’s end-of-life preferences that will allow doctors to direct care towards the 
best possible quality of life and death. 
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INTRODUCTION
The objective of this thesis was to investigate issues of current practice in end-of-life 
care in general practice in the Netherlands. Our main aim was to study epidemiological 
issues of end-of-life care in general practice: needs of patients receiving end-of-life 
care, indicators of quality of end-of-life care by the GP, and organisation of end-of-life 
care at home. We also aimed to explore the opinions of patients and their GPs. This 
chapter will discuss the methodology of the studies, examine the main results in the 
context of current literature and describe the implications for future research, practice 
and policy.
METHODOLOGICAL CONSIDERATIONS
In this thesis, we used two different types of data collection. Quantitative results were 
attained by combining the data collection of the second Dutch National Survey of Gene-
ral Practice (DNSGP-2) with an additional end-of-life care questionnaire. The latter was 
also used to identify the patients receiving end-of-life care. Qualitative data were ob-
tained by performing interviews with 30 patients receiving end-of-life care at home, and 
their general practitioners. In order to discuss the impact of the chosen study design 
and analysis on the results, we will describe the main strengths and weaknesses of our 
studies. 
Dutch National Survey of General Practice
Our study was embedded in the second Dutch National Survey of General Practice 
(DNSGP-2), a nationwide study of doctor-patient contacts in a representative sample 
of general practices in the Netherlands.1 This study generated complex and solid data 
about end-of-life care in general practice in the Netherlands. With the availability of 
this extensive database we selected the data relevant to the study of: needs of end-
of-life patients, quality of end-of-life care by the GP, and organisation of end-of-life 
care at home. 
The data in the DNSGP were collected prospectively. We were able to analyse patient-GP 
contacts and prescribing of pain medication over a three month period preceding death. 
A further strength of this study is the total response rate of 73% to the additional ques-
tionnaire, which is high compared to mean response rates of 61% reported in published 
studies carried out in general practice, and a trend of decreasing rates of response to 
mail questionnaires.2 As most studies in end-of-life care are limited to certain settings 
and to cancer patients3 a further strength is that this study is population based, hence 
including both cancer and non-cancer patients. 
However, this study had some limitations. The DNSGP-2 was not designed speciﬁ cally for 
end-of-life research, so there were no data available on several items that are relevant for 
end-of-life care. For example, there were no data available on the need for palliative care, 
the level of symptom control and whether the management by the GP resulted in impro-
vement of symptom control. Also, we measured symptoms that were prevalent in encoun-
ters according to physicians. In primary care, agreement between the patient’s and GP’s 
assessment on the prevalence of physical symptoms is acceptable,4 but it is likely that GPs 
did not register all the symptoms affecting these patients. Hence, it is likely that patients 
had other symptoms that did not result in a registration or in a patient-GP encounter, and 
that the numbers of symptoms-related encounters we found are underestimations of total 
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symptom prevalence in patients receiving end-of-life care at home. Nevertheless we may 
presume that the symptoms registered in the electronic medical records represent the 
most important symptoms for both the patient and the GP.
The results had primarily a descriptive character. Hence, we lacked detailed information 
about the GPs’ motivation for certain choices. An example of this is that we do no know 
why a GP-patient contact occurred or why GPs did or did not cooperate with other care 
providers. In this respect, we found important results, but these need to be interpreted 
carefully and this thesis evokes many new questions. Finally, we limited our longitu-
dinal analyses to the three months prior to death. This was a practical consideration 
as we had to balance a maximum time-frame to indicate developments in disease and 
care trajectories against the inclusion of as many patients as possible. 
Interviews
In our quantitative survey we investigated epidemiological issues, yet the viewpoints 
of both patients and their general practitioners regarding the quality of end-of-life 
care at home were unknown. In order to investigate the nature of the core values of 
patients and their GPs regarding end-of-life care, we conducted qualitative interviews 
with patients and their GPs. Strengths of this design were that we included both GPs 
with and without special interest in end-of-life care, and patients with cancer as well 
as non-cancer patients. The researchers were not involved in providing end-of-life care 
themselves and interviewed the patients and their GPs according to similar interview 
guides. We assured the patients that the information would remain conﬁ dential and 
that conﬁ dentiality was also assured for their GP.
Also, this qualitative data collection had some limitations. The GPs we interviewed con-
ﬁ rmed that they had made a selection of patients who they thought were suitable to 
be interviewed. Some GPs did not approach patients if the GP-patient communication 
was difﬁ cult, and did not approach patients who were in an instable phase of their ill-
ness. Hence, we probably interviewed the patients who were relatively well and who 
were satisﬁ ed with their GP. Patients who are less satisﬁ ed and who are instable, might 
value different aspects. For example, in patients with a greater risk of poor symptom 
control, aspects such as achieving symptom control might be more important compared 
to availability of the GP or attention. Also, due to the presumably better patient-physi-
cian contact in the patients interviewed, subjects such as euthanasia might have been 
easier to talk about, and GPs might have been more sensitive in exploring the patients’ 
signals. Furthermore, by interviewing these patients only once, we could not monitor 
any change in their opinions. Yet, given these limitations, we have the opinion that they 
did not substantially change our ﬁ ndings.
EPIDEMIOLOGICAL ISSUES OF END-OF-LIFE CARE IN GENERAL PRACTICE
Deﬁ ning the patient population
To a population that died while they were receiving care from their GP, we applied three 
different criteria for end-of-life care, namely (1) non-curative treatment, (2) palliative 
care or (3) death was expected (chapter 2). This made it possible to compare similarities 
and differences between the selected sub-populations. The criterion ‘death was expec-
ted’ included most patients (62%) followed by ‘palliative care’ (46%) and ‘non-curative 
treatment’ (39%). Similarity between the three deﬁ nition-based populations was fair 
to moderate. More ‘palliative care’ and ‘death was expected’ patients had cancer than 
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‘non-curative treatment’ patients, and the ‘palliative care’ population had more doctor-
patient contacts.
The labeling of patients by a caregiver, may possibly inﬂ uence patient care itself. In a stu-
dy focusing on patients with colon and lung cancer, patients whose GP considered the 
care to be palliative died earlier than those whose GP did not.5 This might indicate that 
the label ‘palliative care’ is associated with a more serious illness. Our study shows that 
the ‘palliative care’ population included patients who had more doctor-patient contacts 
than patients included by the other criteria, and that most of these patients had cancer. 
This supports the argument that palliative care is related to intensiﬁ ed care. However, the 
question is: do these patients receive the label ‘palliative care’ because they have can-
cer, or because they need and receive intensiﬁ ed care? If it is the ﬁ rst reason, patients 
with a chronic illness who are labeled as ‘death was expected’, but not as ‘palliative care’ 
patients, might possibly be excluded from receiving the more intensiﬁ ed care that they 
might need.
The ﬁ ndings of this study have implications for the understanding of the composition 
of populations included in end-of-life research. First, the overall distribution shows 
that there is little similarity between patient groups deﬁ ned as ‘end-of-life’ patients. 
It also illustrates the extreme difﬁ culty of deﬁ ning groups in end-of-life research. Fu-
ture research should focus on further investigation of the diversity in characteristics 
of end-of-life care populations. This is only possible if future studies describe in more 
detail the way in which their population is included. If we want to describe differences 
between sub-populations without omitting any potential end-of-life patients, we must 
apply the broadest possible inclusion criteria. Hence, we recommend the use of a com-
bination of different inclusion criteria, which should include at least ‘palliative care’ as 
labeled by (professional) carers, the intention of the palliative care treatment provided, 
and an assessment of the patient’s life-expectancy. 
Needs of end-of-life patients: prevalence of symptoms
In the patients who died at home and who received care until death by their GP, digestive 
symptoms (59%), pain (56%) and psychosocial symptoms (45%) were most prevalent 
in the patient-physician encounters in the last three months of life (Chapter 3). Also, 
musculoskeletal symptoms (20%), chronic ulcer (18%) and requests for/ talking about 
euthanasia (14%) were prevalent. The mean number of encounters about any symptom 
in the last three months of life was higher in cancer patients (11.99) than in non-cancer 
patients (7.62). Also, in younger patients the prevalence of digestive symptoms, pain 
and psychological symptoms was higher than in the elderly. Most symptoms (36%) 
were concentrated in the last two weeks of life.
Our study conﬁ rms the results of other studies that also found that the prevalence of 
symptoms was higher in cancer patients and in younger patients.6,7 Younger patients 
have more encounters about symptoms, which can be explained by the possibility that 
they can stay at home with a more severe disease because they have a reliable sup-
port system.8 Another explanation is that older and non-cancer patients need fewer 
contact because they have a more mitigated disease trajectory.9 Our study is based 
on symptoms registered during encounters, where most other studies measured 
symptoms that were prevalent using a list of possible symptoms, e.g. the Palliative 
care Outcome Scale (POS) or the Edmonton Symptom Assessment System (ESAS).10,11 
Hence, symptom prevalence might be underreported in our study. 
However, the diversity of symptoms is probably larger: not reported in previous end-
of-life studies were musculoskeletal symptoms and chronic ulcer. These are probably 
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typical examples of everyday problems encountered in general practice. This suggest 
that both typical end-of-life symptoms such as pain and digestive tract symptoms, 
and everyday symptoms inﬂ uence the patient’s quality of life. 
In the last two weeks of life we found an increase in the symptoms that are prevalent 
(chapter 3). Also, we found a similar increase in the management of the symptom pain 
by prescribing pain medication (Chapter 4). This development occurs in cancer as well in 
non-cancer patients. This concentrations of symptoms in the last weeks before death 
strongly suggests that this development corresponds with the patient’s needs for pain 
and symptom management. The exponential character of the prevalence of pain and 
symptoms has not been described in end-of-life populations in general practice, and is 
in contrast with the gradual development of symptoms in patients receiving end-of-
life care in nursing homes.12 
Quality of end-of-life care by the GP: prescribing of pain medication
In the DNSGP we were unable to ask patients directly about the quality of end-of-life 
care they received from their GPs, hence we measured indicators of quality of care in an 
indirect way (Chapter 4). Out of many aspects of quality in end-of-life care, we focussed 
on two speciﬁ c indicators for quality of prescribing, namely (1) whether GPs prescri-
bed analgesics according to the World Health Organization (WHO) analgesic ladder, and 
(2) if opioids were combined with laxatives. The WHO analgesic ladder is composed of 
three steps of pharmacological therapy: step 1 involves the analgesics paracetamol and 
nonsteroidal anti-inﬂ ammatory drugs (NSAIDs), step 2 opioids for mild to moderate 
pain (e.g. tramadol and codeine) and step 3 includes opioids for moderate to severe 
pain (e.g. morphine and phentanyl).13 According to the same WHO guideline a laxative 
should be given when an opioid is prescribed. Our study showed that the prescribing of 
GPs differs considerably from these guidelines. Of the patients who were prescribed a 
step 1 analgesic, 40% was prescribed a step 3 opioid without having been prescribed a 
step 2 analgesic. A total of 60% of the non-cancer patients and 41% of the cancer pa-
tients was prescribed an opioid without any prescribed laxative, and 14% of all patients 
was prescribed a laxative three or more days after the start of the opioid.
In our study population, 27% of patients receiving end-of-life care at home, and 19% of 
the cancer patients, were not prescribed analgesics. Although pain is extremely common 
in cancer patients, studies report a wide variation in the prevalence of pain (33-88%).14 The 
proportion of patients receiving a prescription for analgesics in our study, is comparable to 
numbers found in other studies.14;15 Future studies need to investigate why these patients 
are not prescribed analgesics: because there is no need for pharmacological management 
of pain, or because GPs do not adequately manage pain.
Another result was that family doctors often skip the second step of the ladder. Althou-
gh we have not collected data on the level of pain control, the exponential increase of 
prescriptions for strong opioids nearing the patient’s death suggests a corresponding 
increase in pain. Our data imply that for the optimal management of pain, some patients 
might beneﬁ t from the omission of step 2 of the WHO analgesic ladder, as suggested by 
other authors.17 
The proportion of patients who are prescribed laxatives as co-medication is low, although 
this combination is advised in most guidelines.13,18,19 Possibly, prescribing co-medication 
is difﬁ cult to keep in mind for the GP, and this aspect needs more attention in educa-
tion and/or collaboration with pharmacists.20 On the other hand, it might also be that 
there is a substantial proportion of patients who will not beneﬁ t from the prescription of 
laxatives, and GPs in some way are able to discriminate between patients. The question 
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of whether laxatives need to be prescribed to all patients using opioids, is even more 
important to the non-cancer patients as 60% of them do not receive the laxatives they 
might beneﬁ t from. 
Organisation of end-of-life care at home: cooperation between GPs and other 
caregivers 
In almost all cases of patients receiving end-of-life care at home in the Netherlands, 
the GP cooperated with at least one other caregiver, with a mean number of four col-
laborators (Chapter 5). In patients receiving end-of-life care, GP cooperation with other 
caregivers is highly prevalent, with informal caregivers and other primary caregivers the 
most common. The best determinants for cooperation between GPs and other caregivers 
were the patient’s age, the underlying disease and the importance of psychosocial care 
in the care for the actual patient. Cooperation was more prevalent in younger patients, 
patients with cancer as underlying disease, and when psychosocial care was important.
With a mean of four collaborators for each patient receiving end-of-life care, GPs reﬂ ec-
ted the goal of end-of-life care as a multidisciplinary approach.21 In most patients the GP 
works with one collaborator at a level labelled as intensive, and in most cases this was 
the informal caregiver or the district nurse. However, with the aim of directing end-of-life 
care at ‘the patient and their family’21 cooperation with informal caregivers can be impro-
ved to meet the concerns of both patients and their informal carers.22 In about two thirds 
of patients GPs cooperated with district nurses (DNs). This was not considered to be a 
low ﬁ gure, as DNs are involved with more serious physical and psychosocial problems, or 
when technical bedside expertise is needed. 
GP cooperation with colleague GPs was only present in about half of the patients. We 
consider this low as patient information is expected to be handed over after ofﬁ ce 
hours. In the Netherlands over 90% of the population is covered by out-of-hours coo-
peratives.23 It is possible that GPs care for their terminally-ill patients themselves, or 
that GPs do not deﬁ ne handing over patient information as cooperation. Although this 
needs future exploration, it does question the quality of communication and continuity 
by the GP during out-of-ofﬁ ce hours, a difﬁ cult area in end-of-life care at home.24
The most striking determinant of GP cooperation with other caregivers was the importance 
of psychosocial caring in care for the actual patient. This ﬁ nding is difﬁ cult to interpret, as 
we have no data on the content of the collaboration. An explanation may be that the nature 
of the psychosocial problems itself may demand more communication and coordination25, 
or that the prevalence of psychosocial problems is intertwined with somatic issues.26 This 
suggests that communication is not only important in the patient-GP relationship, but 
also in contacts with other care providers.
OPINIONS OF PATIENTS AND THEIR GPs
Good end-of-life care
Patients and GPs identiﬁ ed the same four core aspects as most valued in end-of-life 
care: availability of the GP for home visits and after ofﬁ ce-hours; medical competence 
and cooperation with other professionals; attention; and continuity of care (Chapter 6). 
These values were identiﬁ ed and agreed upon by both patients and their GPs, and by 
cancer patients as well as by non-cancer patients. 
The aspects valued in end-of-life care are comparable with those found in chronically ill 
patients.27,28 Some authors have tried to combine the results from different studies in a 
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conceptual framework for good end-of-life care. Stewart et al. identiﬁ ed in their quality 
of life model three factors that affect quality of life in terminal care: (1) ﬁ xed patient 
and family factors, not amenable to change (2) structure and process factors, and (3) 
outcome factors (Figure 1).29 
 
Figure 1. 
Overall conceptual model of factors affecting quality and length of life of dying patients and their families. 
(Used from Stewart et al.)29 
The aspects mentioned by the patients and GPs in our study are also present in Ste-
wart’s model. Availability of the GP for home visits and medical competence are part of 
the categories of structure and process of terminal care. Attention is related to com-
munication and interpersonal skills, which are elements of the process of terminal 
care. Continuity is also included with the (technical) process factors. The aspects we 
found are all at the level of structure and process of care; we found no outcome-related 
aspects of good end-of-life care. 
In our study potential results of GP interventions, such as less pain or better symptom 
control, were emphasised less than was the availability of the GP. One reason might be 
that patients expected that GPs, in the patients’ opinion medically competent, would 
achieve good control of pain and symptoms; alternatively the lack of outcomes men-
tioned by patients might be because they considered the importance of outcomes to 
be obvious. It might also be the opposite: the failure of health care to cure their illness, 
may possibly have led to low expectations with regard to outcomes of care at home. 
Future studies should investigate how different domains in end-of-life care are related 
and interact.
Communication about euthanasia
Communication about euthanasia does not always mean that the patient has an actual 
request for euthanasia (Chapter 7). Patients prepare themselves for a (worst case) scena-
rio in which they might consider euthanasia. At the same time, GPs are also anticipating 
their (worst case) scenario: a situation in which they are requested to administer lethal 
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drugs. GPs had different opinions about whether they should initiate communication on 
euthanasia, and found it difﬁ cult to judge the right moment to start talking about it. Also 
when their GP started talking about euthanasia, patients expressed their own opinions 
in favour as well as against euthanasia.
In this study, most of the GPs were cautious, and some were even reluctant to initiate 
communication about euthanasia, and approximately half of the patients communi-
cated with their GPs on this subject. In the context of euthanasia as one of the end-
of-life options, we had expected more communication. We also expected that more 
GPs would have initiated communication, because patients should be informed about 
all possible options to enable them to make informed end-of-life decisions.30 It seems 
that the legality in the Netherlands of euthanasia does not make it easy to initiate 
communication about this subject. GPs might fear that starting to talk about it will 
increase the possibility that the patient will actually request euthanasia, but this was 
not mentioned by our patients or GPs. In our opinion, open communication may result 
in agreement between patient and doctor on whether or not to perform euthanasia. 
IMPLICATIONS OF THE RESULTS
In this thesis we presented answers to some questions about issues in end-of-life care 
in general practice. Also, this thesis raised new questions. By discussing some of the 
implications of these answers and questions, we want to stimulate further research, 
improvement of practice and development of policy concerning end-of-life care. 
Implications for further research
In our qualitative study we found four core values of good end-of-life care in gene-
ral practice: availability of the GP for home visits and after ofﬁ ce-hours, medical com-
petence and cooperation with other professionals, attention and continuity of care 
(Chapter 6). Although these are core values according to patients and their GPs, due to 
the selection bias in this small-scale qualitative study, we have to be careful to gene-
ralise these ﬁ ndings. Patients not included in our study, might value different aspects 
as core values. Hence, to assess good end-of-life of care in general practice, we need to 
conﬁ rm our qualitative ﬁ ndings in representative patient populations.
We have studied three epidemiological issues of end-of-life care in general practice: 
needs of patients receiving end-of-life care, quality indicators of end-of-life care de-
livered by the GP, and cooperation in organisation of end-of-life care at home (Chapters 
3, 4 and 5). We found associations between patient characteristics and patient’s needs, 
quality of care and organisation, however, we were unable to measure outcomes of 
care. The study design was not directed to examine end-of-life care. Hence, it was not 
possible to investigate relations between symptoms prevalent in patients, symptom 
management by the GP, achieved symptom control, and the speciﬁ c contributions of 
the caregivers involved. To investigate aspects of quality of end-of-life care in general 
practice in more detail, future studies should be designed to examine these relations 
between patient characteristics, symptoms prevalent in patients, care provided by 
GPs, achieved symptom control and cooperation between different care providers.
The epidemiological issues we examined were related to quality of end-of-life care. 
Symptoms that were prevalent, may indicate a need for symptom management (Chap-
ter 3). Non-compliance to guidelines of prescribing might mean that patients were not 
treated well (Chapter 4), and few other caregivers that cooperated with the GP could 
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mean that knowledge and experience of other caregivers does not contribute to the 
end-of-life care of the patient in question (Chapter 5). These issues, however, do not 
measure whether the care provided by the GP was sufﬁ cient, or how end-of-life care at 
home might be improved. Therefore, we should ﬁ rst be able to measure quality of care, 
and changes in quality of end-of-life care.31 When do we consider end-of-life care at 
home as good? Indicators of quality of care could be deﬁ ned as ‘measurable elements 
of practice performance for which there is evidence or consensus that it can be used 
to assess the quality, and hence the change in the quality of care provided’.32 Howe-
ver, these indicators are not yet well developed in end-of-life care and future research 
should be directed to developing more valid, reliable and responsive quality indicators 
for end-of-life care at home. 
The development of quality indicators for end-of-life care is complex, and faces three 
major challenges. First, there is a lack of measurable elements of practice performance. 
Second, it is difﬁ cult to determine what is ‘good’ end-of-life care. Third, interpretation 
of scores on quality indicators can be problematic, certainly in end-of-life care. 
A lot of possible indicators for quality in end-of-life care have been suggested with re-
gard to the ﬁ rst challenge: the development of measurable elements. Some authors 
have ordered these indicators into comprehensive models, with models of Emanuel 
and Emanuel, and the model of Stewart showed in Figure 1 on page 103 as examples 
of such an approach.29,33 However, for only a few of the aspects, validated instruments 
have been developed to measure them.34 Future research should ﬁ rst aim to develop a 
comprehensive set of validated instruments for the measurement of relevant concepts 
in end-of-life care. 
But even with the availability of good instruments to measure the relevant concepts, 
we face a second normative and conceptual challenge: the task of deﬁ ning the desired 
level of care. How, and from whose perspective, do we deﬁ ne what is ‘good’ in end-of-life 
care? This challenge is complex because end-of-life care is directed at the ‘improvement 
of the quality of life of patients and their families’.21 Due to the incorporation of the per-
spective of both the patient and his family, the determination of the goals in the actual 
care is reached by a process of shared decision making between the patient, the family 
and the GP. It may be that the professional opinion of the GP will conﬂ ict with individual 
preferences of patients and/or families.35 The complexity of problems in end-of-life care 
and the importance of the patient, the family and the professional perspective, might 
make it more difﬁ cult to assess the desired level of quality, compared with other ﬁ elds 
of medicine, where it is easier to predict the outcomes of shared decision making. This 
second challenge asks future studies to determine what is ‘good’, and to ﬁ nd ways to 
incorporate both professional knowledge and the perspective of the individual patients 
and their families in quality indicators of end-of-life care. 
The irregular course of illness trajectories at the end-of-life is a third challenge in 
measuring the quality of care at the end of life (Chapters 3 and 4). It might be that 
initial goals determined for certain aspects of an individual patient’s care will not be 
achieved although optimal quality of care has been given. Reasons for this could be 
that the progress of the disease will have a more negative effect on certain outcomes, 
than the positive effect of intervention(s). Also, goals can be changed because priori-
ties in care may shift throughout the disease trajectory. This illustrates that quality 
indicators in end-of-life care need to be responsive to changing circumstances, hence 
future research should also take into account this perspective when determining qua-
lity indicators.
In conclusion, future research has to develop quality indicators to assess and improve 
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the actual quality of end-of-life care. Only with a good set of quality indicators, we will 
be able to measure the quality of end-of-life care at home and compare it with care 
settings, and to monitor changes in quality over time in relation to developments in 
demographics and the performance and organisation of end-of-life care. 
  
Practice implications 
The studies performed as part of this thesis have some implications for the practice 
of end-of-life care at home. We will discuss how the four core aspects found as most 
valued in end-of-life care might inﬂ uence daily practice. Also, we will examine the con-
sequences of the complex character of end-of-life care and the knowledge and skills 
that are needed in the care of the terminally-ill. Furthermore, we will talk about the 
role of the GP in relation to patients who need spiritual care and communication about 
euthanasia. Finally, we will discuss the possible implications for cooperation with other 
care providers in primary care.
The four core aspects found as most valued in end-of-life care were availability of the 
GP for home visits and after ofﬁ ce-hours; medical competence and cooperation with 
other professionals; attention; and continuity of care (Chapter 6). We did not investi-
gate how GPs were able to perform end-of-life care and what problems they encoun-
tered. However, GPs might incorporate the aspects found as most valued in end-of-life 
care in the organisation of their activities. Home visits might be planned in advance, 
and patients might be given information on who will be available during out-of-ofﬁ ce 
hours, when the GP is not available himself. GPs should make sufﬁ cient time for home 
visits to give patients attention and to allow them to talk about their most important 
concerns. An essential condition to cooperate with other caregivers is that GPs need 
to know how and when they can reach these caregivers. It should also be clear how in-
formation between the patients, the GP and other caregivers will be transferred. When 
personal continuity by one GP cannot be achieved, it should be clear for the patients 
and other caregivers which GPs are involved in end-of-life care and who is responsible. 
In conclusion, anticipation and communication on aspects valued in end-of-life care, 
may bring the patient and the GP clarity and peace, and hence contribute to the quality 
of end-of-life care. 
GPs encounter a wide range of problems in patients receiving end-of-life care in general 
practice, and cooperate with many other caregivers (Chapters 3 and 5). Some problems 
are speciﬁ c to end-of-life care such as pain and digestive tract symptoms, while other 
are also typical problems in a common population of the elderly, such as musculoskel-
tal problems and chronic ulcer. Management of symptoms in terminally-ill patients can 
sometimes be complex. At the same time GPs do not care for that many patients at the 
end of their life. Hence, they build up their experience over years, and need to be sup-
ported by specialised knowledge, e.g. by access to a colleague who is (better) trained in 
end-of-life care. In this respect, the support of a consultation team, and the training of 
GPs or other physicians with specialised knowledge in end-of-life care are essential to 
safeguard good end-of-life care provided by the GP at home. 
Not only pain and physical symptoms require special attention; psychosocial and spiritual 
issues are also part of end-of-life care. Our study showed that with regard to patients in 
whom psychosocial and spiritual issues are important in end-of-life care, GPs more often 
cooperate with colleagues (Chapter 5). As they hardly cooperate with social workers and 
spiritual caregivers, GPs probably deal with these problems themselves, or entrust this 
care to other caregivers not speciﬁ cally trained in these issues such as district nurses 
(DNs). Also possible is that it is not seen as the GP’s task to provide spiritual or social care, 
107
or the GPs may not recognise or respond adequately to patients with these problems. In 
conclusion, GPs need to pay attention to the possibility of psychosocial or spiritual care 
needs in each patient, and communicate with the patient and the caregivers involved 
who will care for these needs. 
As hastening death is a legalised option within medical practice in the Netherlands, it 
is essential to pay more attention to training in communication about death, dying and 
euthanasia. Guidelines, as being developed in Belgium, may support the GP’s need to 
ﬁ nd answers to their individual questions.36 Although euthanasia is only legalised in a 
few countries, this does not mean that patients in other countries do not have a need 
for doctors who communicate well about difﬁ cult end-of-life decisions also. Commu-
nication about end-of-life preferences will allow GPs to direct care for the individual 
patient towards the best possible quality of life and quality of dying. 
Finally, the quality of life may also be enhanced by more cooperation with other care 
providers. Given the complexity of end-of-life care and the diversity of problems that 
may require attention, the involvement of all necessary disciplines must be encou-
raged and facilitated. On the other hand, the number of caregivers needs to be limited 
because patients and family prefer continuity of care with a few caregivers37, and pa-
tients and family caregivers are often reluctant to accept help from others than their 
own GP. One of the caregivers involved in end-of-life care must be responsible for the 
organisation of the involvement of all relevant disciplines. In end-of-life care at home, 
GPs or DNs could perform this task38, however there is still discussion on who should 
be in charge.39-41 For the patient, this is less important as long as a competent care-
giver performs this task. The same goes for prescribing optimal drugs. We have shown 
that not all GPs follow accepted guidelines. First, as we have discussed in the previous 
section, this could mean the guidelines do not comply with the best quality of care 
and GPs have developed this knowledge somehow in their practice. To perform optimal 
pharmaceutical end-of-life care, we would encourage GPs and pharmacists to coope-
rate and attune their practices. One promising development in health care organisation 
is the development of the Electronic Patient Record, in which health care providers can 
register patients’ needs, interventions and outcomes.42 When privacy issues will be 
adequately addressed, this is a promising tool to support continuity, cooperation and 
communication between all health care providers involved in end-of-life care.
Implications for policy
Our study does raise some questions about the quality of future end-of-life care at 
home. Aspects valued in our study might be subject to transitions in demographics 
and primary care which will change the size and structure of the population, the care 
at home and the role of the GP. The population in the Netherlands is ageing, with an 
expected maximum of four million inhabitants aged over 65 in 2040, compared to the 
current 2.5 million.43 In the ageing society, the number of deaths will increase with a 
growing demand for end-of-life care as a result. Meanwhile, the structure and goals of 
primary care will change: the relative number of care-givers decreases, while GPs will 
work more frequently in primary care cooperatives and more GPs will work part-time.44 
The current role of the GP in end-of-life care, and the core values of good end-of-life 
care according to patients and their GPs, might be threatened by these developments. 
First, we will discuss the implications of future changes in the organisation of GP care, 
and second we will put forward some questions that need to be addressed politically in 
order to anticipate these future developments.
First, in primary care there are developments favouring more part-time jobs, wider career 
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possibilities, fewer solo practices and less local cooperation of GPs, especially with respect 
to after ofﬁ ce-hours services.44-46 This could become a threat to the personal continuity 
of care and after ofﬁ ce-hours services for end-of-life care patients.47-48 It will be more dif-
ﬁ cult to organise personal continuity for part-timers, especially after ofﬁ ce-hours. The 
wider career possibilities will make it easier for GPs to move to other practices during their 
careers, and this will also decrease the duration of patient-doctor relation.46 Large-scale 
organisation of after ofﬁ ce-hours services by GP cooperatives will probably not only de-
crease the number of visits after ofﬁ ce hours, but will also imply that these visits will be 
made by a GP who is unfamiliar with the patient and the family. 
Second, the government has to anticipate these developments in order to organise and 
ﬁ nance the care that will be needed. Can we make dying at home possible for all pa-
tients, and if not, for which patients do we want to make dying at home accessible, and 
for which patients we do have to organise good end-of-life care in another setting? And 
when we look at those aspects of end-of-life care which are most highly valued, such as 
home visits and attention, how much care should be provided? How will we determine 
the difference between comfort and care? And when discomfort, symptom burden or 
loneliness eventually contribute to a low(er) quality of life, whose responsibility is it to 
organise care and/or comfort for this patient? To determine ‘quality’ in future end-of-
life care at home, and the responsibilities of the patients and the caregivers involved, 
we need continuing attention and discussion within society. That discussion is needed 
in order to direct future developments of end-of-life care at home, and the position of 
the GP.
REFERENCES
1.   Westert GP, Schellevis FG, de Bakker DH, et al. Monitoring health inequalities through general practice: 
the Second Dutch National Survey of General Practice. Eur J Public Health 2005;15:59-65.
2.   Sibbald B, Addington-Hall J, Brenneman D, Freeling P. Telephone versus postal surveys of general practi-
tioners: methodological considerations. Br J Gen Pract 1994;44:297-300.
3.   George LK. Research design in end-of-life research: state of science. Gerontologist 2002;42 Spec No 
3:86-98.
4.   Ewing G, Rogers M, Barclay S, et al. Palliative care in primary care: a study to determine whether patients 
and professionals agree on symptoms. Br J Gen Pract 2006;56:27-34.
5.   Farquhar M, Grande G, Todd C, Barclay S. Deﬁ ning patients as palliative: hospital doctors’ versus general 
practitioners’ perceptions. Palliat Med 2002;16:247-250.
6.   Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and per-
formance status in 1,000 patients. Support Care Cancer 2000;8:175-9.
7.   Morita T, Tsunoda J, Inoue S, Chihara S. Contributing factors to physical symptoms in terminally-ill can-
cer patients. J Pain Symptom Manage 1999;18:338-346.
8.  Walsh D, Regan J. Terminal care in the home--the general practice perspective. Ir Med J 2001;94:9-11.
9.   Teno JM, Weitzen S, Fennell ML, Mor V. Dying trajectory in the last year of life: does cancer trajectory ﬁ t 
other diseases? J Palliat Med 2001;4:457-64.
10.   Hearn J, Higginson IJ. Development and validation of a core outcome measure for palliative care: the pal-
liative care outcome scale. Qual Health Care 1999;8:219-227.
11.   Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): A simple me-
thod for the assessment of palliative care patients. J Palliat Care 2000;7:6-9.
12.   Echteld MA, Deliens L, Ooms ME, et al. Quality of life change and response shift in patients admitted to 
palliative care units: a pilot study. Palliat Med 2005;19:381-388.
109
13.   WHO. Cancer pain relief: with a guide to opioid availability. 2nd edition. Geneva, World Health Organiza-
tion. 1996.
14.   Higginson IJ, Hearn J. A multicenter evaluation of cancer pain control by palliative care teams. J Pain 
Symptom Manage 1997;14:29-35.
15.   Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up 
care at home. Cancer 1999;85:1849-1858.
16.   Curtis EB, Walsh TD. Prescribing practices of a palliative care service. J Pain Symptom Manage 1993;8:312-316.
17.   Maltoni M, Scarpi E, Modonesi C, et al. A validation study of the WHO analgesic ladder: a two-step vs 
three-step strategy. Support Care Cancer 2005;13:888-894.
18.   Hanks GW, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recom-
mendations. Br J Cancer 2001;84:587-593.
19.   Gordon DB, Dahl JL, Miaskowski C, et al. American pain society recommendations for improving the qua-
lity of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern 
Med 2005;165:1574-1580.
20.   Bouvy ML, Buurma H, Egberts TC. Laxative prescribing in relation to opioid use and the inﬂ uence of 
pharmacy-based intervention. J Clin Pharm Ther 2002;27:107-110.
21.   WHO. National cancer control programmes : policies and managerial guidelines. Geneva: World Health 
Organization, 2002.
22.   Harding R, Higginson IJ, Leam C, et al. Evaluation of a short-term group intervention for informal carers 
of patients attending a home palliative care service. J Pain Symptom Manage 2004;27:396-408.
23.  Uden CJTh, Studies on general practice out-of-hours care. 2005. Maastricht University. 
24.   Worth A, Boyd K, Kendall M, et al. Out-of-hours palliative care: a qualitative study of cancer patients, 
carers and professionals. Br J Gen Pract 2006;56:6-13.
25.   National Breast Cancer Centre and National Cancer Control Initiative. Clinical practice guidelines for the 
psychosocial care of adults with cancer. 2003. Sydney, National Breast Cancer Centre. 
26.   Schulman-Green DJ. Psychosocial issues in palliative care: physicians’ self-perceived role and collabora-
tion with hospital staff. Am J Hosp Palliat Care 2003;20:34-40.
27.   Infante FA, Proudfoot JG, Powell DG, et al. How people with chronic illnesses view their care in general 
practice: a qualitative study. Med J Aust 2004;181:70-73.
28.  Murray SA, Boyd K, Sheikh A. Palliative care in chronic illness. BMJ 2005;330:611-612.
29.   Stewart AL, Teno J, Patrick DL, Lynn J. The concept of quality of life of dying persons in the context of 
health care. J Pain Symptom Manage 1999;17:93-108.
30.   Hermsen M, Ten Have H. Decision-making in palliative care practice and the need for moral deliberation: 
a qualitative study. Patient Educ Couns 2005;56:268-275.
31.   Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and ap-
plying quality indicators in primary care. BMJ 2003;326:816-819.
32.  Lawrence M, Olesen F. Indicators of quality health care. Eur J Gen Pract 1997;3:103-108.
33.  Emanuel EJ, Emanuel LL. The promise of a good death. Lancet 1999;351:21-29.
34.   Tilden VP, Tolle S, Drach L, Hickman S. Measurement of quality of care and quality of life at the end of life. 
Gerontologist 2002;42 Spec No 3:71-80.
35.   Van de Muijsenbergh, METC. Palliatieve zorg door de huisarts. [Palliative care by the general practitioner, 
dissertation]. 2001. Universiteit Leiden. 
36.   Deschepper R, Vander SR, Bernheim JL, et al. Communication on end-of-life decisions with patients wishing 
to die at home: the making of a guideline for GPs in Flanders, Belgium. Br J Gen Pract 2006;56:14-19.
37.   Francke AL, Willems DL. Palliatieve zorg vandaag en morgen. [Palliative care today and tomorrow]. Maars-
sen: Elsevier gezondheidszorg, 2000.
38.   Street A, Blackford J. Communication issues for the interdisciplinary community palliative care team. J 
Clin Nurs 2001;10:643-650.
39.   Groot MM, Vernooij-Dassen MJ, Crul BJ, Grol RP. General practitioners (GPs) and palliative care: perceived 
 
CH
A
PT
ER
 8
tasks and barriers in daily practice. Palliat Med 2005;19:111-118.
40.   Field D. Special, not different: general practitioners’ accounts of their care of dying people. Soc Sci Med 
1998;46:1111-1120.
41.   Van Eijk JThM, De Haan M. Care for the chronically ill: the future role of health care professionals and their 
patients. Patient Educ Couns 1998;35:233-240.
42.   Elektronisch Patiënten Dossier. www.minvws.nl/dossiers/elektronisch-patienten-dossier Website, 6-6-
2006. 
43.   Centraal Bureau voor de Statistiek. Kerncijfers van de bevolkingsprognose, 2004-2050: www.cbs.nl/nl-
NL/menu/themas/mens-maatschappij/bevolking/cijfers/default.htm website, 1-7-2006. 
44.   Health Council of the Netherlands. European primary care. 2004/20E. 2004. The Hague, Health Council 
of the Netherlands. 
45.   Salisbury C. The demand for out-of-hours care from GPs: a review. Fam Pract 2000;17:340-347.
46.   Davies P. The non-principal phenomenon: a threat to continuity of care and patient enablement? Br J Gen 
Pract 2004;54:730-731.
47.   Tarrant C, Windridge K, Boulton M, et al. How important is personal care in general practice? BMJ 
2003;326:1310.
48.   Freeman GK, Olesen F, Hjortdahl P. Continuity of care: an essential element of modern general practice? 
Fam Pract 2003;20:623-627.
111

113SUMMARY
 
 
 
S
U
M
M
A
R
Y
SUMMARY
In the Netherlands, the general practitioner (GP) is the central professional in the ma-
nagement and coordination of the patient’s treatment. Almost 60% of the patients 
with non-acute illnesses die at home, and there is a general consensus that end-of-life 
care, if possible, preferably should be provided in the patient’s home. The actual and 
formal approach of the Dutch government is that end-of-life care should be provided 
as much as possible by generalists, and in this context initiatives to make possible the 
responsible, complex and demanding tasks of providing end-of-life care were stimu-
lated. Because few studies have been performed in order to describe and understand 
the role of the GP, end-of-life care research activities concerning general practice were 
initiated. This thesis aims to investigate issues of current practice in end-of-life care in 
general practice in the Netherlands. 
In this study, the following research questions were addressed:
•  1. What are the consequences of using different inclusion criteria on selected end-
of-life care populations? 
•  2. What is the prevalence of pain and other symptoms in patients receiving end-of-life 
care at home?
•  3. What pain medication is prescribed to patients receiving end-of-life care at 
home?
•  4. What is the extent and the level of GP cooperation with other caregivers in end-of-life 
care at home?
•  5. What are the aspects valued in end-of-life care at home by patients and their ge-
neral practitioners?
•  6. Do patients talk about euthanasia with their GP and if so, how do they communicate 
about this subject?
For this thesis, data from two different studies were used. Quantitative data were col-
lected within the framework of the Second Dutch National Survey of General Practice 
(DNSGP-2), a representative sample of 96 Dutch general practices, and qualitative data 
were obtained by interviews with 30 patients and their GPs.
Deﬁ ning the patient population
In preparing the research of this thesis, we encountered the problem that there is no 
generally accepted research deﬁ nition of end-of-life care, and that there is no gene-
ral consensus what criteria to use for inclusion of patients. Chapter 2 investigates the 
consequences of three inclusion criteria in the build up of different study populations, 
studied in terms of size, number of doctor-patient contacts and demographic charac-
teristics. General practitioners received a questionnaire for all patients who died during 
the DNSGP-2 (n=2,194), to determine whether (1) patients received non-curative treat-
ment, (2) patients received palliative care, and (3) death was expected (total response 
rate=73%). The criterion ‘death was expected’ included most patients (62%) followed 
by ‘palliative care’ (46%) and ‘non-curative treatment’ (39%). Similarity between the 
deﬁ nition-based populations was fair to moderate. More ‘palliative care’ and ‘death was 
expected’ patients had cancer than ‘non-curative treatment’ patients. The conclusions 
show substantial differences in populations according to the different inclusion crite-
ria used to select them. If we want to describe differences between sub-populations 
without omitting any potential palliative care patients, we must apply the broadest 
possible inclusion criterion. Hence, we recommend the use of a combination of inclu-
sion criteria, which should include at least ‘palliative care’ as labeled by (professional) 
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carers, the intention of the treatment provided, and an assessment of the patient’s life 
expectancy. Any future research in end-of-life care should acknowledge the limitations 
of using certain inclusion criteria and explore potential bias.
Epidemiological issues
The main aim of this thesis is to study epidemiological issues of end-of-life care in ge-
neral practice: needs of patients receiving end-of-life care, quality of end-of-life care 
delivered by the GP, and organisation of end-of-life care at home. As indicator for the 
patients’ needs, Chapter 3 aims to study the prevalence of symptoms in patients re-
ceiving end-of-life care at home. Within the framework of the DNSGP, GPs identiﬁ ed 
those patients who received end-of-life care out of all patients who died within the 
one-year survey period (valid response rate 73%). Patients with an observation period 
of at least three months, and who received end-of-life care by their GP until death were 
included (n=429). Information regarding encounters during the last three months of 
life was derived from the electronic medical records kept by the GPs. A symptom was 
prevalent when it was registered by the GP in a patient-physician encounter. Diges-
tive symptoms (59%) and pain (56%) were the most prevalent. The mean number of 
symptoms was higher in cancer patients (11.99) than in non-cancer patients (7.62). 
The number of digestive symptoms, pain and psychological symptoms was higher 
in the lower than in the higher age groups, and higher in cancer than in non-cancer 
patients. Most symptoms (36%) were concentrated in the last two weeks of life. Not 
reported in previous end-of-life care studies were musculoskeletal symptoms (20%), 
chronic ulcer (18%) and discussion about euthanasia (14%). Future studies should ex-
plore the severity and inﬂ uence on quality of life of these lesser known symptoms in 
end-of-life care.
As indicator for the quality of care, we examined what pain medication is prescribed to 
patients receiving end-of-life care at home, and determined the longitudinal develop-
ment of prescribing during the last three months of life (Chapter 4). We also investiga-
ted whether GPs prescribed analgesics according to the WHO ladder, and if opioids were 
combined with laxatives. Within the framework of the DNSGP-2, GPs identiﬁ ed patients 
who received end-of-life care out of all patients who died within the one-year survey 
period (response-rate 74%). We analysed prescribing data of analgesics, laxatives and 
antiemetics of patients with an observation period of at least three months (n=425). Of 
these patients, 73% were prescribed any analgesic; 55% were prescribed a step 1 drug 
of the WHO ladder (paracetamol, NSAIDs), 21% a step 2 drug (weak opioids), and 51% a 
step 3 drug (strong opioids). More younger than older patients were prescribed a strong 
opioid, and more cancer than non-cancer patients were prescribed a drug from all three 
steps of the WHO ladder. The proportion of patients having been prescribed a step 1 or 2 
drug increased gradually and the proportion of patients having prescribed a step 3 drug 
increased exponential nearing the patient’s death. Of those who were prescribed a step 
1 analgesic, 40% was prescribed a strong opioid without having been prescribed a step 
2 analgesic. A total of 48% was prescribed an opioid without any prescribed laxative. 
Current practice concerning the use of the WHO analgesic ladder and the prescribing of 
laxatives differs substantially from accepted guidelines. Future research should inves-
tigate these guidelines, and ﬁ nd evidence for a two step, or a three step strategy in the 
pharmacological management of pain in end-of-life care, and determinants for the need 
to prescribe laxatives next to opioids.
As an indicator of organisation of end-of-life care, Chapter 5 studies the occurrence 
and determinants of such cooperation in end-of-life care at home. For each patient 
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who died during the DNSGP-2, the relevant GP was surveyed on end-of-life care issues 
by an additional mail questionnaire. Of all patients, 2,194 (0.6%) patients died during 
the study period. GPs returned 1,771 (73%) of the additional questionnaires. According 
to the GPs 743 (46%) of their patients received end-of-life care. In almost all patients 
(98%), the GP cooperated with at least one other caregiver, with a mean number of 3.8 
others. Cooperation with informal caregivers (83%) was most prevalent, followed by 
cooperation with other GPs (71%) and district nurses (63%). The best determinants 
for cooperation between GPs and other caregivers were the patient’s age, the underly-
ing disease and the importance of psychosocial care in the care for the actual patient. 
Cooperation is more prevalent in younger patients, patients with cancer as underlying 
disease, and if psychosocial care is important in care for the actual patient. Future re-
search should focus on the underlying problems that need cooperation, how caregivers 
communicate, and what possible barriers they meet.
Opinions of patients and their GPs
In this thesis, we also aim to explore the opinions of two subjects involved: the patients 
and their GPs. In Chapter 6 the aspects valued by both patients and GPs in end-of-life 
care at home are explored. Qualitative, semi-structured interviews were performed 
with 20 GPs and 30 of their patients with a life-expectancy of less than six months, and 
with cancer, heart failure or chronic obstructive pulmonary disease as underlying di-
sease. Patients and GPs had comparable perceptions of good end-of-life care. Patients 
and GPs identiﬁ ed four core items that they valued in end-of-life care: availability of 
the GP for home visits and after ofﬁ ce-hours; medical competence and cooperation 
with other professionals; attention; and continuity of care. Future studies should mo-
nitor the developments in the organisation of primary care, such as the restriction of 
time for home visits, more part-time jobs and GP cooperatives responsible for care 
after ofﬁ ce-hours in the context of these valued aspects in end-of-life care. 
The aim of Chapter 7 is to explore if patients talk about euthanasia with their GP and if 
so, how they communicate about this subject. Qualitative, semi-structured interviews 
with 20 GPs and 30 patients with a life expectancy of less than six months, and with can-
cer, heart failure or chronic obstructive pulmonary disease as underlying disease were 
performed in primary care in the Netherlands, where euthanasia is legalised. In the GPs’ 
perception, communication on euthanasia was more frequent in cancer patients. Initial 
communication between patient and GP concerned an exchange of opinions on pos-
sible situations for which euthanasia was desired. GPs had different opinions whether 
communication should be initiated by the patient or the GP, and found it difﬁ cult to 
schedule the right moment to talk about euthanasia. We found no evidence to believe 
that communication on euthanasia stimulates the patient to request euthanasia. When 
patients and GPs know each others opinions and expectations concerning end-of-life 
preferences, GPs might direct their care towards the best balance between the patient’s 
quality of life, and the quality of death.
General Discussion
GPs encounter a wide range of symptoms in patients receiving end-of-life care. Some 
of these symptoms are typically for end-of-life care, other are common in a general 
patient population. To safeguard quality in end-of-life care, it is important that GPs 
can make an appeal to consultation services, and/or colleagues with speciﬁ c training in 
end-of-life care. In patients receiving end-of-life care, GPs need to pay attention to the 
possibility of psychosocial or spiritual care needs, and communicate with the patients 
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and caregivers in question on this subject. Also, end-of-life care may be enhanced by 
more cooperation with other caregivers. We need evidence-based end-of-life inter-
ventions, as there is lack of evidence, and current practice differs substantially from 
accepted guidelines. There are no good studies regarding the effectiveness of step 2 
(weak opioids) of the WHO analgesic ladder and the necessity of concomitant use of 
laxatives with opioids. We need well designed studies to answer these highly relevant 
questions. 
Finally, our study does raise some questions about the quality of future end-of-life care 
at home. Aspects valued in our study might be threatened by social developments in 
primary care which might change the characteristics of care at home and the role of the 
GP. In primary care there are social developments towards more part-time jobs, wider 
career possibilities, less solo practices and more cooperation of GPs in GP cooperatives. 
These developments could become a threat for the personal continuity of the GP and 
after ofﬁ ce-hours services for end-of-life care patients. As a consequence, the Dutch 
health care system is challenged to make choices in the management of the dying, and 
of the wishes of the dying in our society. Can we make dying at home possible for all 
patients, and if not, for which patients do we want to make dying at home accessible, 
and for which patients we have to organise good end-of-life care in another setting? 
When we look at those aspects of end-of-life care which are most highly valued, such 
as home visits and attention, how much care should be provided? When discomfort, 
symptom burden or loneliness eventually contributes to a low(er) quality of life, who-
se responsibility is it to organise care and/or comfort for this patient? To determine 
‘quality’ in future end-of-life care at home, and the responsibilities of the patients and 
the caregivers involved, we need continuing attention and discussion within society. 
That discussion is needed in order to direct future developments of end-of-life care at 
home, and the position of the GP.

119SAMENVATTING
 
 
 
S
A
M
EN
VA
TT
IN
G
SAMENVATTING
Zorg in de laatste levensfase in de huisartsenpraktijk in Nederland
In Nederland is de huisarts de centrale zorgverlener en het eerste aanspreekpunt voor 
medische zorg. Bijna zestig procent van de patiënten met een niet-acute aandoening 
overlijdt thuis en de meeste mensen geven er de voorkeur aan dat de zorg in de laat-
ste levensfase in de thuissituatie wordt gegeven. De Nederlandse regering heeft het 
standpunt dat zorg in de laatste levensfase zoveel mogelijk door generalisten, zoals 
de huisarts, verleend moet worden. Tot nu toe is er weinig onderzoek gedaan dat zich 
speciﬁ ek richt op de rol van de huisarts in de zorg rond het levenseinde.
In dit proefschrift worden diverse aspecten van de huisartsenzorg in de laatste levens-
fase onderzocht. De volgende onderzoeksvragen komen in dit proefschrift aan bod:
•  1. Wat zijn de gevolgen van het gebruik van verschillende inclusiecriteria voor onder-
zoekspopulaties van patiënten die zorg in de laatste levensfase krijgen?
•  2. Hoe vaak komen pijn en andere symptomen voor bij patiënten die huisartsenzorg 
in de laatste levensfase ontvangen?
•  3. Welke geneesmiddelen worden voorgeschreven om pijn te bestrijden bij patiënten 
die huisartsenzorg in de laatste levensfase ontvangen?
•  4. In welke mate en met welke intensiteit werken huisartsen samen met andere zorg-
verleners bij de zorg voor patiënten in de laatste levensfase?
•  5. Welke aspecten van de zorg in de laatste levensfase worden gewaardeerd door 
patiënten en hun huisartsen?
•  6. Praten patiënten met hun huisarts over euthanasie en zo ja, hoe communiceren zij 
over dit onderwerp?
Om deze vragen te beantwoorden, werden gegevens uit twee verschillende onderzoe-
ken gebruikt. De kwantitatieve data werden verzameld binnen de context van de Tweede 
Nationale Studie naar verrichtingen in de huisartsenpraktijk (NS-2), waaraan een repre-
sentatieve steekproef van 96 huisartspraktijken heeft deelgenomen in de periode van 
2000-2001. De kwalitatieve data werden verzameld in interviews met dertig patiënten 
en hun huisartsen.
Het deﬁ niëren van de patiëntenpopulatie
In de voorbereidingsfase van het onderzoek stuitten we op het probleem dat er geen 
algemeen geaccepteerde deﬁ nitie bestaat van ‘zorg in de laatste levensfase’. Ook be-
staat er geen overeenstemming over welke criteria het beste gebruikt kunnen worden 
om patiënten te deﬁ niëren die ‘zorg in de laatste levensfase’ ontvangen. In hoofdstuk 
2 hebben we onderzocht wat de verschillen in de omvang van de populaties, het aan-
tal arts-patiënt contacten en de demograﬁ sche karakteristieken van de patiënten zijn, 
wanneer de drie criteria voor zorg in de laatste levensfase worden toegepast. Deze 
criteria waren: (1) het levenseinde was volgens de huisarts verwacht, (2) de huisarts 
deﬁ nieerde de zorg als ‘palliatieve zorg’ en (3) de patiënt ontving een behandeling die 
niet gericht was op genezing en ook niet op levensverlenging. De huisartsen kregen een 
vragenlijst voor elke patiënt die overleed tijdens de NS-2 (n=2194) om te bepalen of 
de drie criteria bij de zorg voor de betreffende patiënt van toepassing waren. De totale 
respons op de enquête was 73%. Het criterium ‘het overlijden was verwacht’ was op de 
meeste patiënten van toepassing (62%), gevolgd door ‘palliatieve zorg’ (46%) en ‘een 
behandeling niet gericht op genezing of levensverlenging’ (39%). De overeenstemming 
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tussen de op deze criteria gedeﬁ nieerde populaties was matig tot gemiddeld. In de po-
pulaties gedeﬁ nieerd als ‘palliatieve zorg’ en ‘het overlijden was verwacht’, waren meer 
patiënten met kanker dan bij de patiënten die ‘een behandeling ontvingen die niet ge-
richt was op genezing of levensverlenging’. Er waren substantiële verschillen tussen 
de populaties geselecteerd volgens deze drie criteria. Wanneer we in epidemiologisch 
onderzoek bij patiënten in de laatste levensfase verschillen tussen subpopulaties wil-
len beschrijven zonder hierbij patiënten te missen, dan moeten we een zo breed mo-
gelijk inclusiecriterium gebruiken. Daarom raden wij een combinatie van criteria aan 
met tenminste de volgende inclusiecriteria: ‘palliatieve zorg’, zoals aangegeven door 
de betrokken zorgverleners in combinatie met criteria gebaseerd op de intentie van de 
behandeling en de inschatting van de levensverwachting van de patiënt. Keuzes voor 
bepaalde inclusiecriteria beïnvloeden de samenstelling van de onderzoekspopulatie. 
Daarom dient men bij onderzoek naar zorg in de laatste levensfase ten minste de be-
perkingen van het gebruik van bepaalde criteria te beschrijven en te exploreren hoe de 
gemaakte keuze voor criteria de onderzoeksresultaten zal beïnvloeden. 
Symptomen in de huisartsenpraktijk
Een belangrijke doelstelling van dit proefschrift is om enkele epidemiologische aspec-
ten van de palliatieve zorg in de huisartsenpraktijk te onderzoeken. Dit zijn de behoefte 
aan zorg voor patiënten die palliatieve zorg van hun huisarts ontvangen, de kwaliteit 
van de palliatieve zorg en de organisatie van palliatieve zorg in de huisartsenpraktijk. In 
hoofdstuk 3 wordt een indicator voor de behoefte aan zorg van patiënten in de laatste 
levensfase beschreven. Hierbij hebben we gekeken naar het vóórkomen van sympto-
men bij patiënten in de laatste levensfase in de huisartsenpraktijk. De huisartsen die 
deelnamen aan de NS-2, hadden de patiënten geïdentiﬁ ceerd die palliatieve zorg ont-
vingen en zijn overleden binnen de periode van één jaar waarin de NS-2 plaatsvond 
(respons = 73%). Patiënten die palliatieve zorg ontvingen en tenminste drie maanden 
na de start van de NS-2 zijn overleden, werden opgenomen in dit onderzoek (n=429). 
De benodigde informatie over de huisarts-patiënt contacten tijdens de laatste drie 
maanden van het leven van de patiënt werd gehaald uit de Electronische Medische Dos-
siers van de huisartspraktijken. Een symptoom was aanwezig wanneer het als zodanig 
geregistreerd was door de huisarts. Symptomen gerelateerd aan het maagdarmkanaal 
(59%) en pijn (56%) kwamen het meest voor. Het gemiddeld aantal symptomen per 
patiënt was groter bij kankerpatiënten dan bij patiënten zonder kanker (11,99 vs 7,62). 
Het aantal symptomen aan het maagdarmkanaal, pijn en psychosociale symptomen 
was op jongere leeftijd groter dan op oudere leeftijd. Ook bij kankerpatiënten was dit 
aantal groter dan bij patiënten zonder kanker. De meeste symptomen (36%) traden op 
in de laatste twee weken voor overlijden. In andere onderzoeken komen symptomen 
aan het bewegingsapparaat (20%), chronische huidzweren (18%) en gesprekken over 
euthanasie (14%) niet voor. Verder onderzoek zal de ernst van de symptomen en de 
invloed daarvan op de kwaliteit van leven moeten onderzoeken.
Voorschrijven van pijnmedicatie
Als indicator voor de kwaliteit van zorg, hebben we onderzocht welke pijnmedicatie is 
voorgeschreven aan patiënten in de laatste levensfase (hoofdstuk 4). We hebben be-
paald hoe het voorschrijven zich gedurende de laatste drie maanden heeft ontwikkeld. 
Ook hebben we onderzocht in welke mate het voorschrijfgedrag van huisartsen overeen-
komt met de pijnladder van de World Health Organization (WHO pijnladder) en of sterke, 
morﬁ ne-achtige pijnstillers (opioïden) gecombineerd worden met laxeermiddelen. Van 
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patiënten die tenminste drie maanden na de start van de studie zijn overleden, werden de 
voorschrijfgegevens van pijnmedicatie en laxeermiddelen geanalyseerd. In totaal kreeg 
73% van de patiënten ten minste één pijnstiller voorgeschreven: 55% een pijnstiller uit 
stap één van de WHO-pijnladder (paracetamol of een onstekingsremmende pijnstiller 
(NSAID), zoals ibuprofen), 21% een pijnstiller uit stap twee (zwakke opioïden) en 51% een 
pijnstiller uit stap drie (sterke opioïden). Er waren meer jongere dan oudere patiënten die 
een sterk opioïd voorgeschreven kregen en er waren meer kankerpatiënten dan patiën-
ten zonder kanker aan wie minstens één pijnstiller werd voorgeschreven. Het percen-
tage patiënten dat een pijnstiller uit stap één of stap twee kreeg voorgeschreven, nam 
geleidelijk toe naarmate het levenseinde van de patiënt dichterbij kwam. Dichtbij het 
levenseinde nam het percentage patiënten dat een stap drie pijnstiller voorgeschreven 
kreeg exponentieel toe. Van de patiënten die eerst met één stap een pijnstiller behan-
deld werden, kreeg 40% in een later stadium een stap drie pijnstiller, waarbij de tweede 
stap van de WHO-ladder werd overgeslagen. In totaal kreeg 48% van de patiënten een 
opioïd voorgeschreven zonder dat daarbij een laxeermiddelen werd voorgeschreven. In 
de huisartsenpraktijk in Nederland wijkt het voorschrijfgedrag duidelijk af van de WHO-
pijnladder. Huisartsen combineren opioïden niet altijd met laxeermiddelen, zoals gead-
viseerd wordt in richtlijnen voor palliatieve zorg. Het is belangrijk om nader onderzoek 
te verrichten naar de toepassing van deze richtlijnen. Zo kan worden aangetoond welke 
strategie van pijnbestrijding in de laatste levensfase beter is: een tweestaps of een 
driestaps strategie en welke factoren bepalen of een patiënt die opioïden gebruikt ook 
laxeermiddelen moet gebruiken. 
Samenwerking van huisartsen met andere zorgverleners
Als indicator voor de organisatie van palliatieve zorg is in hoofdstuk 5 de samenwerking 
van huisartsen met andere zorgverleners onderzocht, evenals de invloed van diverse 
factoren op deze samenwerking. Huisartsen die deelnamen aan de NS-2 kregen voor 
elke patiënt die tijdens de studie overleed een vragenlijst toegestuurd over de zorg in 
de laatste levensfase. Van alle patiënten die deelnamen aan de NS-2 overleden er 2194 
(0,6%) tijdens de studie en stuurden de huisartsen 1771 (73%) vragenlijsten terug. De 
huisartsen identiﬁ ceerden 743 (46%) patiënten die palliatieve zorg kregen. In bijna alle 
gevallen (98%) werd samengewerkt met minstens één andere hulpverlener. Gemiddeld 
werd per patiënt met bijna vier andere hulpverleners samengewerkt. Samenwerking 
met mantelzorgers kwam het meeste voor (83%), gevolgd door samenwerking met 
andere huisartsen (71%) en wijkverpleegkundigen (63%). De drie factoren die samen-
werking tussen huisartsen en andere zorgverleners het beste voorspelden waren de 
leeftijd van de patiënt, de onderliggende aandoening en de mate waarin psychosoci-
ale zorg van belang was bij de zorg voor de betreffende patiënt. Samenwerking kwam 
vaker voor naarmate de patiënt jonger was, de patiënt kanker had als onderliggende 
aandoening en als de psychosociale zorg van belang was bij de zorg voor de patiënt. 
Toekomstig onderzoek zal aandacht moeten besteden welke problemen die ten grond-
slag liggen aan de noodzaak tot samenwerking, de manier waarop de verschillende 
zorgverleners communiceren en de belemmeringen die zorgverleners ondervinden bij 
samenwerking. 
Meningen van patiënten en huisartsen over goede palliatieve zorg
Dit proefschrift heeft ook tot doel om inzicht te krijgen in de mening van de patiënt in 
de laatste levensfase en zijn huisarts. In hoofdstuk 6 onderzoeken we welke aspecten 
patiënten en hun huisartsen waarderen in de zorg in de laatste levensfase. Hiervoor 
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hebben we kwalitatieve, semi-gestructureerde interviews afgenomen bij twintig huis-
artsen en dertig van hun patiënten. De patiënten hadden een levensverwachting van 
maximaal zes maanden met als onderliggende aandoening kanker, hartfalen of COPD 
(Chronic Obstructive Pulmonary Disease). Patiënten en huisartsen bleken een verge-
lijkbare visie te hebben op goede zorg in de laatste levensfase. Zij identiﬁ ceerden de 
volgende vier kernwaarden van aspecten die zij het meest waarderen in de palliatieve 
zorg: (1) beschikbaarheid van de huisarts voor thuisbezoeken en buiten kantooruren; 
(2) medische competentie en samenwerking met andere professionals; (3) aandacht 
van de huisarts en (4) continuïteit van zorg. Verder onderzoek zal moeten uitwijzen 
in welke mate huidige ontwikkelingen in de huisartsenpraktijk, zoals minder tijd voor 
huisbezoeken, meer parttime werk en samenwerken in de vorm van huisartsenposten, 
deze kernwaarden van goede palliatieve zorg zullen bedreigen. 
Meningen van patiënten en huisartsen over communicatie over euthanasie
In hoofdstuk 7 hebben we onderzocht of patiënten in de laatste levensfase met hun 
huisarts over euthanasie praten, en zo ja, wanneer dit het geval is en hoe zij over dit 
onderwerp praten. Hiervoor hebben we kwalitatieve, semi-gestructureerde interviews 
afgenomen bij twintig huisartsen en dertig van hun patiënten in Nederland, waar eu-
thanasie is gelegaliseerd. Volgens de huisartsen kwam communicatie over euthanasie 
vaker voor bij kankerpatiënten. In de eerste gesprekken tussen huisarts en patiënt over 
euthanasie werden gedachten uitgewisseld over mogelijke situaties die aanleiding 
zouden kunnen zijn voor euthanasie. De huisartsen verschilden onderling van mening 
of dit onderwerp ter sprake zou moeten worden gebracht door de patiënt zelf of door 
de huisarts. Zij vonden het moeilijk om te bepalen wat het juiste moment was om dit 
onderwerp ter sprake te brengen. Wanneer patiënten en huisartsen op de hoogte zou-
den zijn van elkaars verwachtingen en wensen met betrekking tot zorg in de laatste 
levensfase, zouden huisartsen hun zorg beter kunnen richten op de optimale balans 
tussen kwaliteit van leven en kwaliteit van overlijden.
Discussie
Huisartsen komen veel verschillende symptomen tegen bij de zorg voor patiënten in de 
laatste levensfase. Sommige symptomen zijn typerend voor de laatste levensfase, an-
dere zijn veel voorkomend in een (oudere) patiëntenpopulatie. Om de kwaliteit van zorg 
in de laatste levensfase te bewaken, is het van belang dat huisartsen specialisten op het 
gebied van palliatieve zorg kunnen consulteren. Bij de zorg voor patiënten in de laatste 
fase van hun leven, dienen huisartsen ook aandacht te besteden aan de mogelijke zorg-
behoefte met betrekking tot psychosociale of spirituele aspecten. De palliatieve zorg in 
de thuissituatie kan versterkt worden door meer samenwerking tussen hulpverleners. 
Er is bovendien behoefte aan interventies die gebaseerd zijn op wetenschappelijk onder-
zoek. Deze onderbouwing ontbreekt en de huidige beroepspraktijk met betrekking tot 
het voorschrijven van pijnmedicatie verschilt substantieel van algemeen geaccepteerde 
richtlijnen. Er zijn geen goede studies met betrekking tot de effectiviteit van de tweede 
stap van de WHO pijnladder of studies naar de noodzaak van de combinatie van opioïden 
met laxeermiddelen. Om deze voor de dagelijkse praktijk relevante vragen te beantwoor-
den, moeten nieuwe onderzoeken worden opgezet en uitgevoerd. 
Tot slot roept ons onderzoek enkele vragen op met betrekking tot de kwaliteit van pal-
liatieve zorg in de toekomst. De waarden van palliatieve zorg die uit ons onderzoek naar 
voren komen, zouden kunnen worden bedreigd door ontwikkelingen in de organisatie 
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van de eerstelijns gezondheidszorg. Hierdoor zullen de kenmerken van de palliatieve 
zorg, zoals die nu door huisartsen gegeven wordt, veranderen. Huisartsen zullen vaker 
parttime gaan werken en korter op één werkplek blijven. Er zullen minder soloprak-
tijken zijn en meer samenwerking tussen huisartsen die in diverse vormen onder één 
dak zullen werken. Deze ontwikkelingen kunnen betekenen dat er minder persoonlijke 
continuïteit in de huisartsenzorg zal zijn binnen en buiten kantooruren. Wij zullen en-
kele maatschappelijke keuzes moeten maken over hoe wij willen zorgen voor patiënten 
die zullen gaan overlijden in Nederland. Willen wij thuis overlijden mogelijk maken voor 
alle patiënten? Als dit niet zo is, welke patiënten krijgen dan de mogelijkheid om thuis 
te overlijden? En voor welke patiënten organiseren we zorg op een andere locatie? Hoe 
bepalen we hoeveel zorg we willen en kunnen geven en wanneer kijken we naar de as-
pecten in huisartsenzorg die het meest gewaardeerd worden, namelijk thuisbezoeken 
en aandacht? En als symptomen, ongemakken en eenzaamheid leiden tot een mindere 
kwaliteit van leven, wie is er dan verantwoordelijk voor het organiseren van de beno-
digde zorg? Om te bepalen wat wij onder ‘kwaliteit’ verstaan in onze toekomstige zorg 
en om de verantwoordelijkheden van de betrokken patiënten en zorgverleners in kaart 
te brengen, moeten we een maatschappelijke discussie blijven voeren. Deze discussie 
is noodzakelijk om richting te kunnen geven aan de toekomstige zorg voor patiënten in 
de laatste fase van hun leven en de rol van de huisarts daarbij.
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Een woord van dank aan iedereen die mij de afgelopen jaren gesteund heeft. Direct 
bij het wetenschappelijk werk en tijdens momenten daarbuiten. Dit dankwoord is voor 
mij een herinnering aan de vele mensen, tegen wie je misschien best wel wat vaker 
‘bedankt’ mag zeggen. Als je dit dankwoord openslaat, om wat voor reden dan ook, be-
dankt. In ieder geval voor de interesse in dit proefschrift – of ten minste het dankwoord 
daarvan.
Allereerst ben ik veel verschuldigd aan de patiënten en huisartsen die hebben meege-
werkt aan de interviews en de Tweede Nationale Studie. Door jullie tijd en inzet kon ik 
als buitenstaander zien hoe jullie omgaan met zorg in de laatste levensfase. Ik vond het 
bijzonder jullie visie en ideeën daarover te mogen horen en dit proefschrift is in eerste 
instantie aan jullie te danken.
Wat betreft de wetenschappelijke begeleiding wil ik mijn promotoren bedanken. Luc, 
voor de ondersteuning en input die je in de verschillende fasen van het project hebt 
geleverd. Voor het aantrekken van de teugels wanneer ik weer eens vijf stappen wilde 
doen in één grote pas in veel te weinig tijd. Gerrit, naast je inhoudelijke inbreng, ook 
bedankt voor je rol als manager. Je kan mensen op een vanzelfsprekende manier stimu-
leren om het maximale eruit te halen. Jacques, bedankt voor je inzet die niet geleden 
heeft door de fysieke afstand tussen Maastricht en Amsterdam. 
Co-auteurs en projectgroepleden: Dick, je creatieve manier van meedenken brengt 
mij steeds op nieuwe ideeën. Anneke en Wim, bedankt voor jullie betrokkenheid, 
inspanningen en positieve woorden op de juiste momenten. François, bedankt voor 
het prettige contact en het meedenken bij praktische NS-2 problemen. Wouter, je 
ideeën en enthousiasme zijn altijd stimulerend. Corrie en Barry, jullie inzet tijdens jullie 
wetenschappelijke stages blijkt uit jullie co-auteurschap bij drie artikelen uit dit proef-
schrift. 
Leden van de leescommissie, Bregje, Bart, Johan, Cor Spreeuwenbergh en Theo Voorn 
bedankt voor het kritisch lezen en becommentariëren van het manuscript.
Collega onderzoekers bij het EMGO en QUESTionairs, bedankt voor de leuke discussies 
tijdens werkbesprekingen en het overleg tussendoor. Hella, co-piloot in het Sabena 
vliegtuig, we landen inderdaad ongeveer op dezelfde landingsbaan. Jean-Jacques, we 
komen zowel bij een papieren marathon als één door de Ardennen op ongeveer het-
zelfde moment over de ﬁ nish. Misschien dat een Trappist na onze promotie kan tippen 
aan die na 42 kilometers door de heuvels.
De volgende collega’s wil ik in het bijzonder bedanken. Ivan, ik denk dat onze kroegen-
tocht een hoogtepunt zal blijven in de uitgaanshistorie van Bos en Lommer. Jolanda: 
The Charade-Stories will live on forever! Davide, de kilo’s papier aan boetes vergeef ik je 
en de katers als gevolg van voetbal kijken en stappen waren de moeite waard. Je hard-
loop- en ﬁ etsinitiatieven zorgen voor voldoende compensatie. Hidde, na jouw vertrek is 
tafeltennis op het EMGO nooit meer hetzelfde geweest. Lando, een praatje met jou op 
de zaterdagochtenden afgelopen voorjaar, gaf me weer de nodige moed. Lidewij, jouw 
e-mails print ik uit om mijn messen mee te slijpen. Stefan, ik kan alleen maar met plezier 
luisteren naar je enthousiaste visies op de meest uiteenlopende onderwerpen. Matthijs: 
onze opvattingen liggen soms een halve oceaan uiteen, maar je oprechte attitude maakt 
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dat ik graag met je van woord wissel. Erik: Limburgers op wie je kunt bouwen bestaan. 
Ten slotte, Rita, Inge, Manigeh en Lieke…bedankt voor de ondersteuning die een chao-
tisch persoon als ik af en toe nodig heeft.
Kamergenoten van B-563: Annemieke, Harm-Jan en Marjan: met 4 verschillende men-
sen zaten we op één van de kleinste kamertjes van de afdeling. Als enige warmbloedige 
kende ik mijn plaats in de ‘raam strijd’. Annemieke, je combineert betrokkenheid en be-
langstelling met doelgericht en efﬁ ciënt werken, en daarin was je een vóórbeeld voor mij. 
Buiten het werk vond ik het leuk je beter te leren kennen bij boottochtjes, etentjes en…
wielerﬁ lms. Marjan, ongeveer gelijk begonnen en allebei combineren we het afronden 
van het proefschrift met onderwijstaken. Over een paar maanden ben jij aan de beurt! 
Harm-Jan, gnuiver, ik heb veel aan je gehad door ontspannen en serieus met je te praten 
over diverse onderwerpen van onderzoek tot wielrennen, met de Côtes du Ventoux als 
hoogtepunt. Ik ben blij dat jij vandaag als pinguïn wat wind voor me wilt vangen.
Mijn collega’s van de afdeling Klinische Farmacologie, Theo, Jacqueline en Milan, wil ik 
bedanken voor de prettige samenwerking waarbij ik de ruimte heb gekregen om ver-
schillende banen en verantwoordelijkheden te combineren. Alle student-assistenten 
met wie ik de afgelopen jaren het leeronderzoek Farmacotherapie heb georganiseerd, 
bedankt. In het bijzonder de huidige club van Joke, Souad, Eva, Floris, Mariska, Anneﬂ oor 
en Tessa die tot januari nog wat onder mijn proefschrift stress hebben geleden.
Mijn werkzaamheden op de universiteit heb ik vanaf 2002 kunnen combineren met een 
baan in de Venser Apotheek in Duivendrecht. Gerald, Jerry, Anne en Annemarie: bedankt 
voor wat ik van de apotheekpraktijk heb kunnen leren. Als parttimer heb ik me altijd een 
volledig medewerker gevoeld. Eén dag in de week iets zinnigs proberen te doen in een 
apotheek kan alleen als er mensen werken die er écht iets vanaf weten: Brigitte, Femke, 
Haidy, Santa en alle anderen met wie ik, meestal op vrijdag in de Venser, gewerkt heb: 
bedankt en ik hoop dat de verrassingseieren inmiddels zijn weggegooid. Geralt, zullen 
we ook in de toekomst de geneugten en problemen van het leven blijven toedrinken? 
Ik ben heel blij dat ik de afgelopen jaren dingen heb kunnen delen met goede vrienden. 
Mijn bewondering gaat uit naar de equipes van Fartmedia en Team Bettini, die het toch 
steeds weer aandurven om enig (verbaal) tegengas te geven aan de suprematie van 
AntiClimax. Ik hoop dat we als bejaarde mannen nog met hetzelfde enthousiasme en 
dezelfde humor de Rosier op rijden, alwaar Garzelli, Frigo, Batso, Burgego en onderge-
tekende als vanouds het peloton zullen leiden.
Farma’s: Paul, het pleit voor je dat je met jouw capaciteiten vooral je eigen weg blijft 
gaan. Folgert, Maistro, ik weet nog steeds niet hoe ik van het gifkikkereczeem af kan 
komen. Arie, volgens mij hebben we nog wat glazen whisky in te halen. Alex, over 10 jaar 
een reünie in Nurmu? Maarten, rustige, wijze, family man: naar Hoorn is het makkelijker 
ﬁ etsen dan naar Deurne. Miss Jack, wie is aan de beurt voor de Risk-avond? KB, het moet 
niet gekker worden…straks kom je zomaar een tweede keer binnen een half jaar naar 
Amsterdam. Marjolein, thx for the hospitality and energy I always receive when I visit 
you all over the world.
Menno, als slag van onze roeiploeg waar de debatten over de verzorgingsstaat heftiger 
waren dan de trainingsarbeid, heb je het voortouw genomen in het doctorschap. Rutger, 
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als grootste non-conformist bewonder ik het feit dat je nog steeds een corrupt Irakees 
voetbalteam onder je hoede hebt. Rolf: laten we vooral op zomerse vrijdagmiddagen 
van het gerimpelde uitzicht (of het biertje) op het Leidseplein blijven genieten. Chris, 
ben jij de volgende van ons die promoveert?
Rolf, door jou geniet ik minder van cheeseburgers, maar hebben we wel de sterren zien 
schitteren in de Crucible. Tynke, van serieuze gesprekken tot de zacht geperste sinaasap-
pelsap van de Registratiekamer: we hebben een geweldige tijd gehad in de Marsstraat.
Daniël: old friends never die. Bijzonder dat we elkaar na 30 jaar nog steeds regelmatig 
zien. Arwin, dit proefschrift begon als Beoslo, maar insiders rekenden op de sprint van 
Dekseldraaier. Bedankt voor de vriendschap en het delen van, voor andere soms onbe-
grijpelijke, hersenkronkels en spelplezier. Charly: eigenzinnig, scherpzinnig, ad rem en 
altijd jezelf. Pas je op voor dronken Polen? Beuk, dankzij Jock Stewart en Sean O’Farrell 
zijn we vrienden geworden. Bedankt voor je steun, relativering en humor de afgelopen 
jaren. Harrold, het is uniek om een vriend te hebben als jij die vandaag als paranimf 
naast mij staat. Van de Hallucinogenic Toreador in St. Petersburg tot de pitjes in de 
143 – we hebben nog wat roem af te kloppen. Wat zei je ook al weer over vakanties en 
verstandige jongens in het dankwoord van jouw proefschrift?
Lief broertje, Daan, ik denk dat er weinig mensen zoveel ontbeten hebben als wij, en wij 
kunnen zeggen dat we een afspraak hebben voor de olympische spelen van 2054. Je 
bent een geweldige broer met een goed gevoel voor humor. Lief zusje, Wiedeke, je bent 
een veelzijdige en bijzondere zus. Je bent er eigenlijk altijd, zonder erom te hoeven 
vragen. Waar je ook bent Wied, ik ben trots op je. Lieve papa en mama, bedankt voor 
alle grote en kleine dingen die jullie als ouders allemaal voor mij gedaan hebben. Voor 
de stimulerende, vrije omgeving waarin wij zijn opgegroeid. Mam, jouw enthousiasme 
voor de farmacologie heeft zeker een rol gespeeld bij mijn studiekeuze, evenals papa’s 
inzet voor de wetenschap. Het is ﬁ jn om altijd een thuisfront te hebben waar je op kunt 
bouwen en steunen. 
Lieve Marjan, toen ik je weer tegen ben gekomen heb je me erg geholpen in het leren 
stellen van prioriteiten. Jij hebt nu een grote voorsprong genomen op al die andere 
punten; ik zie er naar uit die ruimte met jou te gaan invullen. Jij.
Bedankt.
Sander
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Curriculum vitae of Sander Borgsteede
Sander Diederik Borgsteede was born in Emmeloord, the Netherlands on November 13, 
1973. He grew up in Lelystad, and completed his pre-university education at the Almere 
College in Kampen, 1992. Subsequently, he went to Groningen to study Pharmacy. During 
these years he also worked as a travel guide for Vinea youth holidays and as a teaching 
assistant for the Department of Social Pharmacy and Pharmacoepidemiology. In the 
same Department he performed his Master’s thesis on ‘Differences between clinical tri-
als and daily practice’ and a three-month project on ‘Drug surveillance on Curaçao’. After 
obtaining an MSc in pharmacy in 1997, he worked one year for the Netherlands Asthma 
Foundation on ‘The Dutch hypothesis in its scientiﬁ c context: the development of a di-
sease concept in pulmonology’. In August 2000 he obtained his Pharmacist’s Degree and 
started a project on end-of-life care in general practice at the Department of Public and 
Occupational Health of the EMGO Institute, VU University Medical Center, Amsterdam. 
Since October 2002 Sander has combined research with daily practice in a community 
pharmacy in the Venser Apotheek, Duivendrecht. From 2005 onward he has also been 
working as a University Teacher at the Department of Clinical Pharmacology and Phar-
macy of the VU University Medical Center. Since November 2006 he has participated in a 
project to improve drug information for patients who are being dismissed from the Sint 
Lucas Andreas Hospital, Amsterdam. He will defend his thesis ‘End-of-life care in general 
practice in the Netherlands’ on December 22, 2006. 
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